Directed Evolution of DNA Polymerases for Advancement of the SeSaM Mutagenesis Method and Biotransformations with P450 BM3 Monooxygenase by Kardashliev, Tsvetan Dinkov
  
 
 
 
 
 
 
 
 
 
Directed Evolution of DNA Polymerases for 
Advancement of the SeSaM Mutagenesis Method 
and Biotransformations with P450 BM3 
Monooxygenase 
 
 
 
 
Von der Fakultät für Mathematik, Informatik und Naturwissenschaften der RWTH 
Aachen University zur Erlangung des akademischen Grades eines Doktors der 
Naturwissenschaften genehmigte Dissertation 
 
 
vorgelegt von 
 
Master of Science (MSc) 
Molecular Life Science 
 
Tsvetan Dinkov Kardashliev 
aus Stara Zagora, Bulgarien 
 
 
 
Berichter:       Universitätsprofessor Dr. rer. nat. Ulrich Schwaneberg 
Universitätsprofessor Dr. rer. nat. Lothar Elling 
 
 
Tag der mündlichen Prüfung:   29. Januar 2015                                                                                          
 
Diese Dissertation ist auf den Internetseiten der Hochschulbibliothek online verfügbar 
  Abstract 
1 
ABSTRACT 
Directed evolution is a powerful algorithm to tailor proteins to needs and requirements in 
industry. Error-prone PCR (epPCR) based methods are the “golden standard” in random 
mutagenesis due to their robustness and simplicity. Despite their wide use in protein 
engineering experiments, epPCR methods are limited in their ability to generate highly 
diverse mutant libraries. This is due to 4 reasons – 1) the redundancy of the genetic code, 2) 
the low mutagenic frequency and lack of subsequent nucleotide exchanges in a standard 
epPCR library, 3) the tendency of polymerases to introduce mutations preferentially in 
certain DNA sequence contexts and 4) the innate transition bias of DNA polymerases leading 
to conservative amino acid exchanges. Sequence Saturation Mutagenesis (SeSaM) is a 
random mutagenesis method that has been developed to overcome the aforementioned 
limitations. SeSaM complements the mutagenic spectrum of epPCR by introducing 
transversions and consecutive nucleotide substitutions. Indeed, SeSaM libraries enriched in 
consecutive nucleotide subsitutions and transversion mutations were reported; however the 
frequency of occurrence of such mutations remains low. In particular, the fraction of 
consecutive transversion mutations accounted for a meager 4.6 %. The increase of the 
fraction of consecutive transversion mutations is critical in order to advance the SeSaM 
technology and access previously unattainable sequence space. This can be achieved by the 
use of DNA polymerases adapted to the requirements of the SeSaM method. The biggest 
challenge is posed in SeSaM step 3 in which the employed DNA polymerase must be able to 
elongate consecutive transversion mismatches formed between degenerate base analogs in 
the primer strand and standard nucleobases in the template strand. The most feasible 
solution to this problem is to engineer a DNA polymerase capable of efficient consecutive 
transversion mismatch elongation. The latter has been the main objective pursued in 
CHAPTER I of this doctoral thesis. The work towards fulfilling this goal included identification 
from genetic databases of 4 potential candidates from the Y-family of DNA polymerases 
(exclusively involved in translesion DNA synthesis), followed by expression and preliminary 
biochemical characterization of the putative polymerases, and, finally, selection of one 
candidate (Dpo4 from Sulfolobus solfataricus) for directed evolution. The protein 
engineering work comprised development of a novel high-throughput screening system for 
non-processive DNA polymerases, screening and identification of Dpo4 variants capable of 
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consecutive mismatch elongation. Finally, the most promising polymerase mutant was used 
in the preparation of a model SeSaM library. Direct comparison to data generated using an 
earlier version of the SeSaM protocol indicated a marked improvement in frequency of 
consecutive transversion mutations (relative increase of 40 %) in the libraries prepared with 
the identified Dpo4 polymerase mutant. The identified polymerase variant enabled a 
significant advancement in consecutive transversion generation and, consequently, of the 
SeSaM random mutagenesis method.  
In CHAPTER II of this dissertation, P450 BM3 monooxygenase was studied in the context of 
regioselective biotransformations of benzenes with isolated enzyme (P450 Project I) and as a 
whole cell catalyst (P450 Project II). P450 BM3 is a promising biocatalyst which enables 
challenging chemical reactions, e.g., insertion of an oxygen atom into a non-activated C-H 
bond. In P450 Project I, P450 BM3 in purified form was employed in the synthesis of mono- 
and di-hydroxylated products from six monosubstituted benzene substrates. A P450 BM3 
mutant (P450 BM3 M2 (R47S/Y51W/A330F) proved to be promiscuous and highly 
regioselective (95 % - 99 %) hydroxylation catalyst achieving good overall yields (up to 50 % 
with benzenes and ≥90 % with phenols). The developed process showed promising potential 
for sustainable synthesis on a semi-preparative scale of valuable chemical precursors, i.e., 
phenols and hydroquinones, even prior to bioprocess optimizations. Nevertheless, 
productivity, especially with non-halogenated substrates, would need to be further 
improved. Especially, whole cell cofactor regeneration systems have to be developed in 
order to bring this attractive synthesis route closer to industrial exploitation. The issue of 
cofactor regeneration served as a stimulus to initiate follow-up project dealing with whole 
cell catalysis with P450 BM3. The requirement for expensive reduced cofactor (NAD(P)H) in 
equimolar amounts is a major disadvantage of P450 BM3 preventing its wider use in organic 
synthesis. The NAD(P)H dependency of P450 BM3 necessitates the use of whole cells in 
preparative synthesis in order to achieve cost-efficient cofactor regeneration. However, the 
semi-permeable nature of the outer membrane of industrially relevant bacteria such as E. 
coli limits their use as whole cell systems. The issue of substrate permeability in whole-cell 
biocatalysts has been addressed in this thesis by co-expressing a large passive diffusion 
channel, FhuA Δ1-160, in the outer membrane of E. coli. The influence of the channel protein 
on P450 BM3-catalyzed conversions of 2 monosubstituted benzenes has been investigated in 
P450 Project II. Preliminary experiments indicated that the co-expression in the outer E. coli 
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membrane of FhuA Δ1-160 had a positive effect, possibly of global nature, on the mass 
transfer in whole cell biotransformations (up to 10-fold relative increase of product titers). 
The presented drawback of whole-cell biocatalysis has not been extensively addressed to 
date, and with these preliminary and promising first results, we hope to entice further 
interest in the topic. 
In summary, this doctoral thesis addresses three questions from the related fields of protein 
engineering and biocatalysis:  
1) Advancement of diversity generation methods in directed protein evolution;  
2) Establishing biocatalytic process for oxy-functionalization of generally unreactive 
aromatic C-H bonds;  
3) Developing a strategy to improve the mass transfer across the outer membrane of E. coli 
in whole cell oxy-functionalization of aromatic compounds. 
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1. Introduction to protein engineering 
In the past 25 years, biocatalysts have increasingly been used in industrial processes, e.g., 
the production of specialty and fine chemicals, pharmaceuticals, vitamins, detergents, 
cleaning agents, biofuels, and in the refinement of textiles, leather and paper, among others 
(Erickson et al., 2012; Philp et al., 2013; Soetaert and Vandamme, 2010). Naturally occurring 
enzymes have evolved to suit the needs of the organisms they are derived from and are 
usually not fit for direct application in industrial processes. Nevertheless, biocatalysts 
become increasingly important for industrial production of chemicals. Their full potential can 
be realized by adapting promising enzymes to the needs of industry by means of protein and 
bioprocess engineering (Bommarius et al., 2011; Bornscheuer et al., 2012; Lan Tee and 
Schwaneberg, 2007). Laboratory protein evolution relies heavily on methodologies for 
generation and screening of mutants libraries (Ruff et al., 2013a; Shivange et al., 2009; Wong 
et al., 2006a). In line with some of the main objectives of this thesis, methods for genetic 
diversity generation including approaches to mutant library creation, drawbacks, advantages 
and remaining challenges are discussed in the following sections.  
1.1. Laboratory evolution 
The understanding of how life on Earth developed has been vastly redefined since the 19th 
century. Despite early criticism (Hull, 1973), Charles Darwin‘s theory of evolution from 1859 
is now a widely accepted idea that not only helps to explain how the tremendous diversity of 
life forms on Earth has developed but also to inspire numerous new scientific concepts 
(Bowler, 1996). For instance, natural evolution has served as a pivotal point for the 
establishment of the modern field of laboratory protein evolution (Bornscheuer and Pohl, 
2001; Jaeger et al., 2001). The idea that biological molecules can be tailored to one‘s needs 
by iterative cycles of mutation and selection has been postulated as early as the 1960s (Mills 
et al., 1967) and since the early 1990s, with the advancement of methods for in vitro DNA 
synthesis and amplification, cloning and recombinant protein expression (Bornscheuer et al., 
2012), laboratory evolution really took off. Until the present moment, protein engineering 
has been applied on numerous occasions to adapt biocatalysts for industrial and medical 
applications (Arango Gutierrez et al., 2013; Bommarius et al., 2011; Gomes et al., 2012; Zhu 
et al., 2010).  
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A typical directed evolution experiment comprises three main steps (Fig. 1). Every laboratory 
evolution campaign starts with generation of genetic diversity of a target sequence by 
random mutagenesis, focused mutagenesis or recombination of highly homologous 
sequences (Ruff et al., 2013b). The functionally expressed genetic diversity is then screened 
on protein level using a validated high-throughput screening or selection system. Finally, the 
genes encoding improved variants are isolated, and, if required, subjected to further rounds 
of diversity generation and screening until the desired improvement of the target property is 
achieved. A successful evolution campaign should have its final goal set such that the desired 
function is physically, biologically and evolutionally plausible (Lan Tee and Schwaneberg, 
2007). When it comes to technical considerations, the successful outcome is largely 
determined by two factors - the quality of the mutant libraries and the robustness, 
throughput and similarity of the employed screening system to the “real-life” application. 
 
Figure 1. Schematic illustrating the main steps of a directed evolution campaign: 1) genetic diversity 
generation; 2) screening of a pool of protein variants; 3) isolation of gene(s) encoding mutants with 
improvement in the desired characteristics. The outlined procedure is usually performed in an 
iterative manner. 
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1.2. Challenges in directed protein evolution 
The limitations in protein engineering can be classified in two categories - challenges of 
diversity generation and challenges arising from the limited screening capabilities of 
commonly used screening platforms. 
1.2.1. The importance of diversity generation 
The diversity challenge of directed protein evolution can be illustrated through a simple 
example in the context of random mutagenesis. In order to thoroughly randomize a short 
polypeptide (say a 50-mer) at every position and to all other 19 amino acids, a protein 
sequence space of 2 x 1050 unique variants is generated. A library of such magnitude covers 
the theoretically attainable genetic complexity. Consequently, this diversity provides the 
maximal number of possible “adaptive pathways” and provides the possibility to circumvent 
local fitness minima (Wong et al., 2006a). In contrast, mutant libraries that do not cover the 
complete genetic diversity (which is the realistic output of the majority of random 
mutagenesis methods (Verma et al., 2012)) will only yield phenotypes with small or medium 
improvement of fitness. This largely disallows reaching an absolute optimum (Wong et al., 
2006a). Thus, mutagenesis methods that can render libraries with broad diversity are 
necessary to identify rare and beneficial variants in laboratory evolution experiments. At 
present most methods, especially those for random mutagenesis, have limited potential to 
cover the theoretical genetic sequence space (Zhao et al., 2014). 
1.2.1. Challenges and requirements for screening of mutant libraries 
On the protein level, the screening of even a fraction of the theoretically attainable genetic 
diversity is understandably a resource- and labor-intensive process. Even the most advanced 
screening and selection systems (e.g., yeast/ E. coli hybrid systems (Stynen et al., 2012), 
molecular display (Bratkovič, 2010) and FACS (Agresti et al., 2010; Ruff et al., 2012a)) are 
limited in their throughput. A screening rate of 107 events per hour can be seen as the upper 
limit of screening systems (Tolia and Joshua-Tor, 2006). Irrespective of its throughput, every 
screening or selection system needs to fulfill a number of criteria in order to be considered 
suitable for application in laboratory evolution. Firstly, these methodologies should be 
reproducing the “real-life” application conditions as close as possible in order to ensure the 
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identification of protein variants with desired properties. For example, the use of a dummy 
substrate in laboratory evolution, e.g., employing a fluorescently labelled disaccharide that 
holds resemblence to the more complex target polysaccharide, often results in a quick 
identification of protein mutants with improved kinetic parameters for the molecule used in 
screening. However, similar or decreased performance with the complex substrate is often 
observed (Leemhuis et al., 2009). Secondly, the screening system must ensure maintenance 
of the linkage between genotype and phenotype during the entire screening procedure. If 
this connection is lost, it is impossible to identify the amino acid exchanges in the target 
protein contributing to the improvement of its fitness. Thirdly, a validated screening system 
should give reproducible results and confer a low coefficient of variation to the overall 
process. Additional desired characteristics of a screening system are an ultra high-
throughput, possibility for automation and low costs in terms of time and resources invested 
in the process. Current state-of-the-art screening technologies fulfill these criteria but 
remain largely limited to sampling only a fraction of the size of diverse mutant libraries 
(Leemhuis et al., 2009; Ruff et al., 2013a; Lan Tee and Schwaneberg, 2007). 
1.3. Strategies for laboratory evolution 
Laboratory evolution of proteins is generally conducted by one of three general strategies 
(Bommarius et al., 2011; Hilvert, 2013; Ruff et al., 2013a; Tee and Wong, 2013) – 1) rational 
protein design (employing focused mutagenesis and, in rare cases, de novo protein design), 
2) directed evolution (employing random mutagenesis) and 3) shuffling of homologous 
sequences (employing DNA recombination). It should be noted that, these strategies for 
protein engineering differ in the way genetic diversity is generated; however they are similar 
in other aspects such as the requirement for a high-throughput screening system and the 
follow-up steps after identification of protein variants with improved properties. Statistical 
data showing the popularity of different mutagenesis strategies for the 5-year period 
between 2008 and 2013 is presented in Fig. 2. 
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A)  
 
 
B)    
Figure 2. Mutagenesis methods embraced in 100 randomly selected papers on protein engineering in 
the period 2011 - 2013. A) Distribution according to diversity generation strategy, also reflecting used 
approach (random vs rational); B) Percentage of usage of the most frequently utilized methods 
classified as random mutagenesis or focused mutagenesis methods ( adapted from Tee and Wong, 
2013).  
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1.3.1. Rational mutagenesis 
Rational protein design is a knowledge-driven mutagenesis approach that heavily relies on 
available information of the target protein. Empirical data from structural, biochemical and 
biophysical characterizations, previous mutagenesis studies, high-resolution crystal 
structures and computational predictive algorithms are used in order to identify potential 
regions within the protein chain for localized mutagenic studies. Such regions can be 
partially or thoroughly randomized in a site-specific manner to generate focused libraries 
with a finite size that can be screened using a validated screening method. This approach is 
particularly helpful for elucidation of structure/function relationships in proteins but has 
been proven useful in generation of mutants with improvement in desired properties as well 
(Bornscheuer and Pohl, 2001; Shivange et al., 2009). From the viewpoint of the 
experimentalist, rational design translates into reduced effort and increased efficiency of 
identifying improved variants (Lutz, 2010). This approach has the potential to largely 
eliminate the need for screening assays with ultra-high-throughput, to provide a framework 
to predict and rationalize experimental findings and, consequently, to alter the field of 
protein engineering from discovery-based to hypothesis-driven (Lutz, 2010). Despite its 
enormous potential, the use of this approach to engineer proteins remains limited because 
of the number of pre-requisites it requires (e.g., detailed structural and functional 
knowledge of the target protein) and the vast computational power needed to predict the 
effect of structural changes on the functional performance of complex biopolymers. This is 
reflected by the fact that rational design mutagenesis is the methodology of choice in less 
than a quarter of recent protein engineering studies (Fig. 2A). A few of the most prominent 
examples of methods for focused mutagenesis are discussed in the next paragraphs. 
1.3.1.1. QuikChange® PCR 
The diversity generation technique in more than half of all rational design studies (Fig. 2A) is 
a whole plasmid PCR amplification method termed QuikChange® PCR (Wang and Malcolm, 
1999). This method enables a thorough or partial exchange of a single residue in a protein 
sequence to any other amino acid or a subset of amino acids in a single step. It employs 
complementary (or partially complementary) primer pair that harbors a sense and antisense 
mutant codon. A high-fidelity DNA polymerase is used to amplify the entire plasmid carrying 
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the target sequence. The resulting “nicked” double stranded DNA, i.e., containing two non-
overlapping DNA breaks, can be directly transformed into competent cells after enzymatic 
digestion of the template plasmid (using DpnI endonuclease) and the non-overlapping 
breaks are repaired in vivo in order to obtain a circular mutated plasmid (Fig 3A). Derivatives 
of this classic method have been developed which enable mutli site-directed mutagenesis (of 
up to 5 sites) often at the cost of decreased mutagenic efficiency (Tee and Wong, 2013).  
1.3.1.2. Overlap-extension PCR (oePCR)  
oePCR (Fig. 2B) is the second most common approach for diversity generation in rational 
design studies (Urban et al., 1997). This method employs two primer pairs whereas one 
primer from each pair carries the mutagenic codon. The four primers are used in PCRs to 
obtain double stranded DNA products that are mixed and hybridized to form two 
heteroduplexes, each of which contains the desired mutagenic codon. The overlapping 3’- 
and 5’-ends of each heteroduplex are filled by application of a polymerase then a second 
PCR reaction with the non-mutated primer pair is performed to amplify the mutated DNA. 
1.3.1.3. OmniChange 
A promising alternative to QuikChange® and oePCR is the method OmniChange (Dennig et 
al., 2011). OmniChange employs sets of primers containing phosphorothioated (PTO) 
nucleotides at their 5`-ends and harbor the randomization codon in the unmodified part to 
amplify fragments that constitute the entire vector and target gene sequence (Fig. 3C). Due 
to the specific primer design these fragments have partially identical sequences at their ends 
which, upon cleavage of the PTO fragments, become complementary and hybridize to each 
other. The DNA hybrids can be directly transformed in competent cells where the DNA nicks 
are repaired. Circular plasmid harboring one or more modified codons (depending on 
experimental design) is eventually rendered. Using this method, up to five sites have been 
randomized with excellent mutagenic efficiency (100% reported) and coverage of the 
theoretical sequence space (NNK coverage of 65 to 85% from analysis of 48 clones is 
reported).  
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A)   B)                 C) 
Figure 3. Graphic representation of selected methods for diversity generation in rational protein 
design. A) QuikChange®; B) Overlap-extension PCR; C) OmniChange. 
 
1.3.2. Directed protein evolution  
Directed evolution is a widespread and well-established approach to modify biomolecules to 
meet application criteria in chemistry and biology (Jaeger et al., 2001; Obeid et al., 2011; Lan 
Tee and Schwaneberg, 2007). In contrast to rational protein engineering approach which is 
largely knowledge-driven, directed protein evolution aims at mimicking the natural evolution 
cycle and relies on random insertion of mutations in the target sequence to generate large 
number of target protein variations. Therefore, structural or functional information about 
the target molecule are not a pre-requisite for carrying our directed evolution. In random 
mutagenesis, libraries are produced and subjected to screening using a high-throughput 
screening system in order to identify variants with improvement in the desired performance 
parameters. Iterative cycles of random mutagenesis and screening are usually necessary to 
identify biomolecules that meet application criteria. 
Random mutagenesis libraries can be generated using a variety of methods. These can be 
generally grouped in 4 categories (Wong et al., 2007a) - enzyme-based methods, chemical 
methods, whole cell methods and hybrid methods (Fig. 4). Enzymatic methods most 
frequently employ DNA polymerases and to a lesser extend other DNA modulating enzymes 
CHAPTER I. Engineering of DNA Polymerases for Application in Directed Protein Evolution 
  Introduction 
 
17 
in order to introduce mutations in DNA strands. The techniques that are classified in the first 
category are the most versatile and commonly used in random mutagenesis. This is due to 
their robustness and simplicity. The “golden standard” in this category is the error-prone 
PCR (epPCR) techniques.  In chemical methods, mutations are usually introduced through 
DNA-modifying agents or degenerate nucleotide analogues and whole cell methods rely on 
engineered “mutator strains” to introduce nucleotide substitutions in vivo. Most of the 
aforementioned methods fail to generate truly diverse libraries on the protein level (Verma 
et al., 2012) which in turn necessitates the advancement of existing technologies and the 
development of completely new strategies for random mutagenesis. A few examples of 
random mutagenesis methods are discussed in more details in the following sections. 
 
 
Figure 4. Classification of random mutagenesis methods (adapted from Tee and Wong, 2013; Wong 
et al., 2006a) 
 
1.3.2.1. Error-prone PCR (epPCR) 
epPCR introduces mutations by altering the fidelity of the DNA polymerase (Pritchard et al., 
2005). The fidelity of polymerases can be affected by modulating the PCR mastermix 
composition, e.g., by addition of divalent ions such as Mn2+ in the or by disbalancing dNTP 
concentrations (Wang et al., 2006a). Sub-optimal reaction conditions can lead to 
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misincorporation of nucleotides during the reaction and yield randomly mutated products. 
In either of the epPCR methods, the frequency of incorporation of nucleotide analogs and, 
consequently, the number of errors introduced into the sequence can be tuned by the 
composition of the mastermix. In a stardard directed evolution experiment by epPCR, the 
mutational frequency is normally set to 1 - 3 base pair substitutions per kilobase of DNA 
(Zhao et al., 2014). The relative simplicity of use and versatility makes epPCR the most 
widely applied mutagenesis method. However, epPCR has its drawbacks. Limitations and 
drawbacks of methods for diversity generation are discussed later in the introductory 
section. 
1.3.2.2. DNA shuffling and staggered extension process (StEP) 
DNA shuffling is an enzyme-based recombination method in which genes with high degree of 
homology are random cleavaged then reassembled in a PCR whereas DNA fragments serve 
to prime each other’s elongation (Stemmer, 1994). Recombination occurs when a fragment 
derived from one gene anneal to fragments from another gene, causing a crossover event. 
This method is generally robust, flexible and the tends to remove non-essential mutations by 
back-crossing to parent, however it suffers from low crossover rate, bias to crossovers in 
highly homology regions and high percentage of remaining unmutated DNA which limits its 
use. 
A variation of the DNA shuffling which requires no fragmentation of parental genes is 
termed StEP (Zhao et al., 1998) . This method uses flanking primers for partial replication of 
target sequence with very short extension times. Short extensions generate truncated DNA 
fragments which are separated from template strand and re-anneal to a different template 
copy acting as primers. The growing DNA strand binds to different templates multiple times 
and accumulates sequences from different parent genes. Two different low-fidelity 
polymerases are routinely used in order to reduce mutational bias, such as, Taq and 
Mutazyme, which has partially complementary mutational spectra. Even though this method 
has certain advantages over DNA shuffling, it largely shares the drawbacks of the classical 
homologous recombination method. 
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1.3.2.3. Sequence Saturation Mutagenesis (SeSaM)  
SeSaM is a four-step chemo-enzymatic mutagenesis method that is capable of targeting all 
nucleotide positions in a target sequence with equal probability and independently of 
polymerase bias and with the possibility of introducing subsequent nucleotide exchanges 
(Wong et al., 2004, 2008b). This method is of special significance for the objectives of this 
thesis; therefore it is extensively discussed in a dedicated section (section 1.4). 
1.3.3. Limitations of random mutagenesis methods 
Three reasons for the limited diversity of most random mutagenesis methods can be 
pinpointed. 
Firstly, the obtainable genetic diversity by methods that sporadically introduce transition 
(i.e., purine-to-purine or pyrimidine-to-pyrimidine) nucleotide exchanges in a sequence (the 
case with most existing methods (Wong et al., 2006a)) leads to preservation of chemical 
functionality on the protein level. This is a consequence of the organization of the genetic 
code (Wong et al., 2006b, 2007a). A transition biased library has been shown to contain half 
the diversity on protein level that could be theoretically obtained in a transversion (i.e., 
pyrimidine-to-purine nucleotide exchange or vice versa) biased library. In quantitative terms, 
a transition biased library contains only 11% of the effective protein space. In a transversion 
biased library, the same accounts for 21.5% of the effective protein space (Wong et al., 
2007b).In addition, a transition biased library contains 34.9% silent mutations while in a 
transversion biased library there are only 15.3% silent mutations (Wong et al., 2007b). The 
average number of unique amino acid substitutions per protein position in a transition 
biased library is 2.2 versus 4.7 for the transversion biased library (Wong et al., 2007b). 
Secondly, random mutagenesis methods seldom introduce subsequent nucleotide 
exchanges. This causes a major limitation in terms of obtainable genetic diversity as only 
40% of the theoretical diversity can be explored by single point mutations (Wong et al., 
2006c, 2007a). The contribution of subsequent nucleotide exchanges is well illustrated in Fig. 
5 on the example of the codon TTA (encoding Leu). A maximum of 9 different codons can be 
obtained by targeting one nucleotide in this codon; this number increases by a factor of 5 
(45 possible amino acid substitutions) with two nucleotide exchanges in the same codon. 
Thirdly, methods that employ DNA polymerases result in uneven distribution of mutations 
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over the gene sequence and generation of mutational “hotspots” (Rogozin and Pavlov, 
2003a). 
Efforts to alleviate the limitations of epPCR have resulted in the development of the 
Sequence Saturation Mutagenesis (SeSaM) method (Wong et al., 2004). In the context of 
random mutant library generation, the Sequence Saturation Mutagenesis (SeSaM) 
represents the most advanced random mutagenesis method. By means of SeSaM, libraries 
enriched in transversion nucleotide exchanges can be generated. Transversion mutations 
translate into much higher diversity on the protein level (Wong et al., 2007b). An additional 
beneficial feature of this mutagenesis method is its ability to introduce subsequent 
nucleotide substitutions which further increases the obtainable diversity on DNA and 
subsequently on protein level(Wong et al., 2007c).  
The decisive factor in the further advancement of SeSaM is the identification of a DNA 
polymerase specifically adapted to the requirements of this mutagenesis method. Fulfilling 
this objective would enable faster, efficient and more cost-effective mutagenesis services for 
industrial biotechnology in general. The advancement has been a major goal of this thesis. 
Before presenting the achievements made in this direction, a comprehensive description of 
SeSaM and DNA polymerases is given in the followin sections of this chapter. 
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Figure 5. The importance of subsequent nucleotide substitutions is demonstrated using TTA codon 
(encoding leucine) as an example. The theoretically obtainable amino acid diversity in case of a single 
nucleotide exchange per codon (top) and two nucleotides exchanges in the same codon (bottom) are 
shown. Two nucleotide substitutions result in 5-fold increase of attainable diversity on protein level. 
The figure has been kindly provided by SeSaM Biotech GmbH (adapted from http://www.sesam-
biotech.com/science-and-technology/sesam).  
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1.4. The Sequence Saturation Mutagenesis (SeSaM) method 
Sequence Saturation Mutagenesis (SeSaM) is a random mutagenesis method specifically 
developed to overcome the limitations of existing error-prone PCR (epPCR) protocols. SeSaM 
is advantageous with respect to 1) elimination of mutagenic “hotspots”, 2) increase in 
frequency of subsequent nucleotide substitutions, 3) control over the mutational bias 
through the utilization of degenerate base analogs and, consequently, 4) the prospect of 
generating transversion enriched mutant libraries. These advanced features lead to 
chemically diverse mutant libraries on the protein level, essentially making SeSaM a 
complementary technology to transition biased epPCR mutagenesis methods.  
The advancement of the SeSaM technology, especially with regard to increasing the fraction 
of consecutive mutations, was a main objective of this thesis. In order to fully grasp the 
essence of the method, a comprehensive overview of the SeSaM protocol at its state prior to 
the beginning of this thesis as well as the remaining challenges are deliberated in this 
section.   
1.4.1. Overview  
Directed evolution is a powerful algorithm for tailoring proteins to practical needs and 
requirements. Error-prone PCR (epPCR) based methods are the standard for random 
mutagenesis due to their robustness and simplicity (Rasila et al., 2009). Despite some 
impressive success stories (Glieder et al., 2002; Zhu et al., 2010), these methods are 
generally limited in their ability to generate highly diverse mutant libraries for the 4 reasons: 
the redundancy of the genetic code; commonly low mutagenic frequency in epPCR libraries 
which disallows subsequent nucleotide exchanges (Ruff et al., 2013a); the innate transitional 
bias of DNA polymerases used in epPCR (transition mutations typically lead to conservative 
amino acid substitutions, for example a hydrophobic to hydrophobic amino acid exchange) 
(Shivange et al., 2009; Wong et al., 2006a); mutagenic “hot spots”, due to the propensity for 
polymerases to introduce mutations preferentially in certain DNA sequence contexts 
(Rogozin and Pavlov, 2003b). Taken together, these factors significantly limit the chemical 
diversity of random mutagenesis methods (Shivange et al., 2009; Wong et al., 2007a). A 
good indication for the latter is the observation that on average only 7 of the 19 possible 
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amino acid substitutions are typically achieved by epPCR (Rasila et al., 2009). To evaluate the 
limitations and facilitate the selection of a suitable random mutagenesis method, 
computational tools such as the mutagenesis assistant program (MAP) (Wong et al., 2006b) 
and its improved version, MAP3D, have been developed. MAP3D is implemented on a server 
(http://map.jacobs-university.de/map3d.htmL) (Verma et al., 2012) and can be used as a 
benchmarking system for random mutagenesis methods on the protein level by comparing 
amino acid substitution patterns. 
Sequence Saturation Mutagenesis (SeSaM) is a chemo-enzymatic mutagenesis method that 
aims at eliminating most limitations of current state-of-the-art random mutagenesis 
techniques. SeSaM is a four step process that employs selective chemical fragmentation of 
DNA, phosphorothioate and degenerate nucleotide analogs as well as several enzymatic 
steps in order to introduce nucleotide exchanges with a desirable mutational bias, 
distribution and frequency. In step 1 of SeSaM, a pool of single-stranded DNA (ssDNA) 
fragments with various gene lengths is generated in a PCR that employs a biotin-labeled 
forward primer and a pre-defined mixture of standard and cleavable phosphorothioate 
nucleotides. Phosphorothioester bonds within the resulting PCR products can be cleaved 
selectively in the presence of iodine, under alkaline conditions and at elevated temperature. 
The ssDNA fragments are subsequently isolated from non-biotinylated DNA strands using 
streptavidin-coated magnetic beads. In step 2, the purified ssDNA fragments are “tailed” 
with a degenerate base of choice in a reaction catalyzed by terminal deoxynucleotidyl 
transferase (TdT). In step 3, the “tailed” ssDNA fragments are elongated to full gene length. 
Step 3 amplicons serve as templates in step 4 where the incorporated nucleotide analogs are 
replaced by standard nucleotides in a final PCR. The two preliminary experiments necessary 
for SeSaM template generation and determination of the optimal concentration of 
phosphorothioate nucleotides (Fig. 6) as well as SeSaM steps 1 to 4 (Fig. 7) are shown below. 
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Figure 6. Illustration of the two preliminary experiments performed prior to SeSaM step 1 to 4. In 
“Preliminary Experiment I”, linear DNA templates used step 1 and step 3 of SeSaM are generated. 
These templates harbor artificial flanking sequences that come into action in SeSaM step 1 and 
SeSaM step 4. In “Preliminary experiment II”, the optimal concentration of phosphorothioate 
nucleotides to use in step 1 is determined. This ensures that fragments with uniform size distribution 
spanning the entire gene sequence are generated in the step 1 of SeSaM. (adapted from Ruff et al., 
2014)  
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Figure 7. Schematic of the SeSaM method comprising four steps. SeSaM step 1: Generation of ssDNA 
fragment pool with random length distribution; SeSaM step 2: Enzymatic elongation of single 
stranded DNA “tailed” with degenerate base; SeSaM step 3:  Synthesis of the full length gene; SeSaM 
step 4: Replacement of degenerate base (adapted from Ruff et al., 2014) 
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A SeSaM library can be completed in two to three days. Despite the increased workload in 
comparison to epPCR methods, SeSaM is a relatively economical and straightforward to 
perform. Notably, through SeSaM three of the four limitations of most random mutagenesis 
methods are eliminated, i.e. each codon in a given gene is targeted with equal probability, 
independently of polymerase bias and with a high probability of consecutive nucleotide 
exchanges. In SeSaM libraries, up to 30% of all substitutions are consecutive, which leads to 
expansion of the obtainable amino acid substitution pattern of epPCR (Mundhada et al., 
2011a). The significance of SeSaM is proven by several success stories (Patents: 
WO2012119955A1; WO2012028709A3; WO2012017008A1) and reports on evolved 
enzymes such as proteases (Li et al., 2012; Martinez et al., 2012) and a phytase (Shivange et 
al., 2012).  
The mutational bias introduced by SeSaM is typically governed by the choice of nucleotide 
analog employed in step 2. Several degenerate bases (Mundhada et al., 2011a; Ruff et al., 
2012b; Wong et al., 2008b) have been used to control the ratio of transition to transversion 
mutations introduced in SeSaM libraries, with dPTP (6-(2-deoxy-ß-D-ribofuranosyl)-3,4-
dihydro-8H-pyrimido-[4,5-C][1,2]oxazin-7-one) being the most frequently used one. dPTP is 
a pyrimidine base analog used to target adenine (A) and guanine (G) in DNA strands. The 
substitution of an A- or G-site with dPTP ultimately results in a transversion nucleotide 
exchange to thymine (T) or cytosine (C) (Fig. 8).  
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Figure 8. The obtainable mutational spectrum when dPTP is introduced at an A- (top) or a T- 
(bottom) site. In SeSaM-Tv-classic, dPTP is used to substitute A (or G, not shown in the figure) in 
order to obtain transversion-enriched libraries. This nucleotide analog is not used at T-sites (or C-
sites) as this would result in either nucleotide preservation or a transition that generates conserved 
amino acid substitution pattern and could be achieved by epPCR. (Ruff et al., 2012b). (taken from 
Ruff et al., 2014)  
  
More recently, dRTP (1-ß-D-ribofuranosyl-1,2,4-triazole-3-carboxamide), a purine analog, 
has been successfully employed in SeSaM to target T- and C-sites in DNA sequences and 
render exchanges to A and G (Ruff et al., 2012b). Thus, all four nucleotides in a DNA strand 
can be methodically exchanged by random mutagenesis. Coding and non-coding DNA 
strands can be independently targeted in step 1 and 2 to generate forward and reverse 
libraries. These can be used separately in step 3 or recombined in order to increase the 
mutational frequency of SeSaM libraries. In step 3, it is also crucial to utilize a DNA 
polymerase capable of elongation of mismatching primer-template DNA. Polymerases such 
as Vent (exo-), 3D1 (a chimera of three genes from the genus Thermus) have been used in 
this step. 3D1 polymerase, for instance, achieves up to 30% subsequent mutations when 
dPTP is used in SeSaM and can even “read” through a triple consecutive mismatch in in vitro 
assays (Agresti et al., 2010) and, in rare occasions, under application conditions (Mundhada 
et al., 2011a). In the last step of SeSaM, Taq polymerase is used in a nested PCR to 
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specifically amplify mutated DNA as well as to exchange the previously introduced 
degenerate base analogs with standard nucleotides. The PCR products of step 4 can be 
directly cloned in an expression vector by restriction cloning, although ligase-independent 
cloning methods such as PLICing (Blanusa et al., 2010a) are recommended in order to 
achieve higher cloning efficiency.  
1.4.2. Advancements of SeSaM in retrospect 
The development of the SeSaM protocol to its present status has been a decade-long, 
cumulative effort of a number of researchers. In the first publication of the series (Wong et 
al., 2004), the overall mutagenic strategy comprising 4 steps (Step 1: Generation of a pool of 
DNA fragments, Step 2: Enzymatic elongation of DNA fragments with degenerate bases, Step 
3: Full-length gene synthesis, and Step 4: Degenerate base replacement) was postulated. 
Validation by preparation of a model mutant library in which adenines were targeted and 
the base analog deoxyinosine (dITP, which pairs with cytosine) provided the first proof-of-
concept and gave hints for its remaining unrealized potential. This first study proved that 
SeSaM is a mutagenesis method that is completely independent of the mutational bias of 
DNA polymerases, and that it is capable of saturating or randomizing every targeted 
nucleotide position in a sequence. The authors reported that 49.0% of all mutations 
appeared at adenine positions (as anticipated) and, interestingly, 24.5% of the mutations 
occur at one or two nucleotides downstream of an adenine position. This observation 
implied that an additional feature of SeSaM could be, after further optimizations, the 
generation of subsequent nucleotide substitutions. This property had not been reported for 
any other random mutagenesis method. This interesting feature was addressed in a later 
study; however expansion of the mutational bias of SeSaM through employment of other 
degenerate or degenerate bases with different base-pairing preferences was pursued next. 
In 2008, the first transversion (Tv) enhanced random mutagenesis protocol (SeSaM-Tv) was 
reported (Wong et al., 2008b). Three degenerate nucleotides (dPTP, dKTP and dITP) were 
investigated in the context of SeSaM for preparation of mutant libraries with increased 
fraction of transversion nucleotide substitutions. While all three nucleotides were proven to 
be accepted by terminal transferase (SeSaM step 2) and confer the expected “read” (SeSaM 
step 3) and “write” (SeSaM step 4) properties, dPTP (6-(2-deoxy-ß-D-ribofuranosyl)-3,4-
dihydro-8H-pyrimido-[4,5-C][1,2]oxazin-7-one) was finally selected by the authors to 
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illustrate the propensity for SeSaM to generate transversion mutations. As anticipated, in 
the model SeSaM library in which Gs were specifically targeted with dPTP, the number of 
transversion mutations was enriched whereas G→T accounted for 16.22 - 22.58% and G→C 
for 6.38 - 9.69% of the observed mutations and even contained a fraction of subsequent 
nucleotide substitutions. The degree to which mutations unobtainable by other epPCR 
methods were generated was largely dependent on the combination of DNA polymerases 
used in the last two steps of SeSaM.  
SeSaM-Tv, a later version of the SeSaM protocol, rendered improvements especially in terms 
of frequency of consecutive nucleotide substitutions but also with regard to achieving a 
homogeneous fragment distribution pattern and improving the incorporation of multiple 
degenerate bases in SeSaM step 2 (Mundhada et al., 2011a). The increase of subsequent 
mutations was achieved by employing 3D1 polymerase in SeSaM step 3. The use of 3D1 
polymerase increased the overall fraction of consecutive mutations a factor of 1.4 and made 
possible for the first time the generation of two consecutive transversion nucleotide 
substitutions. On the protein level, this translated to 40% increase of hardly obtainable or 
unobtainable amino acid substitutions compared to epPCR methods. In quantitative terms 
the beneficial effect on diversity of transversion bias alone was ~2-fold, i.e. a transition 
biased library lead to half the diversity attainable by a transversions biased library (Wong et 
al., 2007b). The latter result indicated that a further increase in the fraction of consecutive 
(double and even triple) mutations is a highly desirable feature in SeSaM. Even though, in 
the SeSaM-Tv protocol (Mundhada et al., 2011a), consecutive mutations were enriched and 
even subsequent consecutive transversion mutations were achieved for the first time, the 
frequency of these remained suboptimal. This was illustrated by the fraction of consecutive 
transversion mutations that accounted for a meager 4.6% of all clones.  
The evolution of SeSaM from a mutagenesis method that eliminates the drawbacks 
associated with the polymerase bias to a technique capable of generating mutant libraries 
with tunable mutational bias and containing consecutive nucleotide substitutions was 
instrumental as both of these features ultimately resulted in previously unexplored protein 
diversity and opened new pathways to climb up the “fitness landscape” of protein 
optimization and adaptation. In particular, the effect of consecutive mutations and 
transversions, even though often overlooked by protein engineers, played a dominant role 
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for the increased diversity on protein level found in mutant libraries prepared by SeSaM. 
However, the low frequency of consecutive transversions which even though conferred a 
spectrum unattainable by conventional random mutagenesis also reinforced the significance 
of DNA polymerases for the successful outcome of SeSaM. Especially in SeSaM step 3 the 
employed polymerase played the leading role in determining the frequency of consecutive 
nucleotide substitution as well as the type of substitution obtained. 
1.4.3. The remaining challenge: SeSaM step 3 
SeSaM is a mutagenesis method that relies on the promiscuous base pairing ability of 
degenerate nucleotides to generate mutations. The nucleotide analogs are added to the 3`- 
end of single stranded truncated gene copies (SeSaM step 1 and 2) which are subsequently 
elongated to full length (SeSaM step 3). In the elongations step, the ‘tailed’ ends of ssDNA 
form mismatches with the supplied template. The magnitude of mismatch increases in 
relation to the number of consecutive degenerate bases and type of mismatch formed. The 
transversion mismatch is most difficult to elongate by DNA polymerases (Huang et al., 1992) 
but notably offers a large number of diverse substitutions (Wong et al., 2007b); therefore, 
transversion mismatch elongation is highly desirable in SeSaM mutant libraries. The only 
feasible solution to further increase the frequency of occurrence of consecutive transversion 
mutations in SeSaM libraries is to employ a polymerase which can elongate at least two 
consecutive transversion mismatches in SeSaM step 3.  
The employed polymerase in the aforementioned step of SeSaM has to match a number of 
criteria in order to generate mutant libraries enriched in transversion mutations as well as 
consecutive nucleotide substitutions. In the first place, the employed DNA polymerase has to 
be able to extend (or “read” through) primers with a non-canonical nucleotides at the 3`-
termini that mispair with the supplied DNA template. Secondly, the polymerase should not 
possess a strong 5`→3` exonuclease activity so that the degenerate bases at 3`-ends of 
primers remain intact. At the same time, sufficient fidelity in order to avoid the introduction 
of secondary mutation is desired. Lastly, the elongation of multiple mismatches at the 3`-end 
of primers is also highly desired in order to be able to target more than one nucleotide in a 
codon and consequently increase the diversity of SeSaM libraries.  
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Consequently, the remaining challenge in SeSaM in order for the method to generate 
libraries with close to theoretically attainable diversity is to improve the efficiency of 
subsequent mismatch elongation in SeSaM step 3. In terms of strategies to achieve this, the 
only plausible solution is the identification or engineering of a DNA polymerase. The latter 
has been a main objective in this doctoral work. For the identification of suitable polymerase 
candidates, our efforts were focused on a special family of polymerases involved in the in 
vivo elongation of non-canonically primed DNA amplification and translesion DNA synthesis.  
1.5. DNA polymerase-based technologies and high-throughput screening 
systems for DNA polymerases 
1.5.1. DNA polymerase-based technologies 
DNA polymerases have been routinely employed in asserted methodologies such as in vitro 
DNA replication and molecular cloning, DNA sequencing, mutagenesis, and diagnostics 
(Blanusa et al., 2010b; Dennig et al., 2011; Erlich, 2013; Shendure and Ji, 2008; Thelwell et 
al., 2000; Wong et al., 2004). However, from a practical perspective, naturally occuring 
polymerases often suffer from a number of drawbacks that limit their biotechnological 
applications. Depending on the envisioned application, these can include insufficient 
processivity and fidelity, inhibition by sample impurities and inability to efficienty utilize non-
canonical nucleotides.  
1.5.2. Screening systems for DNA polymerases 
Platforms for polynucleotide polymerase engineering comprise selection and screening 
systems. One example of the former type is the compartmentalized self-replication (CSR) 
method which allows the enrichment of improved polymerase mutants among more than 
108 individual variants in a single run (Ghadessy et al., 2001). Other selection systems with 
similar throughput are the platform for functional complementation of polymerase activity 
in polymerase deficient strains (Camps and Loeb, 2007) and the duet plasmid-based 
selection system (Brakmann and Grzeszik, 2001). The aforementioned strategies require that 
polymerases possess sufficiently high processivity, fidelity and/or thermostability to be able 
to replicate long fragments of DNA. These selection systems are, therefore, not suited for 
distributive polymerases, e.g., members of the Y-polymearse family. Alternative detection 
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systems for polymerase activity rely on the continuous detection of pyrophosphate release 
during polymerisation of nucleoside triphosphates. The produced diphosphate is quantified 
through a coupled enzymatic cascade (employing ATP-sulfurylase and firefly luciferase) 
(Nyrén, 1987), through pyrophosphate sensors (Fabbrizzi et al., 2002) or changes in current 
during dNTPs polymerisation (Credo et al., 2012). None of these activity assays is designed 
for use in combination with crude cell extracts of E. coli, thus not easily applicable in directed 
evolution of polymerases. 
Quantitative polymerase chain reaction (qPCR) is used for qualitative and quantitative 
analysis of nucleic acids (Orlando et al., 1998). One type of reporters in qPCR are fluorescent 
DNA dyes that become fluorescent upon intercalation with double stranded DNA. An 
alternative approach for detection employs sequence-specific DNA probes of various 
„molecular architecture“ that become fluorescent after hybridization to or release from a 
target DNA sequence. One example of the latter kind, the Scorpion probe, comprise a primer 
with a covalently attached fluorophore. Unelongated Scorpion probes are not fluorescent 
due to hybridization with a separate quenching oligo that is supplied in the reaction mix. 
Elongated Scorpion probes contain the labeled probe element and target sequence on the 
same strand and hybridize preferentially with themselves and not the quencing oligo, thus 
an increase of fluorescence signal is generated. The kinetics of such an intramolecular 
rearrangement is very rapid and ensures reliability of probing as well as high signal-to-noise 
ratio (Thelwell et al., 2000; Whitcombe et al., 1999). The stoichometry of the reaction (one 
amplicon leads to one fluorescent signal) and concentration independency of probing 
provides reliable quantification and enhanced overall sensitivity (Carters et al., 2008). 
Additionally, unlike most qPCR reporters (e.g., TaqMan probes), Scorpion probes rely solely 
on polymerases‘ primary enzymatic activity (Heid et al., 1996; Huggett et al., 2005). Thus, 
Scorpion probes can be used in combination with polymerases that lack secondary 
exonuclease or displacement activities. The adaptation of a Scorpion probe for screening of 
polymerase mutant libraries is described in the “Results and Discussion” section of this 
chapter.  
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1.6. DNA polymerases in diversity generation for directed evolution 
In the context of directed evolution, polymerases which are naturally optimized for error-
free DNA replication in vivo are often limited in their ability to generate diverse mutant 
libraries due to their high fidelity and specificity for natural nucleotides. In contrast, DNA 
polymerases involved in DNA repair which are found in all polymerase families, including the 
most recently reported Y-polymerase family (Ohmori et al., 2001), are generally 
characterized by low fidelity, moderate-to-low processivity as well as augmented ability to 
utilize a range of non-canonical primer-template DNA (Chandani et al., 2010; McDonald et 
al., 2006; Sale et al., 2012; Yang and Woodgate, 2007). Polymerases from the Y-family have 
not been widely employed in random mutagenesis methods despite their promising 
potential. 
1.7. A concise overview of Y-family of DNA polymerases 
Polymerase-mediated replication and repair of DNA are of fundamental importance for the 
survival of all living organisms. Based on sequence homology, DNA polymerases are 
classified in 7 families, A-, B-, C-, D-, X-, Y- and RT-family (Filée et al., 2002). Replicative 
polymerases are found all families while those involved in DNA repair mechanisms belong to 
all but the C- and D-family. The Y-polymerase family (Ohmori et al., 2001) is the most 
recently identified class which encompasses polymerases from prokaryotes and eukaryotes 
alike which are primarily involved in translesion DNA synthesis (TLS). In the context of this 
thesis, Y-polymerases have been considered a good source of candidates to realize the 
objectives related to increasing the efficiency of mismatch elongation, a feature that is 
highly desirable for the generation of transversion-enriched SeSaM libraries. Their intrinsic 
property to ‘read through’ damaged DNA indicates that some Y-family members may already 
be able to fulfil the requirements for implementation in SeSaM or at least provide a good 
starting point for optimization by protein engineering. In addition, a good deal of 
information on the structure-function relationship for some members has been generated 
through crystallography and mutational studies. This section gives a concise overview of 
some structural and mechanistic features of Y-polymerases. 
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1.6.1. Y-family polymerases 
DNA lesions caused by endogenous or exogenous agents represent a common thread to the 
viability of all living cells. Prevention and repair mechanisms exist to revert damage 
(Friedberg, 2003; Friedberg et al., 1995; Kelman and White, 2005; Takata et al., 1998), still a 
portion of damaged DNA can escape this process and stall the DNA replication machinery. To 
tackle this challenge, cells have developed the ability to replicate through lesions. 
Translesion DNA synthesis (TLS) is catalyzed by specialized DNA polymerases referred to as 
Y-family polymerases (Ohmori et al., 2001). Y-family members are characterized by high 
error rates (100- to 1000-fold decrease in accuracy compared to polymerases involved in 
replication of DNA) as well as low processivity (McCulloch and Kunkel, 2008). Different Y-
family members also exhibit different lesion bypass capabilities as well as different 
mutational spectra (Johnson, 2010; Nelson et al., 1996). These enzymes are universally 
conserved in all living organisms but the highest number of crystal structures are those of 
archaeal DinB homologues – Dbh and Dpo4 (Zhou et al., 2001a); however, yeast Polη 
(Trincao et al., 2001), human Polι, Polκ and Rev1 (Nair et al., 2004; Swan et al., 2009; Uljon et 
al., 2004) structures have also been solved. 
1.6.2. Structural features of Y-family polymerases 
Y-family polymerases share with other polymerase families a conserved right-handed 
polymerase core of a thumb, palm and finger domain (Fig. 9). Additionally, a specific 
‘wrist’/little finger (LF), sometimes also termed polymerase associated domain (PAD) domain 
(Goodman, 2002; Ling et al., 2001; Silvian et al., 2001) is found only in members of this 
family and characterizes the structural appearance of  Y-polymerases. By means of multiple 
sequence alignments, at least two specific domains connected by a relatively unstructured 
region can be identified (Pata, 2010). The N-terminal region contains the catalytic core 
(thumb, palm, finger domain) and is functionally well preserved among polymerase families. 
Unlike replicative polymerases, Y-polymerases have a rather small ﬁnger and thumb domain 
which confers an open and solvent accessible active site. The C-terminal region contains the 
unique LF domain and may contain additional features for localization and interaction with 
other proteins (Yang and Woodgate, 2007). The LF has a conserved tertiary structure of four 
beta sheets and two alpha helices. However, there are no primary sequence motifs that are 
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similar among members of the Y-family. The LF appears to be the most mobile region in Y-
family members (Eoff et al., 2007). The LF domain determines the catalytic eﬃciency and 
mutation spectra of each polymerase by inﬂuencing enzyme–substrate interactions. This is 
suggested by the observation that swapping the LF domains between two archaeal DinB 
homologs, Dbh and Dpo4, which share 50% sequence identity, confers drastically diﬀerent 
catalytic eﬃciencies and mutation spectra to these polymerases (Boudsocq et al., 2004). 
 
 
Figure 9. Structural features of the archetypal Y-family polymerase Dpo4 from Sulfolobus 
solfataricus. Ribbon diagram of a ternary complex of Dpo4 with the different structural features are 
highlighted in shades of gray. The important residues in the active site of the protein and discussed in 
section 3 of the chapter are shown as sticks in light grey, the incoming dNTP is shown in black sticks 
and the template and primer DNA stand are presented in light grey sticks. 
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1.6.3. Catalytic Mechanism 
Similar to polymerases from other families, Y-family members show a well-conserved two-
metal ion catalytic mechanism (Trincao et al., 2001; Uljon et al., 2004; Zhou et al., 2001b). 
Two Mg2+ ions (coordinated by carboxylates of two conserved aspartate residues (D7 and 
D105 in case of the archetypal Dpo4 from Sulfolobus solfataricus) stabilize the resulting 
penta-coordinated transition state. One metal ion activates the primer’s 3’-OH for attack on 
the α-phosphate of the dNTP. The other metal ion plays a role of stabilizing the negative 
charge that builds up on the leaving oxygen and chelates the β and γ phosphates. 
Nucleophilic attack of 3’-OH group results in phosphodiester bond formation. In addition to 
participating in coordination with one of the metal ions, the phosphates of the incoming 
nucleotide are bound by conserved residues in the ﬁnger (Y48 and R51 in Dpo4) and the 
palm (K159 in Dpo4) domains. The sugar moiety of the incoming nucleotide is positioned by 
stacking on top of a “steric gate” residue (Y12 in Dpo4; Y or F in other Y-family polymerases) 
and by the 3′-OH's formation of a hydrogen bond with the backbone nitrogen of the same 
residue (Pata, 2010). The steric gate residue selects against the incorporation of 
ribonucleotides by the polymerase (DeLucia et al., 2003). Other interesting features in the 
vicinity of the active site are the “roof-amino acid” (A45 in Dpo4), which is the amino acid 
that lies above the nucleobase of the deoxynucleotide triphosphate (dNTP) and plays a role 
in dNTP insertion efficiency, and a cluster of three amino acids, including the roof-amino 
acid, which anchors the base of a loop, whose detailed structure dictates important 
mechanistic function, i.e., controls of the size of a ‘chimney’ (opening in the protein surface) 
which in turn can favor the insertion of one type of base over the other (Seo et al., 2009). 
1.6.4. Implications of Y-polymerase structure on DNA binding and catalysis 
The implications on the catalytic performance of Y-polymerases’ open and solvent exposed 
active site, especially in comparison to, e.g., Taq polymerase, is illustrated through the 
example of the well-characterized Y-family polymerase, Dpo4 from Sulfolobus solfataricus. In 
Dpo4, the interaction between protein and substrates is mainly through the DNA backbone 
of template and primer, and the sugar-phosphate moiety of an incoming deoxynucleotide 
(Pata, 2010). There is minimal contact between the enzyme’s active site and the replicating 
base pair or preceding DNA duplex in the major or minor groove. This underlies the less 
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stringent distinction of a perfect (Watson-Crick type) or mismatching base pairing in the 
active site. In the case of replicative polymerases where non-Watson-Crick base pairing is 
usually a disallowed conformation, base pairing always provides a ﬂat and smooth minor 
groove with distinct hydrogen bond patterns. The minor groove of mismatched base pairs is 
uneven and presents different patterns of hydrogen-bond donors and acceptors. This 
effectively prevents further catalysis in case of replicative polymerases. The lack of a 
complementary interface between enzyme and replicating base pair in Dpo4 and Y-family 
polymerases in general provides a foundation for the high-error-rate and low-ﬁdelity DNA 
synthesis (Wong et al., 2008a).  
The high ﬁdelity of replicative DNA polymerases also depends on an ‘induced-ﬁt’ - a 
conformational change to discriminate against a wrong incoming nucleotide. A correct 
incoming deoxynucleoside triphosphate makes a Watson–Crick base pair with the opposite 
base which induces structural rearrangement of the ﬁnger domain and secludes the 
replicating base pair in a closed active site (Doublié et al., 1999). An incorrect incoming 
nucleotide or damaged template base hinders this conformational change and reduces the 
rate of polymerization. In contrast to the “induced-ﬁt” mechanism of replicative 
polymerases, the active site of Dpo4 is pre-formed regardless of whether an incoming 
nucleotide is incorrect or the template base is damaged or even absent. Dpo4 is always 
ready to catalyse the nucleotidyl transfer reaction. A preformed active site is a common 
feature among the Y-family polymerases (Yang, 2005).  
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2. Materials and methods 
 2.1. Chemicals 
All chemicals were of analytical grade or higher quality and purchased from Sigma-Aldrich 
Chemie (Steinheim, Germany), AppliChem (Darmstadt, Germany) and Carl Roth (Karlsruhe, 
Germany) unless specified. DNA probes and other oligonucleotides in salt-free, lyophilized 
form were purchased from Biomer.net (Ulm, Germany) and Eurofins MWG Operon 
(Ebersberg, Germany). Degenerate base dPTP was provided by Biolog Life Science Institute 
(Bremen, Germany). The primer sequences used in the project are shown in Table 2 
Commercial enzymes were obtained from New England Biolabs (New England Biolabs, 
Frankfurt am Main, Germany). 
2.2. Bacterial strains, plasmids and list of primers   
 
Table 1. List of bacterial strains used in this study. 
Bacterial strain Genotype Comments 
E. coli DH5α 
[(supE44 ΔlacU169 Φ80 lacZΔM15) hsdR17 recA1 
gyrA96 thi-1 relA1)] 
Life Technonologies, 
Darmstadt, Germany 
E. coli Top 10 
[F- mcrA Δ(mrr-hsdRMS-mcrBC) φ80lacZΔM15 
ΔlacX74 nupG recA1 araD139 Δ(ara-leu)7697 
galE15 galK16 rpsL(Str
R
) endA1 λ
-
] 
Life Technonologies, 
Darmstadt, Germany 
E. coli BL21 (DE3) 
[F- ompT gal dcm lon hsdSB (rB- mB-) λ(DE3 [lacI 
lacUV5-T7 gene 1 ind1 sam7 nin5])] 
Novagen/ Merck KGaA, 
Darmstadt Germany 
E. coli BL21 (DE3) lacI
q1
 
[F- ompT gal dcm lon hsdSB (rB- mB-) λ(DE3 [lacI 
lacUV5-T7 gene 1 ind1 sam7 nin5])] 
(Blanusa et al., 2010b) 
 
Table 2. List of plasmids used in this study. 
Plasmid name Features Comments 
pET28a(+) T7 promoter, His•Tag, lacI, pBR322, Kan, f1 origin Merck KGaA, Darmstadt Germany 
pALXTREME-1a T7 promoter, His•Tag, pBR322, Kan, f1 origin (Blanusa et al., 2010b) 
pALXTREME-5b T7 promoter, pBR322, Amp, f1 origin (Blanusa et al., 2010b) 
pBAD-N Ara promoter, pBR322, Amp, AraC, f1 origin (Guzman et al., 1995) 
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Table 3. List of primers, DNA probes and other oligos used in the study, and primers used in CSR. 
(SNN = randomization codon; S = cytosine or thymine; N = cytosine or thymine or adenine or 
guanine; [FITC] =fluorescein isothiocyanite, fluorescent dye;  [FAM] = 6-carboxy fluorescein, 
fluorescent dye; ~~~~ = Spacer18, hexaethylene glycol; [BHQ]  = black hole quencher-3, quencher 
molecule; [Biotin] = 5`biotin; ctaagaaagcccg = phosphothioated oligo; P = degenerate pyrimidine 
analog, dPTP; codes for A or G in ratio 1.6:1; Y = cytosine or thymine) 
 
PRIMER NAME SEQUENCE (5`-->3`) APPLICATION 
P1 SSM_Fwd CGGTTCCTGGCCTTTTGCTGG SSM library generation 
P2 SSM_RV_Y10 TCAACCTGCGCGTAGAASNNATCAAGTCTACGAACAGC SSM library generation 
P3 SSM_RV_V32 CGAAACGACCGGAGAASNNGCACACAACAACTGGTTT SSM library generation 
P4 SSM_RV_A34 GCTGTCTTCGAAACGACCSNNGAAAACGCACACAACAAC SSM library generation 
P5 SSM_RV_A44 TGCTTCGTAGTTAGCGGTSNNAACCGCACCGCTGT SSM library generation 
P6 SSM_RV_V62 GGCAGGATTTTCTTAGCTTCSNNGATCGGGATACCAGCTT SSM library generation 
P7 SSM_RV_M76 GTTGTTAAACTTCTTTGCGSNNAGGCAGGTAGACGGC SSM library generation 
P8 SSM_RV_K78 GCTCACTTGGTAAACTTCSNNGCGCATAGGCAGGTAG SSM library generation 
P9 SSM_RV_D156 CCGTTCGGTTTAGCCATSNNCGCCGCGATCTTC SSM library generation 
P10 SSM_RV_A181 CCAATGCCTGGAACGTCSNNAATATCCAGTTCGCGG SSM library generation 
P11 SSM_RV_P184 GTGATGTTGCCAATGCCSNNAACGTCAGCAATATCCAG SSM library generation 
P12 SSM_RV_N188 TCAGTTTTTCAGCGGTGATSNNGCCAATGCCTGGAAC SSM library generation 
P13 SSM_RV_A191 CCCAGTTTCTTCAGTTTTTCSNNGTGATGTTGCCAATGC SSM library generation 
P14 SSM_RV_R242 TGCGACCGATGCTCTTSNNCACACGCGTGCGAA SSM library generation 
P15 SSM_RV_R247 ATTACGTTTCATGGTCACAATSNNACCGATGCTCTTGCG SSM library generation 
P16 SSM_RV_K275 GGGATGCGTTTATCCAGSNNATAGTAAGATTCTTCAATAGCG SSM library generation 
P17 SSM_RV_V289 GATGTCCAGATCCTCCGTSNNAGCAACCACGTGGATAG SSM library generation 
P18 SSM_RV_L293 CCGGGACACGATGTCSNNATCCTCCGTAACAGCAAC SSM library generation 
P19 SSM_RV_R331 CACGCCGATACGSNNGATCTTGCGCTC SSM library generation 
P20 SSM_RV_R332 GCGCACGCCGATSNNGCGGATCTTGCG SSM library generation 
P21 SSM_RV_R336 GCCTCGATGAATTTAGAGAASNNCACGCCGATACGGC SSM library generation 
P22 6-FAM 
[FAM]CGCTGAGCAATAACTAGCATAACCGAC~~~~GTGTGATGGC
GTGAGGCAGC 
Scorpion probe primer 
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P23 BHQ-1 GTCGGTTATGCTAGTTATTGCTCAGCG[BHQ1] 
Scorpion probe 
quencher 
P24 
Scorpion template 
match 
CGCTGAGCAATAACTAGCATAACCGACGATAAATCACAATAGGTT
CCTTGTAGGCTGCCTCACGCCATCACAC 
Scorpion probe 
template                   
match 
P25 
Scorpion template 
1 mismatch 
CGCTGAGCAATAACTAGCATAACCGACGATAAATCACAATAGGTT
CCTTGTAGCCTGCCTCACGCCATCACAC 
Scorpion probe 
template                        
1 mismatch 
P26 
Scorpion template 
2         mismatches 
CGCTGAGCAATAACTAGCATAACCGACGATAAATCACAATAGGTT
CCTTGTAGCGTGCCTCACGCCATCACAC 
Scorpion probe 
template                       
2 mismatches 
P27 F1 CGACTCACTATAGGGGAATTGTGAGCGGA 
SeSaM library 
generation 
P28 R3 CGGGCTTTGTTAGCAGCCGGATCTCAG 
SeSaM library 
generation 
P29 SeSaMF1 
CACACTACCGCACTCCGTCGCGACTCACTATAGGGGAATTGTGAG
CGGA 
SeSaM library 
generation 
P30 SeSaMR3 
GTGTGATGGCGTGAGGCAGCCGGGCTTTGTTAGCAGCCGGATCTC
AG 
SeSaM library 
generation 
P31 F1_up CGCCTGTCACCGACTCACTATAGGGGAATTGTGAGCGGA 
SeSaM library 
generation 
P32 R3_dn GCGGACAGTGCGGGCTTTGTTAGCAGCCGGATCTCAG 
SeSaM library 
generation 
P33 Bio_Fw [Biotin]CACACTACCGCACTCCGTCG 
SeSaM library 
generation 
P34 Bio_Rv [Biotin]GTGTGATGGCGTGAGGCAGC 
SeSaM library 
generation 
P35 SeSaM_Fw CACACTACCGCACTCCGTCG 
SeSaM library 
generation 
P36 SeSaM_Rv GTGTGATGGCGTGAGGCAGC 
SeSaM library 
generation 
P37 Vector_PTO_Fw ctaacaaagcccgAAAGGAAGCTGAGTTG 
Cloning of SeSaM 
libraries 
P38 Vector_PTO_Rv attgtgttcagcGATATCCATGGCCATC 
Cloning of SeSaM 
libraries 
P39 Insert_PTO_Fw gctgaacacaatCCAGTCGTTATGGTTC 
Cloning of SeSaM 
libraries 
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P40 Insert_PTO_Rv cgggctttgttagCAGCCGGATCTCAG 
Cloning of SeSaM 
libraries 
P41 F1_short CGACTCACTATAGGGGAATTGTGAGC 
Compartmentalized 
Self-replication 
P42 R3_short CGGGCTTTGTTAGCAGCCGGATCTC 
Compartmentalized 
Self-replication 
P43 F1_PP CGACTCACTATAGGGGAATTGTGAGCG*P*P 
Compartmentalized 
Self-replication 
P44 R3_PP CGGGCTTTGTTAGCAGCCGGATCTC*P*P 
Compartmentalized 
Self-replication 
P45 F1_YY CGACTCACTATAGGGGAATTGTGAGCGYY 
Compartmentalized 
Self-replication 
P46 R3_YY CGGGCTTTGTTAGCAGCCGGATCTCYY 
Compartmentalized 
Self-replication 
P47 FITC-PP [FITC]-GCAATACGCAAACAGTCTCTCTTPP 
Forward primer 
elongation assay 
P48 
FITC_template  
match 
GCAATACGCAAACAGTCTCTCTTGGGCCCCG 
Forward primer 
elongation assay 
P49 
FITC_template  
1_mismatch 
GCAATACGCAAACAGTCTCTCTTGCGCCCCG 
Forward primer 
elongation assay 
P50 
FITC_template 
2_mism. 
GCAATACGCAAACAGTCTCTCTTTCGCCCCG 
Forward primer 
elongation assay 
P51 
FITC_match 
complementary 
CGGGGCCCAAGAGAGACTGTTTGCGTATTGC 
Forward primer 
elongation assay 
P52 
FITC_ 1_mism. 
complementary 
CGGGGCGCAAGAGAGACTGTTTGCGTATTGC 
Forward primer 
elongation assay 
P53 
FITC_2_mism.  
complementary 
CGGGGCGAAAGAGAGACTGTTTGCGTATTGC 
Forward primer 
elongation assay 
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2.3. Cloning procedures 
The genes which encode putative Y-family polymerases have been codon optimized for 
expression in E. coli and ordered as synthetic constructs (Mr. Gene Geneart, Darmstadt, 
Germany). The synthetic DNA was cloned in pET28a(+) (EMD Bioscience, Darmstadt, 
Germany), pALXtreme-1a (Blanusa et al., 2010b) in frame with N-terminal poly His-tag and in 
pALXtreme-5b (Blanusa et al., 2010b) and pBADN (Life Technologies, Darmstadt, Germany) 
using standard cloning protocol and NdeI/XhoI restriction enzymes (New England Biolabs, 
Frankfurt am Main, Germany). The resulting constructs were checked for the presence of the 
correct insert by analytical restriction digestion and sequencing, and transformed into 
expression host E. coli Bl21 Gold (DE3) lacIq1 (Blanusa et al., 2010b). 
2.4. Pilot expression and purification of putative Y-polymerase genes 
2.4.1. Pilot expresion studies 
Flask expression in 500 mL Erlenmeyer flasks was carried out in 50 mL TBKan. The main 
culture was inoculated with 1% (v/v) overnight pre-culture of E. coli BL21 Gold (DE3) lacIq1 
pET28a(+) or pALXtreme-1a harboring the gene of interests, prepared in LBKan and cultivated 
at 37 °C, 250 rpm for 12 -14 h. . Induction of Dpo4, Mse and Tps was carried out at OD600 of 
0.6 with 0.1 mM IPTG and cell cultures were incubated for 12 - 14 hours at 37 °C. Induction 
of Pto was achieved by addition of IPTG to a final concentration of 0.1 mM when OD600 
reached 0.6 and cells were grown for 4 hours at 37 °C. Expression cultures were harvested 
by centrifugation (4 °C, 3 220 × g, 20 min, Eppendorf 5810R centrifuge, Eppendorf AG, 
Hamburg, Germany), washed with phosphate-buffered saline (PBS, pH 7.4) and used 
immediately or stored at −20 °C. 
2.4.2. Pilot purification studies 
Cell pellets were thoroughly re-suspended in 1× LEW washing buffer (Macherey–Nagel, 
Düren, Germany) such that a 40% (w/v) cell suspension was prepared. Cells were lysed by 
sonication (10 × 1 min, 40% sonication amplitude) using Bandelin M73 sonotrode (or where 
specified, by B-PER lysis reagent (Thermo Fischer Scientific, Waltham, USA) according to 
manifacturer’s instructions), followed by heat treatment (60 °C or 80 °C, 10 min) to denature 
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E. coli proteins and separation by centrifugation (4 °C, 16 000 × g, 20 min, Eppendorf 5804, 
Eppendorf, Hamburg, Germany). The crude cell extracts were further clarified by filtration 
through a low-protein-binding filter (0.45 μm; Minisart RC 25 disposable syringe filter; 
Sartorius, Hamburg, Germany) before being subjecting to His-tag purification (pre-packed 
Protino® Ni-IDA columns; Macherey–Nagel, Düren, Germany). After extensive washing with 
1× LEW buffer (5 × 5 mL), the His-tagged protein was eluted in 3 mL 1× Elution Buffer 
(Macherey–Nagel, Düren, Germany). Elution fractions of 500 μL were collected and the 
protein content of each was estimated using NanoDrop spectrophotometer (NanoDrop 
Technologies Inc., Wilmington, USA). Fractions containing more than 0.3 mg mL-1 of protein 
were pooled and concentrated using Amicon centrifugal filters (Millipore Inc., Billerica, USA), 
if necessary. Samples were collected after each purification step for SDS-PAGE analysis. 
Purified proteins were dialysed using appropriate dialysis membrane (Spectra/Por® dialysis 
membrane 10 - 12 kDA, Spectrum Laboratories Inc, Rancho Dominguez, USA) to exchange 
the elution buffer which contained imidazole with buffer suited for storage of polymerases 
(10 mM Tris, 100 mM KCl, 1 mM DTT and 10 mM EDTA). On the following day, 50% glycerol 
was added to the purified fractions to prepare the proteins for long term storage at -20 °C. 
2.5. Thermostability valuation in crude cell extract 
Thermostabiltiy tests were performed with crude cell extracts of cell cultures expressing Y-
polymerases. Cells were lysed by sonication (40 % (w/v) cell suspension, 10 x 1 min 
sonication and 40% sonication amplitude) and clarified cell extracts were subjected to heat 
treatment at temperatures ranging from 40 °C to 90 °C for 10 min in a thermo block 
(Eppendorf ThermoMixer® C, Eppendorf, Hamburg, Germany). Precipitated and soluble 
proteins were separated by centrifugation (4 °C, 16 000 × g, 20 min, Eppendorf 5804, 
Eppendorf, Hamburg, Germany) and separately loaded on SDS acrylamide gel for analysis. 
2.6. In vitro expression of Dpo4 
In vitro expression of Dpo4 was carried out for 1.5 hours from a linear DNA template using 
EasyXpress Protein Synthesis Kit (Qiagen, Hilden, Germany) according to the manufacturer’s 
recommendations. Emulsification of in vitro expression mix was carried out as outlined in 
section 2.8.1. 
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2.7. Forward primer extension assay 
A fluorescently-labelled (FITC-labeled) primer harboring two pyrimidine base analogues 
(dPTP) at its 5′-end was extended by Dpo4 polymerase on a short, single-stranded DNA 
template (Table 3; P47 - P50)  in the presence of dNTPs and ThermoPol activity buffer (NEB, 
Frankfurt am Main, Germany). The primer extension reaction with Y-polymerases was 
carried out in ThermoPol buffer (New England Biolabs, Frankfurt am Main, Germany) using 
final concentrations of up to 550 nM protein, 2 μM template, 1 μM FITC-labelled primer and 
0.2 mM dNTPs in a total volume of 25 μL. Primer and template were annealed to each other 
by heating the reaction mix to 95 °C for 2 min, then slowly cooling it down to 4 °C prior to 
enzyme addition. Samples were incubated at 37 °C/ 55 °C or run using thermocycling 
conditions (e.g., 80 °C, 30 sec; 55 °C, 1 min) and collected at different time 
intervals/thermocycles and immediately treated with EDTA (20 mM, final) to terminate the 
polymerization reaction. Competitor DNA (Table 3; P51 - P53) was added in 100-fold excess 
and the samples were heated up to 95 °C for 5 min. In this way, elongated primer was 
detached from the template and reaction products alone could be separated on 25% native 
acrylamide gel and visualized (ex: 494 nm; em: 518 nm) on a FLA 3000 PhosphorImager 
(FujiFilm, Düsseldorf, Germany). 
2.8. Compartmentalized self-replication 
2.8.1 Oil Phase preparation 
The following components were mixed together in the listed order to prepare the oil phase: 
95.05% Light Mineral Oil (Cat. No. M5904, Sigma) 
4.5% Span 80 (Cat. No. 85548, Fluka) 
0.4% Tween 80 (Cat. No. P8074, Fluka) 
0.05% Triton X-100 (Cat. No. A4975, AppliChem) 
Components were thoroughly mixed by stirring in 5 mL cryogenic tube (Cat. No. 60.58.001, 
Sarstedt, Nümbrecht, Germany). Tips with cut edges or specialized tips for viscous liquids 
were used for pipetting. The oil phase was stored in the dark at room temperature for up to 
2 weeks. 
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2.8.2. Cell sample preparation 
Expressed clones (in flasks) harboring polymerase genes and empty vector were harvested 
by centrifugation. The cell pellets were once washed with phosphate buffer saline (PBS) and 
re-suspended in PBS such that OD600 of the suspension was 5. Cell suspensions were kept on 
ice until needed but always used it within 30 min after their preparation 
 2.8.3. Preparation of aqueous phase, emulsification and PCR reaction 
The mastermix was prepared on ice according as outlined below. All components were 
thawed on ice prior to use. 
 1x 4x 
10x ThermoPol buffer (NEB) 5 μL 20 μL 
dNTPs (10 mM) 1 μL 4 μL 
F1/F1PP (5 μM) 4 μL/10 μL 16 μL/ 40 μL 
R3/R3PP (5 μM) 4 μL/10 μL 16 μL/ 40 μL 
ddH2O 35 μL/ 23 μL 128 μL/ 96 μL 
Cell suspension, OD600 = 5 1  μL 4 μL 
<Taq Pol (5U/μL)> <0.25 μL> <1 μL> 
Total Volume 50 μL 200 
All components were mixed on ice. Cell suspension was added at last just before 
emulsification Taq polymerase (1.25 U in 50 μL) was on some occasions added to the 
mastermix when F1PP and R3PP primers (Table 3; P43 - P44) were used. (NOTE: Taq 
polymerase cannot elongate the latter primers but it can take over the elongation once a 
mutant polymerase has overcome the mismatch. This can be particularly helpful when 
mutant libraries of low processive polymerases such as Y-family polymerases are screened.)  
For emulsification, 150 μL aqueous phase was added drop-wise to 300 μL oil phase in 5 mL 
cryogenic vial (Corning, Kaiserslautern, Germany) under constant stirring (700 rpm, IKAMAG 
REO, IKA-Werke, Staufen, Germany) with magnetic stirring bar (8 x 3 mm with pivot ring) on 
ice. Stirring for 5 min after addition of the last drop of aqueous phase was done. The 
resulting emulsion appeared creamy white and viscous. The emulsion was distributed into 
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PCR tubes (50 μL/ tube) with tips with cut edges to avoid damaging of the formed 
compartments. Thermocycling program  (25 cycles; volume: 25 µL; 105 °C heated lid) : 2 min 
90 °C (1x); 30 sec 90 °C, 30 sec 51 °C, 3 min 65 °C (24x); Hold 8 °C; annealing temperature for 
F1PP and R3PP is 51 °C;or 60 °C if F1 and R3 primers were employed (Table 3; P27 - P28). 
After thermocycling the emulsion remained white and creamy and was overlaid by a thin 
layer of clear oil phase 
2.8.4. DNA recovery and re-amplification 
After thermocycling, all samples were pooled together in 1.5 mL tube and centrifuged for 2 
min at 13 200 x g. Three distinct phases were formed after centrifugation. The clear oil phase 
on top was pipetted out and 1 mL butanol was added thoroughly mixed in by vortexing. The 
sample was centrifuged again for 3 min at 13 200 x g. A small pellet appeared at the bottom 
of the tube. The liquid is removed as much as possible by pipetting and the samples were 
further dried at 70 °C to remove any traces of butanol. The pellet was then re-suspended in 
15 - 30 μL ddH2O. Re-amplification of emulsion PCR products was usually necessary, 
especially when selection pressure was applied. Re-amplification PCR was be carried out 
with F1 short and R3 short (Table 3; P41 and P42) and Taq polymerase after DpnI digestion 
of emulsion PCR products to remove methylate plasmid DNA. Alternatively, F1YY and R3YY 
primers (Table 3; P45 and P46) and Taq polymerase were used which in theory specifically 
bind to emulsion PCR products and form mismatching pairs with plasmid DNA. 
2.9. PicoGreen® assay 
2.9.1. Protein expression in 96-well microtiter plates (MTP) 
Master microtiter plates containing Dpo4 WT cloned in pALXtreme-5b vector and 
transformed in E. coli BL21 Gold (DE3) lacIq1 were duplicated using a 96-well pin replicator 
(constructed in Werkstatt der Biologie, RWTH Aachen Unviersity, Aachen, Germany) to pre-
culture flat bottom microtiter plates (Greiner Bio-One, Frickenhausen, Germany) containing 
200 μL LBAmp per well. The latter were cultivated for 12 h in a microtiter plate shaker 
(Multitron II, Infors GmbH, Einsbach, Germany; 37 °C, 900 rpm, 70% relative humidity) 
before being replicated to V-bottom microtiter plates (transparent polystyrene plate, 
Corning, Kaiserslautern, Germany) with 150 μL TYM-5052Amp auto-induction media per well 
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(Studier, 2005). Expression was carried out at 37 °C for 12 h in a microtiter plate shaker 
(Multitron II, Infors, Einsbach, Germany; 900 rpm, 70% relative humidity), the expression 
cultures were harvested by centrifugation (4 °C, 3 220 × g, 20 min) using Eppendorf 5810R 
centrifuge (Eppendorf, Hamburg, Germany) stored at -20 °C for up to one week. ). Cell lysis 
was performed by addition of 50 μL lysozyme solution (2 mg mL-1, 50 mM Tris, pH 7.4), 
followed by incubation (37 °C, 1 h) and centrifugation (4 °C, 3 220 × g, 20 min). 
2.9.2. PicoGreen® assay in 96-well microtiter plates 
Crude cell extract prepared and used for elognation of a short PCR product from pALXtreme-
1a empty vector using primers P27 and P28 (Table 3). For the PCR (90 °C 2 min (1x), 90 °C 30 
sec, 56 °C 30 sec, 65 °C 3 min, (25x ); 65 °C for 10 min (1x)), 1 – 4 µL crude cell extract, 0.20 
mM of dNTP mix, 50 ng of plasmid template (pALXtreme-1a empty), and 10 pmol of each 
primer were used. PicoGreen® (Promega, Madison, USA) based quantification of dsDNA in 
MTP was performed according to manufacturer’s recommendation. 
2.10. 96-well microtiter plate-format Scorpion probe fluorescent screening 
assay for DNA polymerase activity 
2.10.1. Dpo4 expression in 96-well MTP 
Master microtiter plates containing Dpo4 mutant libraries cloned in pALXtreme-5b vector 
and transformed in E. coli BL21 Gold (DE3) lacIq1 were duplicated using a 96-well pin 
replicator (constructed in Werkstatt der Biologie, RWTH Aachen Unviersity, Aachen, 
Germany) to pre-culture flat bottom microtiter plates (Greiner Bio-One, Frickenhausen, 
Germany) containing 200 μL LBAmp per well. The latter were cultivated for 12 h in a microtiter 
plate shaker (Multitron II, Infors, Einsbach, Germany; 37 °C, 900 rpm, 70% relative humidity) 
before being replicated to V-bottom microtiter plates (transparent polystyrene plate, 
Corning GmbH, Kaiserslautern, Germany) with 150 μL TYM-5052Amp auto-induction media 
per well (Studier, 2005). Expression was carried out at 37 °C for 18 h in a microtiter plate 
shaker (Multitron II, Infors, Einsbach, Germany; 900 rpm, 70% relative humidity), the 
expression cultures were harvested by centrifugation (4 °C, 3 220 × g, 20 min) using 
Eppendorf 5810R centrifuge (Eppendorf, Hamburg, Germany) stored at -20 °C for up to one 
week. 
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2.10.2. Scorpion probe assay in 96-well microtiter plates 
The 96-well microtiter plates containing different Dpo4 variants were taken out of the 
freezer and kept at room temperature for 5 min. Cell lysates were prepared by imbibing 
each cell pellet for 5 min in 100 μL Tris–HCl buffer (50 mM Tris-HCl, pH 7.4) and re-
suspending by shaking (1 200 rpm for 5 min) using microplate shaker TiMix 2 (Edmund 
Bühler, Hechingen, Germany). Cell lysis was performed by addition of 100 μL lysozyme 
solution (2 mg mL-1, 50 mM Tris, pH 7.4), followed by incubation (37 °C, 1 h) and 
centrifugation (4 °C, 3 220 × g, 20 min). 
The cell lysate (10 μL) was mixed with 15 μL Scorpion probe reaction mix containing 1x 
ThermoPol buffer (New England Biolabs, Frankfurt am Main, Germany), 0.2 mM dNTP mix, 
0.25 μM 6-FAM-labeled Scorpion probe (Biomers.net, Ulm, Germany), 0.533 μM BHQ-1 
quencher (Biomers.net, Ulm, Germany) and 0.016 μM single-stranded DNA template in a 96-
well white PCR plates (Flat deck Therma-Fast 96 detection plate, Thermo Scientific, Bonn, 
Germany) sealed with transparent film (MicroAmpTM Optical Adhesive Film, AB Biosciences, 
Allston, USA). Thermocycling (80 °C 30 sec, 51 °C, 30 sec, 65 °C, 1 min (25x)) and 
fluorescence reads during step 3  (65 °C, 1 min) of each cycle were carried out in Applied 
Biosystems 7300 Real Time PCR System (AB Bioscience, Allston, USA).  
Standard deviation for the screening system was determined after transforming the Dpo4 
WT plasmid cloned in pALXtreme-5b and transformed into the E. coli BL21 Gold (DE3) laqIq1 
strain. Colonies from LBAmp agar plates were transferred to 96-well microtiter plates and 
screened as described above. To get the true standard deviation, standard deviations of the 
slopes calculated for the first 15 cycles were calculated on the relative fluorescence values 
obtained from the 96-well microtiter plate (90 Dpo4 WT clones, 3 empty vector controls, 3 
wells filled with growth media only).  
2.11. Construction and screening of epPCR libraries of Dpo4 
For the mutagenic PCR (98 °C 2 min (1x ); 98 °C 30 sec,56 °C 30 s, 72 °C 1 min (25x); 72 °C 3 
min (1x)), 2.5 U of Taq DNA polymerase, 0.20 mM of dNTP mix, 50 ng of plasmid template 
(pALXtreme-5b harboring sso), 0.1 – 0.5 mM MnCl2, and 10 pmol of each primer (CCG GAT 
CGG ACT ACT AGC AGC TGT AAT AC and CGT GAC ATA ACT AAT TAC ATG ATG CGG) were 
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used. PCR products were purified by using a NucleoSpin PCR Purification Kit (Macherey-
Nagel, Düren, Germany), re-amplified with primers P29 and P30 (Table 3) and cloned using 
PLICing as previously described (Blanusa et al., 2010b). 
epPCR libraries cloned in pAXLtreme-5b and transformed in E. coli Bl21 Gold (DE3) lacIq cells 
were plated on LBAmp plates supplemented with 0.1 mM IPTG and incubated at 37 °C for 18 h 
until sizeable uniform colonies were present. All cells were harvested from the agar plates 
and lysed by sonication and the supernatant was clarified by centrifugation (4 °C, 3,220 × g, 
20 min) using Eppendorf 5810R centrifuge (Eppendorf AG, Hamburg, Germany). The 
resulting cell-free extract was used in a forward primer extension assay (see section 2.7) 
whereby the amount of product after 20 thermal cycles was analyzed on a 25 % acrylamide 
gel. 
2.12. Construction of saturation mutagenesis libraries of Dpo4 
In total, 19 non-conserved amino acid residues positioned within 4 - 6 Å from the substrate 
were selected for site-saturation mutagenesis based on Dpo4 crystal structure with bound 
matching and mismatching DNA template/primer (PDB codes: 1S9F and 1S97, respectively 
(Trincao et al., 2004)), HotSpot Wizard and conservation analysis. A two-step approach was 
utilized for the generation of SSM whereby pALXtreme-5b-dpo4 WT, an universal forward 
primer binding upstream of dpo4 and deleting a XbaI restriction site, and a site-specific 
reverse primer were used for generation of „megaprimers“. Reactions contained 1x Phusion 
High-Fidelity buffer and 2 U Taq Phusion polymerase (New England Biolabs, Frankfurt, 
Germany), 0.4 μM of each primer (Table 3; P1-P21), 0.2 mM of each dNTP and template (10 
ng plasmid/50 μL mastermix). The following PCR protocol was used: 98 °C 30 sec (1 cycle); 98 
°C 15 sec, 60 °C 30 sec, 72 °C 30 sec/kb template (18 cycles); 72 °C 3 min (1 cycle). The gel 
extracted „megaprimers“ (Nucleospin Extract II kit, Macherey Nagel, Düren, Germany) were 
cloned by MEGAWHOP (Miyazaki, 2011).  Following template DNA removal through 
digestion by DpnI and XbaI (New England Biolabs, Frankfurt am Main, Germany), the libraries 
were transformed into E.coli Bl21-Gold (DE3) lacIq1 and plated on LBAmp agar plates. Next, 
master microtiter plates were prepared by transferring individual clones to 96-well, flat 
bottom microtiter plates (transparent polystyrene MTPs (Greiner Bio-One, Frickenhausen, 
Germany) containing 100 μL LBAmp, grown until saturation in a microtiter plate shaker 
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(Multitron II, Infors, Einsbach, Germany; 37 °C, 900 rpm, 70 % relative humidity) then stored 
at -80 °C after addition of sterile glycerol solution (25 % (v/v) final concentration).  
2.13. Purification of Dpo4 variants for biochemical characterization 
2.13.1. Flask Expression  
Flask expression was carried out in 500 mL Erlenmeyer flasks filled with 50 mL TYM-5052Kan 
auto-induction media (Studier, 2005) by inoculating with 1% (v/v) overnight culture of E. coli 
Bl21 Gold (DE3) lacIq1 pALXtreme-1a-dpo4 prepared, cultivating the expression culture at 37 
°C, 250 rpm for 18 hours and harvesting by centrifugation (4 °C, 3 220 × g, 20 min, Eppendorf 
5810R centrifuge, Eppendorf, Hamburg, Germany), washed with phosphate-buffered saline 
(PBS, pH 7.4) and used immediately or stored at -20 °C.  
2.13.2. Purification 
Cell pellets were thoroughly re-suspended in 1xLEW washing buffer (Macherey Nagel GmbH, 
Düren, Germany) such that 40% (w/v) cell suspension was prepared. Cells were lysed by 
sonication (5 x 1 min, 40% sonication amplitude) using Vibracell VCX130 sonicator (Sonics & 
Materials, Newton, CT, USA), followed by heat treatment (80 °C, 10 min) to remove most 
E.coli proteins and centrifugation (4 °C, 16 000 x g, 20 min, Eppendorf 5804R, Eppendorf, 
Hamburg, Germany). The crude cell extracts was further cleared by filtration through a low-
protein-binding filter(0.45 μm; Minisart RC 25 disposable syringe filter; Sartorius, Hamburg, 
Germany) before applying them to His-tag purification, pre-packed Protino® Ni-IDA columns 
(Macherey Nagel, Düren, Germany). After extensive washing with 1x LEW buffer (5 x 5 mL), 
the His-tagged protein was eluted in 3 mL 1x Elution Buffer (Macherey Nagel GmbH, Düren, 
Germany) whereby 10 - 12 fractions of 300 μL each were collected, analyzed on 10% SDS 
acrylamide gel and only the purest fractions were taken for buffer exchange by dyalisis 
against storage buffer (10 mM Tris-HCl, 100 mM KCl, 1 mM DTT, 10 mM EDTA, pH 7.9). On 
the following day, the purified protein was either used for activity assays and 
characterization or stored at -20 °C after addition of glycerol (50% (v/v), final concentration). 
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2.14. Detailed SeSaM-Tv protocol 
2.14.1 Biological and chemical materials 
1) Purified plasmid containing the gene of interest suspended in nuclease-free water or TE 
buffer: 10 mM Tris-Cl (pH 7.5), 1 mM EDTA. 
2) Six PCR primer sets for the preliminary steps and steps 1 to 4 of SeSaM (also included in 
Table 3). As a rule, the primers should not exceed 50 nucleotides in length and should 
preferably be of HPLC purity grade. The melting temperature of the primers should be 
calculated only for the gene-specific portion excluding the attached synthetic sequences 
(where applicable).   
i. Primer set 1 amplifies fragment(s) that contains the region targeted for random 
mutagenesis not exceeding 1.5 kb in length (as this would negatively affect the 
efficiency of step 3), preferably including gene-flanking restriction sites. Each 
primer binding site should be located 20 – 80 bp up- or downstream of the region 
to be mutagenized. The gene specific primer region should have a length of 18 - 25 
bp. Name these primers “fwd_X” and “rev_X”, where X stands for the abbreviated 
name of the gene of interest 
ii. Primer set 2 comprises the gene specific forward and reverse primers (i.e. identical 
to the primer set 1 sequences) but with the following artificial oligos attached at 5`-
ends. Name these primers “SeSaM_fwd_X” and “SeSaM_rev_X”, respectively. 
SeSaM_fwd sequence: 5’- CACACTACCGCACTCCGTCG -3’ 
SeSaM_rev sequence: 5’- GTGTGATGGCGTGAGGCAGC -3’ 
iii. Primer set 3 has gene specific sequences identical to primers set 1 with the 
following SeSaM_up or SeSaM_dn sequences attached at the 5’ ends of the 
forward and reverse primer, respectively. Name the primers “SeSaM_up_X” and 
“SeSaM_dn_X”. 
  SeSaM_up sequence:  5’- CGCCTGTCAC -3’ 
  SeSaM_dn sequence:  5’- GCGGACAGTG -3’ 
iv. Primer set 4 comprises solely the following sequences:  
SeSaM_fwd sequence: 5’- CACACTACCGCACTCCGTCG  -3’ 
SeSaM_rev sequence: 5’- GTGTGATGGCGTGAGGCAGC -3’ 
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v. Primer set 5 comprises the following primer sequences, each of which additionally 
harbors a biotin tag (Bio-TEG, a biotin attached to a 15-atom mixed polarity 
triethylene glycol spacer) at 5`-ends. Name these primers “Bio_SeSaM_fwd” and 
“Bio_SeSaM_rev”: 
Bio_SeSaM_fwd: 5'- [Biotin]CACACTACCGCACTCCGTCG  -3’ 
Bio_SeSaM_rev:  5'- [Biotin]GTGTGATGGCGTGAGGCAGC -3’ 
vi. Primer 6 is labeled with the fluorescent dye (FITC, fluorescein isothiocyanate) at the 
5’-end. This primer is used for quality control of SeSaM step 2. 
FITC: 5’- [FITC]GCAATACGCAAACAGTCTCTCT -3’ 
3) NucleoSpin Extract II PCR Purification Kit (Macherey Nagel, Düren, Germany) and the 
associated buffers NT, NT3 as well as NTC buffer. NTC buffer which is separately supplied 
by Macherey Nagel, Düren, Germany, is indispensable for efficient purification of ssDNA 
in steps 1 and 2 of SeSaM. This system is highly recommended since the SeSaM protocol 
has been validated with this particular kit. 
4) Nuclease-free water (for PCR amplification and elution of DNA after purification) and 
deionized water (for buffer preparation). 
5) Solution M: 100 mM NaOH in deionized water. Store at 4 °C. 
6) Solution R: 0.1 % SDS (w/v) in deionized water. Store at 4 °C. 
7) Binding and Washing buffer 1 (1x B&W): 10 mM Tris-HCl (pH 7.5), 1 mM EDTA (pH 8.0), 2 
M NaCl. 
8) Binding and Washing buffer 2 (2x B&W): 10 mM Tris-HCl (pH7.5), 1 mM EDTA (pH 8.0), 1 
M NaCl. 
9) dNTP buffer (pH 7.5): 1 mM Tris-HCl (pH 7.5), 0.1 mM DTT. Store at -20 °C. 
10) Ethanol (99% purity). 
11) Solution C: 20 mM Iodine in ethanol (99%). Store solution C for not more than 1 week at 
4 °C. 
12) Oligo buffer: 10 mM Tris-HCl (pH 7.5), 0.1 mM EDTA (pH 8.0). Store at -20 °C 
13) 10x Tris borate EDTA buffer (10x TBE):  0.89 M Tris-HCl (pH 8.0), 0.89 M boric acid, 20 
mM EDTA (pH 8.0). Store at room temperature. 
14) Tris borate EDTA loading dye (6x TBE-loading dye): 60% 10 x Tris borate EDTA buffer 
(v/v), 30% glycerol (v/v), 1 mg mL-1 (w/v) bromophenol blue. Store at 4 °C. 
15) 40% acrylamide-bis-acrylamide solution. Store at 4 °C. 
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16) 10% (w/v) Ammonium persulfate solution (10% APS), prepared in deionized water. Store 
at -20 °C. 
17) N,N,N',N'- Tetramethylethylenediamine (TEMED, 99% purity). Store at room 
temperature. 
18) Taq DNA polymerase and corresponding buffer (e.g. New England Biolabs, Frankfurt, 
Germany). Store at -20 °C. 
19) High fidelity (HF) DNA polymerase and corresponding buffer (e.g. Phusion® DNA 
polymerase and 5x Phusion® buffer; New England Biolabs, Frankfurt, Germany). Store at 
-20 °C. 
20) Terminal deoxynucleotidyl transferase (TdT) (20 U µL-1) and 10x TdT buffer (New England 
Biolabs, Frankfurt, Germany). Store at -20 °C. 
21) 3D1 polymerase (5 U µL-1) and 10x SuperTaq reaction buffer (HT BioTechnology, 
Cambridge, U.K.). Store enzymes at -20 °C. 3D1 polymerase was expressed and purified 
to homogeneity according to published protocols (d’ Abbadie et al., 2007a; Mundhada et 
al., 2011a). Vent (exo-) DNA polymerase and ThermoPol buffer from New England 
Biolabs (Frankfurt, Germany) can be used as alternative enzymes in step 3 of SeSaM. 
Using the Vent (exo-) instead of the 3D1-polymerase generates fewer consecutive 
nucleotide exchanges in SeSaM-Tv-classic libraries. Vent (exo-) should be the polymerase 
of choice in step 3 of SeSaM-R protocol. The reaction conditions with either polymerase 
remain the same. 
22) Streptavidin coated magnetic beads (e.g. M-PVA SAV1, Chemagen, Baesweiler, 
Germany). Store at 4 °C. 
23) 50x TAE-buffer: 2 M Tris,1 M Acetic acid 50 mM EDTA, with pH adjusted to 8.5 using 
NaOH. Store at room temperature.  
24) 0.8% (w/v) agarose solution in 1x TAE-buffer. Store at 65 °C for up to 2 weeks. 
25) 0.001 % (v/v) ethidium bromide prepared in deionized water. Store at room 
temperature. 
26) 6x DNA Loading dye: 67% (v/v) glycerol, 1 mg mL-1 bromophenol blue, 10% 10x TAE-
buffer. Store at -20 °C.  
27) Nucleotide analog dPTPS as well as phosphorothioated nucleotides (dATPS, dCTPS, 
dTTPS, dGTPS) which can be purchased from BIOLOG Life Sciences Institute (Bremen, 
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Germany); standard dNTPs are available from NEB (New  England Biolabs, Frankfurt, 
Germany). Prepare the following dNTP solutions in oligo buffer and store at -20 °C: 
i. individual solutions of dATP, dGTP, dCTP and dTTP; stock concentration of 100 mM; 
ii. dNTP mix: 10 mM each of dATP, dGTP, dTTP, dCTP; 
iii. individual solutions of phosphorothioate nucleotides (dATPαS, dGTPαS, dCTPαS and 
dTTPαS); stock concentration of  5 mM;  
iv. d(GTP/TTP/CTP)-mix: 10 mM each of dGTP, dTTP, dCTP; 
v. d(ATP/TTP/CTP)-mix: 10 mM each of dATP, dTTP, dCTP; 
vi. d(ATP/TTP/GTP)-mix: 10 mM each of dATP, dTTP, dGTP; 
vii. d(ATP/GTP/CTP)-mix: 10 mM each of dATP, dGTP, dCTP;dPTPS (6-(2-deoxy-β-d-
ribofuranosyl)-3,4-dihydro-8H-pyrimido-[4,5-C][1,2]oxazin-7-one); stock 
concentration of 20 µM; The rate of incorporation of dPTPαS by TdT is lower relative 
to that observed for non-phosphorothioate dPTP. This allows more precise control 
over the addition pattern obtained in SeSaM step 2.  
viii. d(ATP/ATPαS/GTP/TTP/CTP)-mixes: in total 8 mixes with 0%, 10%, 15%, 20%, 25%, 
30%, 35% and 40% dATPαS should be prepared and labeled “A0” to “A40”, 
respectively; on these labels “A” stands for adenine and the number (e.g. 10) signifies 
the percentage of dATPαS in relation to the total amount of adenine species (dATPαS 
+ dATP); the final concentration for each nucleotide in the mix should be 1 mM (e.g. 
to prepare 50 µL A10 mix combine 9 µL dATP (5 mM stock), 1 µL dATPαS (5 mM 
stock), 5 µL d(GTP/TTP/CTP)-mix (10 mM stock), 35 µL dNTP buffer); 
ix. d(GTP/GTPαS/ATP/TTP/CTP)-mixes: in total 8 mixes with 0%, 10%, 15%, 20%, 25%, 
30%, 35% and 40% dGTPαS should be prepared and labeled “G0” to “G40”, 
respectively; “G” stands for guanine and the number (e.g. 10) signifies the percentage 
of dGTPαS in relation to the total amount of guanine species (dGTPαS + dGTP); the 
final concentration for each nucleotide in the mix should be 1 mM; (e.g. to prepare 50 
µL G10 mix combine 9 µL dGTP (5 mM stock), 1 µL dGTPαS (5 mM stock), 5 µL 
d(ATP/TTP/CTP)-mix (10 mM stock), 35 µL dNTP buffer); 
x. d(CTP/CTPαS/ATP/TTP/GTP)-mixes: in total 8 mixes with 0%, 10%, 15%, 20%, 25%, 
30%, 35% and 40% dCTPαS should be prepared and labeled “C0” to “C40”, 
respectively; “C” stands for cytosine and the number (e.g. 10) signifies the percentage 
of dCTPαS in relation to the total amount of cytosine species (dCTPαS + dCTP); the 
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final concentration for each nucleotide in the mix should be 1 mM; (e.g. to prepare 50 
µL C10 mix combine 9 µL dCTP (5 mM stock), 1 µL dCTPαS (5 mM stock), 5 µL 
d(ATP/TTP/GTP)-mix (10 mM stock), 35 µL dNTP buffer); 
xi. d(TTP/TTPαS/ATP/GTP/CTP)-mixes: in total 8 mixes with 0%, 10%, 15%, 20%, 25%, 
30%, 35% and 40% dTTPαS should be prepared and labeled “T0” to “T40”, 
respectively; “T” stands for thymine and the number (e.g. 10) signifies the percentage 
of dTTPαS in relation to the total amount of thymine species (dTTPαS + dTTP); the 
final concentration for each nucleotide in the mix should be 1 mM; (e.g. to prepare 50 
µL T10 mix combine 9 µL dTTP (5 mM stock), 1 µL dTTPαS (5 mM stock), 5 µL 
d(ATP/GTP/CTP)-mix (10 mM stock), 35 µL dNTP buffer); 
2.14.2. Equipment 
1) Microcentrifuge (e.g. Eppendorf, Hamburg, Germany) with rotor for 1.5 mL and 2 mL 
tubes. 
2) Thermocycler with gradient and temperature decrement option (e.g. Thermocycler proS, 
Eppendorf, Hamburg, Germany).  
3) Small volume photometer for quantitation of DNA concentrations in sample volumes of 1 
– 2 µL (e.g. NanoDrop photometer, NanoDrop Technologies, Wilmington DE, USA). 
4) Agarose gel electrophoresis equipment. 
5) Phosphorimager with capability to measure Excitation 494 nm; Emission 518 nm (e.g. 
FLA-3000 from Fujifilm, Düsseldorf, Germany).  
6) Acrylamide gel electrophoresis system (e.g. Mini-Protean Tetra Cell system from Bio-Rad, 
München, Germany). 
7) Recommended: Automated gel electrophoresis system (e.g. Experion system and High 
Sens RNA chip from Bio-Rad, München, Germany). 
8) PCR tubes (0.2 mL). 
9) Microcentrifuge tubes (1.5 mL or 2 mL). 
10) 4 magnets (diameter 20 - 30 mm).  
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2.14.3. SeSaM preliminary experiments 
When SeSaM is performed for the first time for a given gene, the following two preliminary 
experiments should be performed.  
2.14.3.1. SeSaM preliminary experiment I: SeSaM step 1 and step 3 template 
generation 
In the first preliminary experiment, linear DNA templates for step 1 and step 3 of SeSaM 
must be generated. These templates harbor artificial flanking sequences which play an 
important role in SeSaM step 1 and 4.  
1) Assemble the following pre-mastermix (200 µL) on ice in a 0.2 mL tube. Thaw all non-
enzyme components at room temperature and enzymatic components on ice, mix by 
vortexing and collect by a brief centrifugation. 
 
Pre-mastermix (160 µL):     Volume:    
5x Phusion® polymerase buffer    40 µL 
dNTP-mix (10 mM)      4 µL 
Plasmid template       40 ng/kb of plasmid
 Δ 
Phusion® polymerase (2 U/μL) *    2 µL 
Nuclease-free H2O      to a total volume of 160 µL 
* High-fidelity polymerases such as Phusion® are recommended in the preliminary step I to ensure error-
free synthesis of templates. High-fidelity polymerases should not be used in steps 1 to 4 of SeSaM.  
Δ
 e.g. for a plasmid with a total length of 5 kb, use 2 µL of a 100 ng/µL purified plasmid. 
 
2) Mix the pre-mastermix by pipetting. 
3) Divide the pre-mastermix into 4x 40 µL aliquots, then add to each tube add a total of 10 
µL from the following primer pairs (i.e. 5 µL apiece of forward and reverse primer).  
i. SeSaM_fwd_X and Rev_X; Recommended labeling of the PCR reaction and 
product - “step 1_fwd_X”. 
ii. SeSaM_Rev_X and fwd_X; Recommended labeling of the PCR tube reaction and 
product - “step 1_rev_X”. 
iii. SeSaM_fwd_X and SeSaM_dn_X; Recommended labeling of the PCR tube reaction 
and product - “step 3_rev_X”. 
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iv. SeSaM_rev_X and SeSaM_up_X; Recommended labeling of the PCR tube reaction 
and product - “step 3_fwd_X”. 
4) If the optimal annealing temperature for these primer sets has been confirmed 
experimentally, skip points 5 - 7 and proceed to point 8. 
5) Split each PCR reaction (50 µL) into 4 x 12 µL aliquots in fresh PCR tubes. This allows each 
aliquot to be tested at a different annealing temperature in a gradient PCR in order to 
identify the most suitable annealing temperature for each primer set.  
6) Run PCR samples using a temperature gradient in the range 50 °C to 70 °C as follows: 98 
°C 30 sec (1 cycle); 98 °C 15 sec, gradient Tm 30 sec, 72 °C 20 sec/kb of the SeSaM 
template (18 x); 72 °C 5 min (1 x); followed by a 4 °C hold to protect the samples. 
7) Analyze PCR products on a 0.8% TAE agarose gel (7.5 V/cm; 40 min). Identify the primer 
annealing temperature at which the highest amount of specific product is formed and 
use this annealing temperature for the following PCR reactions. 
8) Set up PCR mastermixes (as outlined in points 1 - 3) whereby a total volume of 200 µL 
per primer pair is prepared and split into four aliquots of 50 µL before thermocycling 
using the PCR program with the selected Tm outlined in point 6, above. Combine each 4x 
50 µL of identical PCR products after the PCR is completed. 
9) Confirm that PCR products were successfully obtained by loading a 4 µL aliquot from 
each reaction on a 0.8% TAE agarose gel (7.5 V/cm; 40 min). It is important that the 
SeSaM step 1 template is not contaminated with non-specific products. If nonspecific 
products are present, load and separate the PCR product on agarose gel and perform a 
gel extraction/ purification. 
10) Individually column-purify the remainder of each reaction using the NucleoSpin Extract II 
PCR purification kit and determine the concentration of dsDNA photometrically (e.g. 
using NanoDrop spectrophotometer). Store the purified samples at -20 °C until needed. 
2.14.3.2. SeSaM preliminary experiment II: determination of the optimal 
concentration of phophorothioate nucleotides for step 1 of SeSaM 
When SeSaM is performed for the first time for a given gene, it is also crucial to determine 
the optimal concentration of phosphorothioate nucleotides to use in step 1. This ensures 
that fragments with uniform size distribution spanning the entire gene sequence are 
generated in the first step of SeSaM. 
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1) Prepare a “forward” (fwd) and a “reverse” (rev) mastermix (180 µL each) in 1.5 mL tubes 
on ice. Thaw all non-enzymatic components at room temperature, mix by vortexing and 
collect by brief centrifugation. Keep enzymes on ice. 
 
Forward (fwd) pre-mastermix (144 µL):   Volume:    
10x Taq DNA polymerase buffer    18 µL 
SeSaM_fwd primer (5 µM)     18 µL 
Rev_X primer (5 µM)      18 µL 
SeSaM_fwd_step 1 template      96 ng/kb of SeSaM template * 
Taq DNA polymerase (5 U/µL)     3.6 µL 
Nuclease-free H2O       to a total volume of 144 µL  
 
Reverse (rev) pre-mastermix (144 µL):    Volume:    
10x Taq DNA polymerase buffer    18 µL 
SeSaM_rev primer (5 µM)     18 µL 
fwd_X primer (5 µM)      18 µL 
SeSaM_rev_step 1 template       96 ng/ 1 kb SeSaM template * 
Taq DNA polymerase (5 U/µL)     3.6 µL 
Nuclease-free H2O      to a total volume of 144 µL 
* e.g. for a gene of 1 kb, a total of 4.8 µL of a 20 ng/µL purified SeSaM_step 1 template is used. 
 
2) Prepare the PCR reactions for the test library on ice using 16x 8 µL aliquots of either 
reverse or forward pre-mastermix in PCR tubes. Label tubes “AF0” - “AF40” for A-forward 
test libraries, “AR10” - “AR40” for A-reverse test libraries; “GF0”-“GF40” for G-forward 
libraries and “GR10”-“GR40” for G-reverse test libraries. To each tube add 2 µL of the 
corresponding phosphorothioate nucleotide premix (“A0” to “A40” or “G0” to “G40”, 
respectively), prepared as described in Materials, point 27. When performing preliminary 
experiment II for SeSaM-R protocol d(CTP/CTPαS/ATP/TTP/GTP)-mixes (C0-C40) or 
d(TTP/TTPαS/ATP/GTP/CTP)-mixes (T0-T40) should be used to target T- and C-sites. No 
other modifications in reaction conditions are required. 
3) Run all samples in a PCR cycler for 15 cycles using the following PCR settings: 94 °C 120 
sec (1 x); 94 °C 30 s, optimal Tm of primers 30 s, 72 °C 30 s/kb of SeSaM template (14 x); 
72 °C 180 sec (1 x); followed by a 4 °C hold to protect the samples. 
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4) After completion of the PCR reaction, add 1.1 µL of freshly prepared solution C (the 
iodine solution used to cleave phosphorothioester bonds) to each PCR tube. Mix each 
tube immediately and vigorously by vortexing (10 sec). 
5) Incubate the samples in a PCR cycler for 30 min at 70 °C. Make sure the lid of the thermal 
cycler is pre-heated to 80 °C to prevent sample evaporation. After 30 min the solutions 
should change color from brownish-orange to transparent.  
6) Run the samples (4 µL) on a 0.8% TAE agarose gel (7.5 V/cm; 40 min). Evaluate the gel 
images to determine the condition under which the most homogeneous distribution of 
DNA fragments is achieved, i.e., select the concentration of dNTPαS at which the 
fragments are homogenously distributed over the entire gene length and only traces of 
the uncleaved, full length DNA band are visible (Box 1). 
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BOX 1 
 
An exemplary agarose gel used for evaluation of the optimal phosphorothioate nucleotide 
concentration. A0 to A40 indicates the fraction of phosphorothioate adenine in relation to 
adenine expressed in percentage. Uncleaved PCR product (A0) is loaded in the leftmost lane; in 
the samples prepared with dNTP-mix that contains a certain percentage of phosphorothioate 
nucleotides (right of A0), one can observe a decrease in intensity of the full length band as well as 
a smearing below that increases with dNTPαS concentration. This smearing signifies DNA 
cleavage at sites where phosphorothoate nucleotides have been incorporated. The lane labeled 
A40 represents a case where the concentration of dNTPαS nucleotides is too high as hardly any 
uncleaved fragment are visible and the distribution of fragments is uneven (i.e., small fragments 
are predominant). Lane A10 shows a case when the concentration of phosphorothioate 
nucleotides is too low, i.e. uneven smearing with prevailing large fragments and a very high 
fraction of uncleaved PCR product is observed. A final concentration of phosphorothioate 
nucleotides of 25% (A25) for the SeSaM_rev_library seems to be the optimal condition in the 
presented example. 
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2.14.4. SeSaM step 1: Generation of ssDNA fragment pool with random 
length distribution 
In step 1 of SeSaM, the incorporation of phosphorothioate nucleotides into PCR products is 
carried out. The optimal phosphorothioate nucleotide concentration is determined as 
explained in SeSaM preliminary step II. In SeSaM-Tv classic protocol, A- and G-sites are 
targeted with the pyrimidine analog dPTP, therefore dGTPS or dATPS are randomly 
incorporated in the gene sequence. In step 1 of SeSaM-R protocol, instead of preparing an A- 
and G- library, carry out a T- and C-library (e.g. for preparation of a T-library replace the 
d(ATP/TTP/CTP)-mix with d(ATP/GTP/CTP)-mix; similarly dGTP should be replaced by dTTP 
and dGTPαS by dTTPαS). 
SeSaM step 1 comprises two parts – the incorporation of the phosphorothioate nucleotides 
and the iodine cleavage of the PCR products and resulting biotinylated ssDNA fragments are 
isolated using streptavidin-coated magnetic beads. 
1) Assemble the following “forward” (fwd) and “reverse” (rev) pre-mastermixes (2 x 423 µL) 
on ice. Thaw all non-enzyme components at room temperature, mix by a brief vortex and 
collect by a brief centrifugation. Keep all enzymatic components on ice. 
 
Fwd pre-mastermix (423 µL):      Volume:    
SeSaM template (SeSaM step 1_fwd_X template)   360 ng/kb SeSaM template *  
10x Taq DNA polymerase buffer    45 µL 
Taq DNA polymerase (5 U µL
-1
)    9 µL 
SeSaM_fwd_Bio primer (5 µM)    45 µL 
rev_X primer (5 µM)      45 µL 
Nuclease-free H2O      to a total volume of 423 µL 
 
Rev pre-mastermix (423 µL):     Volume:    
SeSaM template (SeSaM step 1_rev_X template)   360 ng/kb SeSaM template * 
10x Taq DNA polymerase buffer    45 µL 
Taq DNA polymerase (5 U µL
-1
)    9 µL 
SeSaM_rev_Bio primer (5 µM)     45 µL 
fwd_X primer (5 µM)      45 µL 
Nuclease-free H2O      to a total volume of 423 µL. 
* e.g. for a 1 kb gene use a total of 6 µL of a 60 ng/µL purified SeSaM_fwd_step 1 template 
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2) Pipette 188 µL from each mastermix into each of two new PCR tubes and keep the 
remaining volume of each pre-mastermix (47 µL) in the original PCR tube. Add the 
respective nucleotide mix according to the pipetting scheme as follows. 
 
A-fwd library mastermix:     Volume:    
fwd pre-mastermix:      188 µL 
d(GTP/TTP/CTP)-mix (10 mM)     4 µL 
dATP (5 mM)      X µL *    
dATPS (5 mM)      Y µL * 
Total volume:      200 µL 
 
A-rev library mastermix:     Volume:    
rev pre-mastermix      188 µL 
d(GTP/TTP/CTP)-mix (10 mM)     4 µL 
dATP (5 mM)      X µL *   
dATPS (5 mM)      Y µL * 
Total volume:      200 µL 
 
G-fwd library mastermix:     Volume:    
fwd pre-mastermix      188 µL 
d(ATP/TTP/CTP)-mix (10 mM)     4 µL 
dGTP (5 mM)      X µL *   
dGTPS (5 mM)      Y µL * 
Total volume:      200 µL 
 
G-rev library mastermix:     Volume:    
rev pre-mastermix      188 µL 
d(ATP/TTP/CTP)-mix (10 mM)     4 µL 
dGTP (5 mM)      X µL * 
dGTPS (5 mM)      Y µL *
 
Total volume:      200 µL 
*The total volume of dATP and dATPS (dGTP and dGTPS, respectively) should add up to 8 µL; X µL is the 
volume of dATP (dGTP, respectively) and Y µL the volume of dATPS (dGTPS, respectively) used the 
respective reactions (e.g. to prepare dNTP mix (A25) containing 25 % dATPS, one would add 2 µl of 
dATPS and 6 µL of dATP to the reaction mixture. The percentage of dATPS used for a given gene should 
be determined experimentally as outlined in SeSaM Preliminary Step II). 
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Positive control mastermix:     Volume:    
Pre-mastermix      47 µL 
Nuclease-free H2O       2 µL 
dNTP-mix (10 mM)       1 µL 
Total volume:      50 µL 
 
3) Split each mastermix (200 µL) into 4 x 50 µL aliquots in 0.2 mL PCR-tubes and run all 
samples in a PCR cycler using the following parameters: 94 °C 120 sec (1 x); 94 °C 30 sec, 
60 °C 30 sec, 72 °C 30 sec/kb of the SeSaM template-DNA (19 x); 72 °C for 3 min (1 x); 
followed by a 4 °C hold to protect the samples. 
4) Pool the four identical PCR reactions together and run 4-5 µl from each sample on an 
0.8% TAE agarose gel (7.5 V/cm; 40 min). A specific band corresponding to the length of 
the gene of interest should be clearly visible on the gel. 
5) Column-purify the dsDNA products using NucleoSpin Extract II PCR Purification Kit and NT 
buffer according to manufacturer’s recommendation. Elute DNA in 92 μL elution buffer 
(NE-buffer or nuclease-free water) and determine dsDNA concentration. 
6) Combine 80 µL of the purified products with 10 µL of 10x Taq DNA polymerase buffer in a 
fresh 0.2 mL tube. Add 10 µL of freshly prepared solution C to each tube, and thoroughly 
mix by pipetting. Incubate for 30 min at 70 °C in a thermal cycler. During this incubation 
period proceed with steps 7 - 10.  
7) Resuspend the magnetic beads by a brief vortex, until all beads are in suspension. 
8) Transfer 50 µL of the magnetic bead solution into each of four 0.2 mL tubes. Magnetic 
beads tend to precipitate from solution so make sure they are fully suspended before 
aliquoting them. Place each tube horizontally on a magnet and wait until the beads have 
settled down. Discard the liquid while keeping the tube pressed against the magnet. 
9) Add 100 µL 2x B&W buffer to each tube and resuspend by pipetting. Place tube on the 
magnet and wait until the beads have settled down. Prolonged contact between the PCR 
tubes and the magnet may cause the magnetic beads to firmLy stick to the wall of the 
tube and make resuspension difficult. Remove the supernatant by pipetting. 
10) Add 100 µL 2x B&W buffer to each tube and resuspend by pipetting.  
11) Run 4 µL of the cleaved DNA on an 0.8% TAE agarose gel in order to check the 
fragmentation pattern of samples after cleavage and before purification (use 7.5 V/cm; 
40 min), as explained in SeSaM preliminary step II.  
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12) Transfer the remainder of each cleaved library to one of the four tubes containing the 
magnetic beads resuspended in 2x B&W buffer, and mix by pipetting. Incubate each tube 
for 30 min at room temperature to allow the biotin tag to interact to the streptavidin-
coated beads. After the incubation period is over, place each tube on a magnet and wait 
until the beads have settled down. Remove the supernatant by pipetting. 
13) To each tube, add 100 µL solution M and resuspend by pipetting. Incubate each tube for 
2 min at room temperature. Place each tube on the magnet and wait until the beads 
have settled down. Remove the supernatant by pipetting. 
14) Add 100 µL solution M and resuspend by pipetting. Place tube on a magnet and wait 
until the beads have settled down. Remove the supernatant by pipetting (it is important 
to make sure that all traces of solution M are removed). 
15) Add 100 µL 1x B&W buffer and resuspend by pipetting. Place tube on a magnet and wait 
until the beads have settled down. Remove the supernatant by pipetting. 
16) Add 75 µL solution R and resuspend by pipetting. Incubate the samples in a PCR cycler 
for 10 min at 98 °C. Make sure the lid is pre-heated to 104 °C to avoid sample 
evaporation. Do not let the tube cool down! 
17) Place the hot tube on a magnet, wait until the beads have settled down and immediately 
recover the supernatant by pipetting in a fresh 1.5 mL tube. Keep the supernatant. 
Individually column-purify the recovered ssDNA fragments from each tube with 
NucleoSpin Extract II PCR Purification Kit. Use NTC buffer (300 µL per 75 µL ssDNA) for 
binding DNA to the column instead of NT buffer. Elute DNA in 30 μL NE-buffer or 
nuclease-free water. Measure the concentration spectrophotometrically using 
appropriate settings for ssDNA. The concentration of ssDNA fragments after SeSaM step 
1 is usually in the range of 10 - 20 ng µl-1. 
18) If available, we recommend using a microfluidic electrophoresis device (e.g. Experion 
Automated Electrophoresis System from BioRad) after DNA purification to confirm and 
accurately evaluate the size distribution of ssDNA fragments, especially those in the low 
molecular weight range. The fragments generated should be homogeneously distributed. 
If the majority of PCR product remains uncleaved for a particular fragment library, repeat 
SeSaM step 1 by increasing the concentration of dNTPαS by 5% for the corresponding 
library. On the other hand, if many short fragments are observed, repeat SeSaM step 1 
by decreasing the concentration of dNTPαS by 5%.  
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2.14.5. SeSaM step 2: Enzymatic elongation of single stranded DNA with 
degenerate base 
In SeSaM step 2, the ssDNA fragments generated in step 1 are elongated with degenerate 
base analog dPTPS in a TdT-catalyzed reaction.  
1) Prepare five reactions (A-fwd, A-rev, G-fwd, G-rev libraries and the positive control) in 0.2 
mL tubes, on ice, as detailed below. Reaction components should be added in the listed 
order. Make sure TdT is added last. All non-enzyme components should be thawed at 
room temperature and all enzymatic components on ice.  
 
Degenerate base addition reaction mix:   Volume:    
10x TdT buffer       2.5 µL 
10x CoCl2  (25 mM)     2.5 µL 
SeSaM step 1 product      1 pmol of step 1 product  
dPTPαS (20 µM)      2 µL 
TdT (20 U µL
-1
)      2 µL 
Nuclease-free H2O       to a total volume of 25 µL 
 
Positive control (25 µL):      Volume:    
10x TdT buffer      2.5 µL 
10x CoCl2 (25 mM)      2.5 µL 
FITC-labeled primer (2 µM)     2 µL  
dPTPαS (5 µM)      2 µL  
TdT (20 U µL
-1
)      2 µL 
Nuclease-free H2O       14 µL  
 
2) Run all samples in a PCR cycler at 37 °C for 120 min, immediately followed by heat 
inactivation of TdT for 30 min at 75 °C. Make sure the lid of thermal cycler is pre-heated 
to 40 °C during first incubation step and to 80 °C during the inactivation step to prevent 
evaporation.   
3) Keep the positive control aside (SeSaM step 2 positive control; store at -20 °C), and purify 
the other 4 samples using the NucleoSpin Extract II PCR Purification Kit and NTC buffer 
according to manufacturer’s recommendation. Elute DNA in 25 μL elution buffer or 
nuclease-free water.  
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4) Measure the concentration of ssDNA spectrophotometrically and store samples (SeSam 
step 2 products) at -20 °C until the positive control has been analyzed.  
5) Run the positive control of SeSaM step 2 on a 25% acrylamide gel in order to evaluate the 
resulting degenerate nucleotide addition pattern. To cast a 25% acrylamide gel, mix in a 
clean vessel 1.7 mL of deionized H2O, 2 mL of 5x TBE buffer, 6.25 mL of 40% acrylamide-
bis-acrylamide solution, 100 µL of APS and 8 µL of TEMED. Allow the gel to solidify for at 
least 15 min. Place the gel in the running chamber filled with fresh 1x TBE buffer and run 
the gel for 5 min at 100 V prior to applying your samples. In the meantime, mix 5 µL of 6x 
TBE loading dye with the 25 µL positive control reaction. Prepare a negative control by 
mixing together 2 µL FITC primer (2 µM), 8 µL deionized water and 2 µL of 6x acrylamide 
loading dye. Load 6 µL of positive control sample and 4 µL of negative control samples 
per well. Do not use the outermost wells of the gel if possible. Run the gel at 170 V and 
300 mA for 2.5 h. Visualize the gel without removing it from the glass casting chamber 
using phosphorimager/ scanner (ex. 494 nm/ em. 518 nm). Based on this gel, a 
conclusion about the number of nucleotide additions can be drawn. Ideally, all FITC 
primers should be “tailed” whereby fragments elongated with 2 or 3 degenerate base 
analog additions should be the predominant product (see Box 2). 
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BOX 2 
 
Elongation of FITC labeled primer by TdT separated on acrylamide gel and visualized on 
phosphoroimager (ex. 494 nm/ em. 518 nm). Each stair of the ladder in the lane 1 (positive 
control) represents an addition of one universal base to the FITC labeled oligonucleotide. In 
lane 2 (negative control) FITC primer that has not been subjected to elongation reaction is 
loaded as a reference. 
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2.14.6. SeSaM step 3:  Synthesis of the full length gene 
In step 3 of SeSaM, the “tailed” DNA fragments (step 3 products from Section 3.3) are 
elongated to full length genes. In this step the forward and reverse libraries are elongated by 
combining the “SeSaM_step3_ templates” (generated in SeSaM preliminary experiment II) 
with the step 2 products (from step 4 of Section 3.3). If a recombined library with increased 
mutational load is desired, in SeSaM step 3 use equal amounts (80 ng each) of SeSam step 2 
forward and reverse products. No SeSaM_step3_templates should be supplied as forward 
and reverse products serve to template each other’s elongation. 
1) Prepare pre-mastermix for four reactions of 50 µL (2 for fwd and 2 for rev libraries) on 
ice in 0.2 mL tubes.  
Pre-mastermix (120 µL):     Volume:    
10x SuperTaq buffer      20 µL 
dNTP-mix (10 mM)     5 µL 
3D1 polymerase (5 U µL
-1
)     4 µL 
Nuclease-free H2O       to a total volume of 120 µL 
 
2) Split the pre-mastermix into 4 x 30 µL aliquots in fresh 0.2 mL tubes. 
3) To each aliquot, one of the following combinations of SeSaM_step 3_templates and 
SeSaM step 2 products should be added; 80 ng from each in a total volume of 50 µl is 
recommended 
v. Mastermix + step 3_fwd template + A-Fwd step 2 library 
vi. Mastermix + step 3_fwd template + G-Fwd step 2 library 
vii. Mastermix + step 3_rev template + A-Rev step 2 library 
viii. Mastermix + step 3_rev template + G-Rev step 2 library 
e.g. for a 1 kb gene a total of 2 µL of a 40 ng/µL purified SeSaM_step 3_template from 
preliminary experiment II, 8 µL of a 10 ng/µL purified SeSaM step 2 product and 10 µl 
Nuclease-free H2O should be used. 
 
4) Run all samples in a PCR cycler for 20 cycles and preheated lid to 105 °C as follows: 94 °C 
120 sec (1 x); 94 °C 30 sec, 52 °C 1 min, 72 °C 1 min/kb of the SeSaM template-DNA (19 
x); followed by a 4 °C hold to protect the samples.  
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5) When Dpo4 polymerase was employed the mastermix was pre-heated to 98 °C for 2 min 
and cooled down slowly to room temperature, followed by enzyme addition and 
incubation at 55 °C for 120 minutes. The resulting products were purified (NucleoTrap 
Extract II kit) in preparation for the final step of SeSaM. 
6) Column-purify the elongated ssDNA fragments individually using the Nucleospin Extract 
II PCR Purification Kit and NTC buffer according to the manufacturer’s recommendation. 
Elute DNA in 25 μL elution buffer or nuclease-free water. 
7) Measure the concentration of dsDNA spectrophotometrically and store samples at -20 
°C. 
2.14.7. SeSaM step 4: Replacement of degenerate base 
In the last step of SeSaM, Taq polymerase is used in a nested PCR to specifically amplify 
mutated DNA as well as to exchange the previously introduced degenerate bases with 
standard nucleotides. The PCR products can be directly used for cloning in an expression 
vector. 
1) Prepare the following pre-mastermix (400 µL) on ice in a 1.5 mL tube: 
 
Pre-mastermix (360 µL):     Volume:    
10x Taq DNA polymerase buffer    40 µL 
SeSaM_fwd primer (5 µM)     40 µL 
SeSaM_rev primer  (5 µM)     40 µL 
dNTP mix (10 mM)      8 µL 
Taq DNA polymerase (5 U µL
-1
)    8 µL 
Nuclease-free H2O      to a total volume of 360 µL 
2) Divide the pre-mastermix into 4 aliquots of 90 µL in 0.2 mL PCR-tubes.  
3) Add 50 ng per kb of the respective SeSaM step 3 products and adjust the final volume to 
100 µL with nuclease-free water, if necessary.  
4) Split each mastermix into 2x 50 µL in 0.2 mL PCR-tubes. 
5) Run the reactions in the PCR cycler using the following program: 94 °C for 120 sec (1 x); 
94 °C 30 sec, 60 °C 30 sec, 72 °C 45 sec/kb of the SeSaM template-DNA (20 x); 72 °C 3 min 
(1 x); followed by a 4 °C hold to protect the samples. 
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6) Combine each set of duplicate aliquots in one tube and run 5 µL of each sample on a 
0.8% agarose gel (7.5 V/cm; 40 min) to evaluate the quality of PCR amplification. PCR 
clean-up the products using Nucleospin PCR clean-up kit and NT buffer and elute in 25 μL 
in elution buffer or nuclease-free water. If unspecific bands are observed, the specific 
product bands can be isolated in an agarose gel extraction step.  
7) Store the completed SeSaM library at -20 °C or proceed to cloning in an expression 
vector using your preferred methods. 
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3. Results and discussion  
This part is divided into 3 sections, each concluded by a short summary and discussion of the 
most significant findings. The identification of putative Y-polymerase genes by data mining 
and their subsequent cloning, expression, and preliminary biochemical characterization with 
focus on elongation of subsequent transversion mismatches is described in section 3.1. The 
work relevant to development of a suitable high-throughput screening system is summarized 
in section 3.2. In section 3.3, the application of the developed screening system in protein 
engineering of the Y-polymerase Dpo4 from Sulfolobus sulfataricus is presented. From this 
engineering campaign, a Dpo4 mutant with an increased transversion mismatch elongation 
capability was identified. The application of this mutant in the preparation of a model SeSaM 
library and the incurred implications on the quality of the generated library are also 
discussed in section 3.3. 
3.1. Identification and preliminary characterization of Y-family polymerases 
with suitability for SeSaM 
This section presents the identification of putative Y-polymerase genes by data mining, 
cloning, expression, and preliminary biochemical characterization with focus on elongation 
of subsequent transversion mismatches. At the end of the section, the reasons for selecting 
Dpo4 polymerase from Sulfolobus solfataricus for the follow-up work are presented. 
3.1.1. Identification of Y-family polymerases by database mining 
Dpo4 from Sulfolobus sulfataricus P2 has been extensively described in literature, both 
structurally and functionally (Boudsocq et al., 2001; Eoff et al., 2007; Wu et al., 2011; Zhang 
et al., 2009). This polymerase can be regarded as an archetype of the Y-family of DNA 
polymerases (Eoff et al., 2009). In search of proteins with similar properties, a BLASTp search 
(http://blast.ncbi.nlm.nih.gov) against amino acid sequence of Dpo4 (UniProt Accession 
number Q97W02) was carried out. The query identified more than 250 putative polymerase 
sequences exhibiting at least 30 % sequence homology to the query. Two of highest scoring 
sequences from the thermophilic archaeal species Metallosphaera sedula DSM 5348 (58 % 
identity) and Pictophilus torridus DSM 9790 (48 % identity) together with a low scoring 
sequence from Thermoanaerobacter pseudethanolicus ATCC 33223 (37 % identity) as well as 
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that Dpo4 from Sulfolobus sulfataricus were chosen for wet lab investigations. At the time of 
selection, none of these sequences was covered by patents which made them suitable for a 
copy protection with regard to an envisioned commercial application of a SeSaM 
mutagenesis kit. The cDNA for each amino acid sequence was designed to contain flanking 
NdeI and XhoI restriction sites for cloning. A codon optimization of the gene sequences for 
expression in E. coli was also performed. The synthesis of the resulting DNA sequences was 
outsourced to a specialized provider. 
 
 
Figure 10. Phylogenetic tree based on amino acid sequence data, showing the estimated relationship 
between a selection of Y-family polymerases and the ones chosen for preliminary biochemical 
investigations (marked with an arrow). The tree was calculated using the BLASTp algorithm. 
 
3.1.2. Cloning of synthetic genes in expression vectors 
The putative polymerase gene sequences were obtained as synthetic genes from a 
specialized provider in pMA synthetic vectors. Each of 4 genes was re-cloned in 4 different 
vectors suitable for expression in E. coli via restriction cloning. The synthetic vectors were 
digested with NdeI and NotI restriction enzymes to cut out the encoding DNA fragment. The 
digested gene fragments were purified from agarose gel, then cloned in vectors pET28a(+), 
pBADN, pALXtreme-1a and pALXtreme-5b (derivatives of pET28a(+) and pET22b(+) vectors, 
respectively). pET28/22 and pALXtreme-1a/5b vectors harbor a T7 promoter-based 
expression system. The control of expression from pBADN is regulated by araBAD promoter. 
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pET vectors were used in pilot expression and purification studies. In the directed evolution 
experiments of the most suitable Y-polymerase, pALXtreme vectors were employed due to 
their small size which facilitated DNA manipulations, e.g., for cloning of random mutant 
libraries and site-saturation mutagenesis PCR. Cloning of genes was verified by colony PCR 
using vector specific primers and after plasmid isolation, analytical digestion from least 2 
positive colonies was performed as a second confirmation. An exemplary gel of the double 
digestion to verify cloning in pBAD vectors is presented in Fig. 11. In this figure, the correct 
insertion of the genes is marked with an arrow at ~1.1 kb corresponding to the average size 
of the investigated genes. Important to mention is that cloning in pET28a(+) and pALXtreme-
1a was done in frame with a N-terminal histidine-tag which facilitated protein purification.  
 
 
Figure 11. Cloning of the synthetic polymerase genes in pBADN expression vector. An exemplary gel 
showing the result of analytical digestion of pBADN vectors harbouring polymerase genes. For each 
pBADN construct two positive clones after colony PCR were grown in liquid media and the contained 
plasmids were isolated and digested with NdeI and XhoI restriction enzymes. As positive control 
(marked “+”) in this experiment, previously prepared and verified by sequencing pALXtreme-5b 
vectors with the correct inserts were also digestion and loaded on the gel. The digestion of pBADN 
and pALXtreme-5b by NdeI and XhoI exhibited different restriction patterns due to difference in size 
of both vector backbones; however, the contained inserts were identical. The appearance of the 
highlighted specific bands at ~1.1 kb signified a successful cloning procedure. The analytical digestion 
was carried out for a short period of time and was not driven to conclusion, thus the presence of 
additional bands on the gel corresponding to undigested, circular   vector. 
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3.1.3. Preliminary expression studies  
Preliminary expression studies of the putative polymerases were carried out in E. coli BL21 
Gold (DE3) - pET28a and E. coli BL21 Gold (DE3) lacIq1 - pALXtreme-1a expression systems 
using TB growth medium. Expression was carried out in 500 mL flasks containing 50 mL 
media inoculated with saturated pre-culture such that the starting OD600 of the main cultures 
was ~0.1. Cells were grown at 37 °C until OD600 reached ~0.6 then induced with different 
concentrations of IPTG. Samples were collected at regular intervals over a period of 24 h. At 
harvesting of Dpo4, Tps and Mse cultures, OD600 of ~12 and wet cell weight from 50 mL 
culture of ~2 grams were reached. Pto expression yielded OD600 of 5 and wet cell weight 
from 50 mL culture of ~0.9 gram.  In the case of Dpo4 from Sulfolobus sulfataricus and Mse 
from Metallospheara sedula, pellets were incubated with B-PER lysis reagent, according to 
manufacturer’s recommendation to separate cytosolic proteins from cell debris and 
inclusion bodies, then both fractions were loaded on denaturing polyacrylamide gels (Fig. 
12B and 12C). Expression of Pto from Pictophilus torridus and Tps from Thermoanaerobacter 
pseudethanolicus was checked by preparing whole cell samples for SDS-PAGE analysis (Fig. 
12D and 12E). Fig. 12 showed that overexpression was achieved for all four polymerases, 
however the experiment carried out with B-PER lysis reagent suggested that proteins were 
expressed in insoluble form as the expected protein band was found in pellet fractions. 
Subsequent experiments using sonication as a lysis method showed that the enzymes were 
solubly expressed and that the originally employed B-PER lysis was inefficient (Fig. 13). An 
additional benefit of using sonication was that lysis by ultrasound sheared genomic DNA 
(gDNA). The fractionation of gDNA ensured that in follow-up work, the interference of gDNA 
which can potentially serve to template unspecific DNA amplification in PCR or affect the 
interactions between protein and purification matrix, could be minimized.  
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A) B)     
C)  D)  E)  
Figure 12. Expression profiles of Y-polymerases in E. coli BL21 Gold(DE3) pET28a expression system 
and TB media. A) empty vector; B) Dpo4 from Sulfolobus sulfataricus; C) Mse from Metallospheara 
sedula; D) Pto from Pictophilus torridus; E) Tps from Thermoanaerobacter pseudethanolicus. In the 
case of Dpo4 and Mse, cell lysis was done by treatment of whole cells with B-PER reagent, expression 
cultures of Pto and Tps were lysed by sonication. Soluble and insoluble (pellet) fractions were loaded 
on each gel.  Expected protein sizes were in the range of 40 kDA and the corresponding region on 
each gel is highlighted.  
 
 
Figure 13. Utilization of sonication as lysis method for lysis of E. coli expressing Dpo4 polymerase. 
The assay was performed by preparing 30 % cell suspension of expression culture and sonicating on 
ice for 20 min (1 min intervals) using 40 % amplitude. After every 5 sonication cycles samples were 
taken and insoluble fraction (marked P for pellet) were separated from the soluble fraction (marked 
SN for supernatant) and analyzed on a denaturing acrylamide gel. Expected protein size – ca. 40 kDA 
– is highlighted. 
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3.1.4. Thermostability studies with Y-family polymerases in crude cell extracts 
One important criterion for using polymerases in in vitro DNA assays is stability at elevated 
temperatures (≥ 60 °C). Elevated thermostability is also an important pre-requisite for 
application of Y-polymerases in SeSaM step 3 in which truncated gene fragments harboring 
multiple degenerate bases at their 3’-ends have to be accurately hybridized to a template 
and elongated to full length. This can only be achieved if the reaction mixture is iteratively 
brought to high temperature. In addition, the envisioned activity and screening assays for 
polymerases also required thermocycling conditions. The three putative Y-polymerases 
genes were chosen based on sequence similarities to the moderately thermostable Dpo4 
from Sulfolobus sulfataricus. In addition, the selected genes originated from thermophilic 
microorganisms. These two criteria alone did not guaranteed that the resulting proteins 
would indeed be sufficiently thermostable for the envisioned application. Therefore, a 
simple experiment to evaluate the ability of the selected proteins to withstand elevated 
temperature was carried out. Clarified cell extracts were subjected to heat treatment at 
temperatures ranging from 40 °C to 90 °C for 10 minutes. Precipitated and soluble protein 
fractions were separated by centrifugation and separately loaded on SDS acrylamide gel. The 
resulting gel images are presented in Fig. 5. Dpo4 and Mse showed a similar degree of 
thermostability. These proteins remained soluble even after incubation at 80 °C for 10 
minutes (Fig. 14A and 14B). Tps could withstand up to 60 °C but precipitated when exposed 
to higher temperatures (Fig. 14C). Pto exhibited much lower stability at elevated 
temperatures. The latter protein was found in the insoluble fraction after incubation at mild 
temperature (40 °C) and no soluble protein could be detected after heat treatment at 70 °C 
(Fig. 14D). Based on these observations it was concluded that Pto from Pictophilus torridus is 
not a suitable polymerase for use in SeSaM (unless it was first evolved for increased 
thermostability). Nevertheless, Pto was employed together with the other three enzymes in 
preliminary activity tests. Thermostability valuation also provided important hints on how to 
efficiently purify polymerases that exhibited resistance to treatment at elevated 
temperature. Simply by heating up crude cell extracts most E. coli proteins could be 
precipitated leaving only a fraction of E. coli native proteins to be removed by 
chromatographic methods. 
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A)  B)  
 
C)  D)  
Figure 14. Thermostability studies for A) Dpo4; B) Mse; C) Tps; D) Pto. Expected Y-polymerase sizes 
of ca. 40 kDA are highlighted on each gel picture. Soluble fractions are marked with SN and insoluble 
fractions with P. 
 
3.1.5. Purification of Y-family polymerases 
The cloning of Y-family polymerases in pET28a(+) and pALXtreme-1a using a NdeI restiction 
site allowed protein expression in frame with a N-terminal His-tag and, consequently, 
purification by affinity chromatography. Expression of the four polymerases was carried out 
as outlined in the previous paragraph. Crude extracts containing Dpo4, Mse and Tps were 
heat treated at 80 °C (60 °C for Tps) for 10 min prior to applying the clarified cell extract on 
Protino Ni-IDA pre-packed columns. Cell extract of Pto were loaded on the Ni-NTA column 
without heat denaturation of E. coli proteins. Column washing and elution was conducted as 
described in “Materials and Methods” section. The resulting gels containing samples at 
different stages of purification are presented in Fig. 15. The fraction of target protein in the 
purified samples varied from ~60 % (for Dpo4) to ~80 % (for Pto) and protein concentration 
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reached up to 5.5 µg/mL (for Pto). These purity levels were sufficient to conduct preliminary 
activity assays with purified enzymes. At a later stage, the purification protocol for Dpo4 was 
refined by supplying more stringent heat denaturation, washing and sample elution (see 
section 3.3).  
A)   B)   C)    D)  
Figure 15. SDS-PAGE gel images after pilot purification of A) Dpo4; B) Mse; C) Tps; D) Pto. Whole cell 
extracts (CFE) were clarified and heat treated at 80 °C (or 70 °C) for 10 minutes. Heat denaturation 
step was omitted in the case of Pto. Soluble fractions were applied to pre-packed Ni-IDA column and 
washed extensively with LEW buffer supplied with the Protino Ni-IDA purification kit. Flow-through 
fractions (FT) were also loaded on the gel. Protein of interest was eluted from the column by addition 
of elution buffer supplied with the Protino Ni-IDA purification kit. The proteins of interest 
(highlighted in a rectangular box) could only be detected in the elution fractions (marked as E).  
 
3.1.6. Forward primer elongation assay with purified Y-polymerases 
Forward primer elongation assay has been commonly used as an activity assay to probe the 
specific activity of polymerases with non-canonical primer-template pairs. This assay is 
especially useful for characterization of distributive (i.e., low-processive) polymerases (Avkin 
et al., 2004; McCulloch and Kunkel, 2008; Prakash et al., 2005). The assay procedure 
comprises DNA polymerase-catalysed elongation of a fluorescently labeled primer on a short 
single-stranded template, separation of DNA products on an acrylamide gel and visualization 
of the fluorescent probe on a fluorescence imager (Fig. 16A). In this study, forward primer 
elongation assay was used to evaluate the ability of the purified Y-polymerases to elongate 
primer-template pairs forming one or multiple transversion mismatches at 3`-end of 
primers. In the employed setup, the fluorescently-labeled primer oligo was designed to 
contain two degenerate pyrimidine base analogs (dPTP; pairs with A and G) attached at 3’-
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end of the primer. This nucleotide was used because it is routinely employed in the 
preparation of transversion-enriched SeSaM mutant libraries. Templates forming a match, a 
single or double mismatch at the 3`-end of the primer provided the possibility to probe the 
capability of the investigated polymerases to “read” mismatches of increasing complexity 
(no mismatch vs a single transversion mismatch vs a double transversion mismatch). Relative 
mismatch elongation efficiency of Dpo4, Mse, Tps and Pto was estimated after incubating 
pre-hybridized primer-template pairs with equal amount enzyme at 37 °C for 60 min (Fig. 
16B). This preliminary test showed that all four enzymes could efficiently elongate a dPTP-
tailed primer when a matching template was supplied. Elongation of a single transversion 
mismatch could be carried out with low efficiency by Dpo4, Pto and Tps but hardly any 
elongation could be catalyzed by Mse under the aforementioned reaction conditions. Two 
consecutive transversion mismatches could not be elongated by any of the Y-polymerases. 
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A)                                   
B)                                  
Figure 16. A) A schematic outlining forward primer elongation assay procedures; B) Monitoring of 
the extension of FITC-labeled primer with two 3’-attached dPTP bases by four Y-family polymerases. 
FITC-labeled products separated on acrylamide gel and visualized on phosphoroimager (ex. 494 nm/ 
em. 518 nm). Each band represents an addition of nucleotide(s) to the FITC labeled oligonucleotide. 
In the lanes labeled “-“ (negative control), reaction mastermix  subjected to incubation without 
addition of enzyme is loaded as a reference sample. See Box 2 for further explanations on how to 
interpret results. 
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3.1.7. Summary: Identification and preliminary characterization of Y-family 
polymerases with suitability for SeSaM  
To resolve the bottleneck in step 3 of the SeSaM method by achieving more efficient 
elongation of consecutive nucleotide mismatches at 3`-end of primers, 4 genes (3 putative + 
1 described) encoding Y-family DNA polymerases were selected for preliminary studies. 
Members of this polymerase family are exclusively involved DNA synthesis past damaged 
DNA (Ohmori et al., 2001) and were, therefore, perceived as suitable starting point for this 
study. All four genes were successfully cloned, expressed and purified in preparation for 
preliminary characterization. Activity assay with purified enzyme confirmed that the genes 
identified from genetic databases were correctly assigned and indeed encoded DNA 
polymerases. The results from the biochemical and thermostability tests were useful for 
ranking of the polymerases in terms of suitability for application in SeSaM step 3. After the 
thermostability tests, Pto polymerases was excluded due to its low stability at elevated 
temperatures. After testing for the desired mismatch elongation activity, the least efficient 
polymerase (Mse) which under the applied conditions was not able to elongate efficiently 
even a single transversion mismatch was also eliminated from the selection. Moreover, the 
activity assay showed that none of the polymerases is capable of efficiently elongating a 
consecutive transversion mismatch, reinforcing that protein engineering of polymerases 
would be necessary in order to improve the efficiency of SeSaM step 3 and further advance 
the SeSaM method. Taking into account that valuable biochemical and structural data for 
Dpo4 was readility available in literature, Dpo4 polymerase from Sulfolobus solfataricus was 
to initiate a protein evolution campaign aiming at identifying a polymerase variant with 
improved mismatch elongation efficiency.  
3.2. Development of a screening system for high-throughput screening of Y-
family polymerases  
In order to engineer Dpo4, a high-throughput screening system that reflects well the 
envisioned application in SeSaM is indispensable. The development of such screening system 
is described in this section. The activity assay (i.e., forward primer elongation assay) used for 
the preliminary characterization of Y-family polymerases, although reliable, lacked the 
required throughput to screen large mutant libraries and identify a mutant with improved 
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performance. Finding an alternative screening approach with a high-throughput for testing 
consecutive transversion mismatch elongation efficiency was therefore crucial for the 
successful outcome of the entire project. Three approaches to the challenge were tested: 1) 
compartmentalized self-replication (CSR),2) a screening approach based on dsDNA 
quantification using a double stranded DNA binding dye and 3) a duplex DNA probe used for 
real time quantitative PCR (termed Scorpion probe). The duplex Scorpion probe-based 
screening system in 96-well plate format for directed evolution of polymerases was 
eventually selected and optimized for screening applications.  
3.2.1. Emulsion-based screening system for directed evolution of the Y-
polymerase 
At first, an emulsion-based selection system termed compartmentalized self-replication 
(CSR) was employed with the Y-family polymerase Dpo4. CSR has been successfully used to 
evolve replicative polymerases (Ghadessy and Holliger, 2007; Tubeleviciute and Skirgaila, 
2010), (Ghadessy et al., 2001). CSR uses a simple feedback loop involving a polymerase that 
self-replicates only its own encoding gene (Fig. 17). Self-replication occurs in separate, non-
interacting compartments formed by a heat-stable water-in-oil emulsion. 
Compartmentalization mediates the linkage of phenotype and genotype by ensuring that 
each polymerase replicates only its own encoding gene. Single cells and other components 
necessary for PCR reactions (DNA primers, dNTPs, Mg2+, etc.) are compartmentalized 
individually in thermostable water-in-oil emulsions. Individual compartments contain one 
cell and consequently a single Y-polymerase variant. The emulsions are incubated under PCR 
conditions and only active Y- polymerase mutants can form a PCR product. The supplied 
primer pairs are designed such that Y-polymerase gene which encode active Y-polymerase 
mutants are exponentially amplified. In addition, the primers used form a transversion 
mismatch between two degenerate base analogs (dPTPs) at the 3'-ends of primers and two 
pyrimidine bases in the template strand in accordance with the requirements of the SeSaM 
technology. The attempts to adapt CSR to screening of mutant libraries of Dpo4 polymerase 
proved unsuccessful. Consequently, only the main results are discussed in short.  
In the early experiments, CSR was attempted by emulsifying cells expressing Dpo4 
polymerase, however polymerase expression level was insufficient for gene self-
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amplification to take place. Even though Dpo4 is known to amplify long DNA fragments 
when sufficiently high enzyme concentration is provided in the mastemix (Boudsocq et al., 
2001), it remains a distributive polymerase largely limited in its processivity. The achieved 
Dpo4 expression level from a single cell in emulsions (an estimated 0.06 ng  µL-1, under 
optimized expression conditions) corresponded to only 0.6 % of the enzyme amount (~10 ng 
µl-1 mastermix) needed for PCR amplification (Fig. 18). The addition of a small amount Taq 
polymerase to the reaction mix (in order facilitate DNA amplification after Dpo4-catalysed 
elongation of the transversion mistmatch) also did not lead to substantial increase in 
product formation (data not shown). As a next step, an in vitro Dpo4 expression coupled to 
PCR amplification in emulsions was attempted. The in vitro expression of Dpo4 was 
successful as confirmed via forward primer elongation assay (Fig. 19A); however, the in vitro 
expression level of Dpo4 was not sufficient to generate full-length products by PCR in tubes 
or PCR in emulsions as illustrated in Fig. 19B.  
DNA-binding domain, Sso7d, can be fused to polymerases in order to increase their 
processivity of polymerases (Wang et al., 2004). These fusion polymerases are characterized 
by very high processivity and are among the most efficient, commercially available DNA 
polymerases (e.g., Phusion® polymerase from New England Biolabs). This strategy was 
applied in order to increase the processivity of Dpo4 and decrease the necessary enzyme 
load per emulsion compartment. Therefore, Dpo4 was genetically fused to Sso7d and the 
resulting construct was expressed and purified (Fig. 20A). A simple PCR-based experiment 
was carried out to check whether the fusion polymerase, Dpo4S, exhibited increased 
processivity. DNA sequences of different length (0.2 to 2.5 kb) were amplified with varied 
amount of purified enzyme (30 to 240 ng per 25 µl reaction)., Amplification by Dpo4S of the 
0.2 kb target sequence could be observed only at an enzyme dose of ~10 ng µl-1 (Fig. 20B). 
Therefore, Sso7d domain did not affect positively the processivity of Dpo4 and the approach 
was not pursued any further. 
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Figure 17. Schematic of the compartmentalized self-replication selection system. A library of 
polymerase genes is cloned and expressed in E. coli. Spheres represent active polymerase molecules. 
Bacterial cells containing the polymerase and encoding gene are suspended in reaction buffer 
containing ﬂanking primers and dNTPs and segregated into aqueous compartments. The polymerase 
enzyme and encoding gene are released from the cell, allowing self-replication to proceed. Poorly 
active polymerases (white hexagons) fail to replicate their encoding gene. The offspring polymerase 
genes are released and re-cloned for another cycle of CSR (adapted from Ghadessy et al., 2001). 
 
 
Figure 18. PCR amplification with varied concentration of purified Dpo4 polymerase in order to 
determine the minimal Y-polymerase concentration necessary for amplification of a 1 kb DNA 
fragment. Legend: M, marker; 1.2 µg Dpo4/25 µl mastermix; 0.6 µg Dpo4/25 µl mastermix; 0.3 µg 
Dpo4/25 µl mastermix; 0.15 µg Dpo4/25 µl mastermix. 
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A)     B)  
Figure 19. A) In vitro expression of Dpo4 coupled to forward primer elongation assay in emulsions. 
Legend: I - negative control; II – non-emulsified purified Dpo4; III – emulsified purified Dpo4; IV – 
non-emulsified in vitro/reaction mastermix; V – emulsified in vitro/reaction mastermix; B) 
Comparison of the activity (no mismatch supplied) of purified and in vitro expressed Dpo4 enzyme 
for PCR reactions in emulsions. The positive control Taq polymerase (+) shows the target band of an 
ordinary PCR which could also be obtained with purified Dpo4 (I). The negative control without 
enzyme showed no target band (-). Dpo4 enzyme from in vitro expressions is not visible by ordinary 
target amplification PCR (II) or in the emulsion PCR sample (III). 
 
A)   B)  
Figure 20. A) Cloning and purification of Dpo4S; Left) a DNA gel showing the linearized genetic 
construct is presented, M - DNA marker, A – Dpo4, B - Dpo4S; Right) an image of the polyacrylamide 
gel after expression of Dpo4S is shown, M - protein standard, 1 - Soluble cell-free extract after heat 
precipitation 80 ° C, 2 – flow through after HisTag purification, 3 - eluate with Dpo4S. The arrow 
indicates the purified fusion protein Dpo4S; B) Result of the amplification of sequences of varied 
length (0.2 kb, 1 kb and 2.5 kb) using 30 ng (A) 60 ng (B), 120 ng (C) and 240 ng (D) Dpo4S in 25 µl 
reaction volume. Also shown are DNA marker (M) and a positive control with Taq polymerase (+) and 
negative control without added enzyme (-). 
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3.2.2. PicoGreen® double stranded DNA (dsDNA) dye-based screening system 
One common way of quantifying DNA accumulation (e.g., in qPCR) is by the use of dsDNA 
intercalating dyes such as PicoGreen® (Dragan et al., 2010; Holden et al., 2009; Singer et al., 
1997). These dyes interact specifically with dsDNA and upon intercalation become 
fluorescent. The intensity of fluorescent signal is proportionate to the amount of DNA 
formed. This property can be used to measure the degree to which DNA polymerases are 
able to generate dsDNA product in a defined time span. In the envisioned screening system 
setup, Dpo4 polymerase was expressed in microtiter plates (MTPs), then cells were lysed 
and the cell supernatant was used to amplify short DNA fragment (200 bp long). The amount 
of DNA formed after thermocycling was detected via PicoGreen® dsDNA dye as 
recommended by the manufacturer. Preliminary studies in which a short template was 
amplified with primers forming no mismatch showed that even though DNA product could 
be generated and visualized on agarose gel, the background fluorescence was too high for 
reliable dsDNA quantification. The high background was due to the fact that crude cell 
extracts were used, therefore E. coli-derived dsDNA was also present in the cell supernatant 
(Fig. 21). This idea was abandoned in favor of a more specific, fluorescence-based probe for 
detection of polymerase activity which is described next.  
A)  B)  
Figure 21. A) Agarose gel visualization of 200 bp product produced with 1 µL (I), 2 µL (II), or 4 µL (III) 
of concentrated cell lysate containing Dpo4 or expressing no polymerase (EV); B) PicoGreen® dye 
quantification of PCR products produced with 1 µL, 2 µL or 4 µL of cell lysate containing Dpo4. The 
values for lysate of cells harboring empty vector is an average of 3 measurements and the values for 
lysates of cells harboring Dpo4 encoding gene is an average of 6 measurements. 
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3.2.3. Establishment of a Scorpion probe-based screening system for Y-family 
polymerases 
Earlier attempts to establish a screening system , even though unsuccessful, showed that an 
ideal screening system for directed evolution of Y-polymerases comprises of a highly specific, 
sensitive, closed-tube, robust assay that allows for continuous monitoring of activity that is 
capable of detecting enzymatic activity idependent of polymerases’ processivity, 
thermostability, displacement and exonuclease activity. Bearing these pre-requesites in 
mind, a fluorescent probe for polymerases originally employed in genotypic assays (Carters 
et al., 2008), single nucleotide polymorphisms or alllelic discrimination (Solinas et al., 2001) 
was finally selected as a suitable reporter for polymerase activity. Scorpion probes are bi-
functional molecules in which a primer oligo is linked in a flexible manner to a probing oligo. 
The probe element which is covalently attached a fluorophore can hybridize to a specific 
DNA sequence generated after elongation of the primer.  If the primer is not elongated, the 
fluorescence is quenched by a separate quencher-bound oligo that pairs with the probe 
element. In the presence of the intramolecular target sequence which appears when the 
primer element is elongated, the fluorophore and the quencher separate and the elongated 
Scorpion rearranges which leads to an increase in the fluorescence signal as outlined in Fig. 
22. The kinetics of such a rearrangement mechanism are very rapid, thus not a rate-limiting 
step. The specificity of binding of the probe element to its target (or quencher, respectively) 
ensures reliability of probing and high signal-to-noise ratio. Additionally, the stoichiometry of 
the reaction (one amplicon leads to one fluorescent signal) and concentration independency 
of probing provides reliable quantification and enhances overall sensitivity (Carters et al., 
2008).  
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Figure 22. Principle of action of the Scorpion probe assay adapted for detection of DNA polymerase 
ativity. A Scorpion probe comprises a primer covalently bound through a spacer molecule to a probe 
oligo with a fluorophore attached at its 5`-end. A separate quencher molecule consists of a quencher 
dye attached to a oligonucleotide complementary to the probe element. Prior to primer elongation 
on a synthetic, single stranded template designed to contain a specific sequence at its 5’-end which 
upon replication results in a region complementary to the probe sequence, the probing element is 
attached to the quencher, thus fluorescence levels are kept low. After extension of the primer 
element, the probe element is on the same strand as its complementary target and the probe can 
bind to its complement by a rapid intramolecular rearrangement. As a result, the fluorophore 
becomes unquenched which leads to an increase in specific fluorescence.  
 
The probe design and reaction conditions were selected in accordance with the 
corresponding protocol published in the book „Molecular Beacons: Signalling Nucleic Acid 
Probes, Methods, and Protocols“ (Carters et al., 2008) with minor modifications. To adapt 
the probe for application in enzyme screening, a synthetic, single-stranded DNA template 
was employed such that a 73-mer oligo harbouring the target sequence at its 3‘-end is 
elongated. Such an amplicon length ensured sufficient flexibility for molecular 
rearrangement to take place and short enough to minimize formation of non-specific but 
stable secondary DNA structures. Further flexibility is achieved through the incorporation of 
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a spacer molecule between the primer and probe element and ensures that the probe 
element is not incorporated in PCR product.   
The Scorpion probe screening system was optimized for subsequent transversion mismatch 
elongation by first employing varying concentrations of purified Dpo4 wild type (WT) in 
order to determine the assay‘s working range and compensate for the inherent fluroescence 
loss at low protein concentrations (Fig. 23). From this experiment it was deduced that ~200 
ng of Dpo4 is the lower detection limit for reliable determination of Dpo4 activity. In the 
latter case, a linear response was achieved from the first to at least the 15th thermal cycle.  
 
 
Figure 23. Dpo4 polymerase concentration (per 25 μL) in response of Scorpion probe fluorescence; 
50 ng Dpo4 are sufficient for detection of polymerase activity; in the screening of mutant libraries 
~200 ng Dpo4 were employed. 
 
The Scorpion screening system was parallelized in 96-well microtiter plates (MTP) using 
crude cell extracts of E.coli expressing Dpo4 WT. Cell lysates were prepared such that the 
pre-determined amount of polymerase (accounting for roughly 20 % of total protein in the 
soluble fraction) could be supplied after cell lysis in 96-well MTP format and resulted in a 
standard deviation of 25 % (Fig. 24). Deviations of ~20 % have been reported in successful 
directed evolution campaigns (Lan Tee and Schwaneberg, 2007). Stringent selection 
conditions are important prerequisites to identify improved muteins; therefore only hits 
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with at least a 2- fold relative increase in activity were considered for re-screening and 
characterization studies. 
 
 
Figure 24. Activity values in descending order of Dpo4 catalyzed transversion mis-match elongation 
in a 96-well microtiter plate using optimized Scorpion probe screening system. The measured 
coefficient of variation was 25 %. 
 
3.2.4. Summary: Development of a screening system for high-throughput 
screening of Y-family polymerases  
In summary, three different strategies to establishing a screening system for Y-family 
polymerases and Dpo4 from Sulfolobus solfataricus in particular have been pursued. The 
application of compartmentalized self-replication (CSR) approach were not suitable for Y-
family polymerases due to inherent low processivity and, therefore, inability to amplify long 
DNA fragments at low enzyme load  and self-amplify its encoding gene. Thus, despite the big 
advantages with regard to throughput, the idea of using CSR as a selection system for Dpo4 
variants capable of elongating consecutive transversion mismatches was abandoned and 
other microtiter plate-based screening systems were investigated. The use of dsDNA binding 
dye which was attempted as a second approach was also unsuccessful. This was due to the 
high background fluorescence as a result of genomic and plasmid DNA added with crude cell 
extracts. The third strategy to adapt a fluorescent probe for real-time PCR to screening of 
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polymerase libraries was successful.  From the plethora of RT-PCR probes available, Scorpion 
probe was identified to be suitable for the envisioned application, also with regard to the 
peculiarities of Y-family polymerases (i.e., low processivity, no exonuclease and 
displacement activity). The Scorpion probe could be adapted to screening of polymerase 
mutant libraries. After some optimization, good enzyme concentration dependent response 
and an acceptable coefficient of variation were achieved. The system was further validated 
by screening of mutant libraries of Dpo4 polymerase. The screening campaign and 
characterization of hits from mutant libraries is described in section 3.3. 
3.3. Engineering of the Y-family polymerase Dpo4 for application in directed 
evolution  
The engineering of Dpo4 polymerase from Sulfolobus solfataricus towards more efficient 
elongation of consecutive transversion mismatches is presented in this section. To achieve 
this objective, the Scorpion probe screening system was used to screen saturation 
mutagenesis libraries of Dpo4. The screening campaign resulted in the identification of a few 
hits which were subsequently purified and characterized with respect to the desired activity. 
Finally, one of the improved Dpo4 mutants was employed in SeSaM step 3. The resulting 
library contained a significantly increased fraction of the desired mutation type in 
comparison to a reference libraries prepared Dpo4 WT as well as 3D1 polymerase, which has 
been routinely employed in SeSaM. These favorable results also served to validate the 
developed screening system for distributive polymerases.  Other aspects, such as the 
selection of position for mutagenesis and the generation of site specific mutagenesis 
libraries as well as of random mutagenesis libraries and their pre-screening are also 
discussed in this section. 
3.3.1. Generation and pre-screening of random mutagenesis libraries 
The generation of epPCR libraries was performed with Taq polymerases, balanced dNTPs 
and varied concentration of Mn2+. The libraries were cloned into pALXetrme-5b using a 
ligase independent method, PLICing (Blanusa et al., 2010b). The cloned libraries were 
transformed first into E. coli DH5α and re-transformed in E. coli BL21 Gold (DE3) LacIq1 cells 
for screening. As expected, the amount of epPCR product and transformation efficiency 
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decreased with increasing Mn2+. However, at least 1500 clones were obtained even for the 
PCR product obtained even with the highest manganese concentration employed for 
mutagenesis (Fig. 25A). Due to throughput limitations of the available screening 
methodology, it was opted for a “quick-and-dirty” test to check for desired activity in the 
epPCR libraries with the lowest and highest mutational load. The test was carried out by 
expressing mutant libraries on LB agar supplemented with IPTG. Next, individual clones were 
pooled and crude cell extracts of the mix of mutants was prepared. The cell-free lysate was 
used for elongation of a FITC-labeled primer on short linear templates with which the 
fluorescent primer formed either a match or a double transversion mismatch at the primer‘s 
3‘-end. Visualization of the resulting products on acrylamide gels was performed as a final 
step. Protein expression was confirmed by visualizing the products on a protein gel. In 
addition, enzymatic activity could be detected when a matching template was employed, 
reaffirming that target proteins were successfully produced. However, no activity could be 
detected when a template forming a consecutive transversion mismatch was employed in 
the reaction even when at high enzyme load. Expression and screening results are 
summarized in Fig. 25B. The negative result and the presumably better prospects of finding 
an improved mutant by semi-rational design, made screening of individual clones from 
epPCR libraries in microtiter plates undesirable. In stead, more efforts were focused on 
screening of saturation mutagenesis libraries. 
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A)    
 
B)  
Figure 25. Generation and screening of random mutagenesis libraries by epPCR using Taq, balanced 
dNTPs and increasing concentration of Mn2+ and cloned using PLICing. A) On the left, epPCR products 
visualized on an agarose gel. On the right, a table showing the transformation efficiencies obtained 
for epPCR libraries; B) Screening of entire epPCR libraries 0.1 mM and 0.5 mM for elongation of a 
double transversion mismatch elongation using the forward primer elongation assay. Reactions with 
lysate of expression culture comprising a mix of epPCR mutants was carried out with FITC-PP primer 
and matching as well as double trasversion mismatch templates; 2 μL and 10 μL of crude cell extract 
was used in the case of double transversion elongation. 
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3.3.2. Selection of amino acid positions for saturation mutagenesis studies. 
A total of 21 amino acid residues for saturation mutagenesis were selected, namely Y10, 
V32, A34, A44, V62, M76, K78, D156, A181,P184, 188, A191, R242, R247, K275, V289, L293, 
R331, R332 and R336. The selection of residues for saturation mutagenesis was done in a 
semi-rational manner whereas computational tools and literature search were used to 
identify potential sites for mutagenesis. Firstly, a Hotspot Wizard (Pavelka et al., 2009) 
analysis of the amino acid sequence and crystal structure of Dpo4 was carried out. Hotspot 
Wizard is a program that combines bioinformatics databases and computational tools to 
perform simultaneous structural and evolutionary analyses for automated identification of 
sites for engineering of substrate specificity, activity or enantioselectivity of enzymes. 
Residues identified as “hotspots” for mutagenesis are rated according to their mutability and 
are accompanied with the structural and functional information. The statement of variability 
at the respective positions enable rational predictions about the mutability of the amino 
acids and serves as an indicator of the possible (functional) diversity. The top scoring 
positions from Hotspot Wizard analysis of the amino acid sequence of Dpo4 were visualized 
on the available crystal structure in order to identify those residues that participate in 
substrate binding (i.e., were found less than 6 Å from the DNA substrate).  As a second 
selection criterion, the difference in B-factors for Dpo4 crystal structures with matching 
(PDB: 1S97) and mismatching (PDB: 1S9F) template-primer-DNA substrate and these values 
were used to refine the primary selection of residues for mutagenesis. With the help of the 
B-FITTER program (Reetz and Carballeira, 2007), one can analyze the electron density 
distributions in crystal structures and study the flexibility and importance of individual amino 
acids (reflected in their B-factor values) on properties such as thermostability and substrate 
specificity. The least flexible residues from the primary assortment were excluded from the 
selection. In a last selection step, an in-depth literature search was carried out in order to 
find experimental evidence for the importance of as many positions from the secondary 
assortment and to narrow down the final selection to ~20 positions. The residues that 
comprised the primary selection as well as those that were finally selected for mutagenesis 
are presented in Fig. 26.  
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A)                                   
 B)                               
Figure 26. Crystal structure of DNA polymerase IV from Sulfolobus solfataricus bound to G:T 
mispaired DNA substrate in the presence of an incoming nucleotide (PDB ID 1S97) A) Amino acid 
residues within 6 Å from the DNA substrate; B) 21 residues were selected for saturation mutagenesis; 
20 residues (Y10, V32, A34, A44, V62, M76, K78, D156, A181,P184, P188, A191, R242, R247, K275, 
V289, L293, R331, R332)  are shown as sticks and residue R336, later identified in this study 
mutagenic hotspot, is represented in balls. 
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3.3.3. Generation of saturation mutagenesis libraries 
The generation of saturation mutagenesis libraries was carried out using a two-step PCR 
procedure involving amplification of “megaprimers” harboring point mutations and the 
subsequent cloning of these DNA fragments using MEGAWHOP. The “megaprimers” were 
generated with a degenerate forward primer and a site-specific reverse primer harboring the 
mutagenic codon. The overall strategy is presented in Fig.  27A. The PCR product from the 
“megaprimer” and MEGAWHOP PCRs are shown in an exemplary gel for 8 positions in Fig. 
27B. The transformation efficiencies for the MEGAWHOP primers varied significantly, 
however they were sufficient for the preparation of 2 MTPs per position (i.e., at least 200 
clones were obtained). 
A)                                    
B)                    
Figure 27. Generation of saturation mutagenesis libraries. A) Schematic outlining the 2 step PCR 
procedure involving a “megaprimer” PCR and a MEGAWHOP PCR for generation of saturation 
mutageneis libraries as well as the preliminary template generation step for the “megaprimer” PCR; 
B) An exemplary agarose for 8 positions after “megaprimer” PCR (left) and MEGAWHOP PCR (right). 
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3.3.4. Screening of saturation mutagenesis libraries 
A total of 21 saturation mutagenesis (SSM) libraries were generated at positions Y10, V32, 
A34, A44, V62, M76, K78, D156, A181, P184, N188, A191, R242, R247, I248, K275, V289, 
R298, L293, R331, R332 and R336. The respective mutant libraries were first screened for 
improved elongation of a defined double transversion mismatch (i.e., GC in the primer stand 
facing GC in the template strand) using Scorpion detection system in MTPs. The overall 
screening strategy is shown in Fig. 28. The data from the primary screening was analyzed 
and based on the result 3 new 96-well MTPs were prepared comprising only hits from the 
initial screening. A new test with the help of the Scorpion detection system was carried out 
in duplicate (Fig. 29A), and only the most reproducible results were considered for further 
characterization by forward primer elongataion assay. Fifty positive hits were tested using 
forward primer extension assay for elongatation of degenerate double transversion 
mismatch, i.e., PP in the primer strand and CT in the template strand, where „P“ is the 
degenerate pyrimidine analogue, dPTP, employed in SeSaM (Fig. 29B). The clones were aslo 
sequenced to identify the mutations contained by individual hits. The highest activities were 
detected in SSM libraries at positoins R242 and especially R336. Consequently, one mutant 
from library R242 and two mutants from library at position R336 were selected for 
characterization in purified form. 
 
 
 
 
 
 
 
CHAPTER I. Engineering of DNA Polymerases for Application in Directed Protein Evolution 
  Results and Discussion 
 
98 
 
Figure 28. Scorpion probe screening system for relative quantification of polymerase activity in 96-
well microtiter plate format. A Scorpion probe comprises a primer that is covalently bound via a 
spacer (Spacer18, hexaethylene glycol) to a probe oligo with a fluorophore (6-FAM, 6-
carboxyfluorescein) attached at its 5`-end. A separate quenching primer consists of a quencher 
molecule (BHQ-1, black hole quencer 1) that is attached to an oligo with a complementary sequence 
to the 6-FAM oligo. If the probe is not elongated, the quenching primer hybridizes to the probe oligo 
and fluorescence is quenched. In case that the oligo probe is elongated an intramolecular 
hybridization sequence without a quencher is generated. As a results the probe rearranges and the 
fluorophore becomes unquenched generating a fluorescence signal (ex: 495 nm; em: 520 nm) 
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A)  
B)                                       
Figure 29. Exemplary results from re-screen of positive hits from site-saturation mutagenesis libraries 
at positions R242, R247 and R336 using A) Scorpion assay and B) forward primer elongation assay; 
full length product indicated by an arrow. 
 
3.3.5. Purification of improved Dpo4 variants 
Dpo4 mutants R242L, R336N and R336W were selected for characterization and together 
with Dpo4 WT were expressed in flasks and purified via affinity chromatography (His-tag) as 
described in Materials and Methods. The elution fractions were subjected to SDS-PAGE 
analysis to determine the purity of individual samples (Fig. 30 A). Purity above 95 % could be 
achieved by a combination stringent washing and sampling procedures. After dialysis of the 
purest fractions, protein concentration was measured using bicinchoninic acid assay (BCA) in 
preparation for activity tests. Protein concentrations of above 200 mg/mL could be achieved 
for all purified polymerase variants. The purified proteins were used immediately after 
purification for activity assays. 
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A)    B)  
Figure 30. Purification of Dpo4 WT and 3 Dpo4 mutants. A) Exemplary gel after column purification. 
Dpo4 WT and mutants were from E. coli BL21 Gold DE3 lacIq1-pALXtreme-1a and purified by His-tag 
affinity chromatography. Crude cell extracts were heat treated to precipitate E.coli host proteins 
prior to the chromatography step. Aliquots were collected during purification and analysed by SDS-
PAGE. Only the purest fractions were taken for dialysis against polymerase storage buffer. M – 
marker; CFE – cell free extract; 80 °C – heat precipitation of E. coli proteins at 80 °C for 10 minutes; 
FT – flow through fraction after washing; 1-12 – elution fractions; B) Concentration determination of 
Dpo4 polymerase variants via BCA assay. 
 
3.3.6. Transversion mismatch elongation tests with purified Dpo4 variants 
Dpo4 variants R242L, R336N and R336W were first characterized using the Scorpion probe 
activity assay for elongation efficiency of a defined consecutive transversion mismatch 
(GC:GC) after normalization to protein concentration (Fig. 31). This tests showed that Dpo4 
R336N and R336W were approximately twice as efficient in elongating a GC:GC mismatch 
when compared to Dpo4 WT; the activity of Dpo4 R242L after purification was comparable 
to that of Dpo4 WT. Consequently, R336N and R336W were investigated for their ability to 
elongate a degenerated double Tv mismatch (PP:CT, where „P“ is a degenerate pyrimidine 
analogue, also employed in SeSaM using the well established forward primer elongation 
assay. Figure 32 shows that R336N and R336W were roughly 1.5-fold more efficient in 
elongating a consecutive transversion mismatch of the aforementioned type. 
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Figure 31. Scorpion probe assay based characterization of purified Dpo4 WT and muteins R242L, 
R336W, R336N. Muteins are evaluated for their ability to elongate a double Tv mismatch (GC:GC) by 
comparing the slope of first 10 PCR cycles of each reaction. 
 
A)           
B)                                
Figure 32. Forward primer elongation assay was performed with purified Dpo4 WT and the Dpo4 
variants R336W and R336N. R336W and R336N were evaluated for their ability to elongate a double 
transversion mismatch with the degenerated P-base (PP:TC; ‘‘P’’—a degenerated pyrimidine 
analogue dPTP). A) Exemplary acrylamide gels on which product profiles of reactions with Dpo4 WT 
and the Dpo4 variants R336W and R336N are visualized. Artificial color is added for more clear 
representation; B) Densitometric analysis of three independent sample series. The depletion of non-
elongated primer is quantified by ImageJ software (Abramoff et al., 2004) and plotted over PCR cycle 
and the respective slopes are plotted as an activity measure and plotted in Microsoft Excel. Error 
bars represent the calculated standard deviation.  
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3.3.7. Validation of Dpo4 R336N in Step III of SeSaM  
Three model SeSaM libraries of bsla (546 bp-long gene encoding lipase A from Bacillus 
subtilis ) were prepared in which 3D1 , Dpo4 WT, and Dpo4 R336N have been employed in 
Step III of SeSaM. The sequencing results of all three SeSaM libraries are summarized in 
Table 4; transitions were roughly twice as abundant as transversions in all SeSaM libraries. 
The percentage of non-mutated DNA ranged between 18.9 % for the 3D1 library, 12.2 % for 
the Dpo4 R336N library, and 7.9 % for Dpo4 WT. The percentage of consecutive mutations 
ranged from 20.2 % (3D1) to 9.8 % (Dpo4 R336N). Most notably, R336N generates >2.5 times 
more subsequent transversions than Dpo4 WT. Dpo4 also creates more consecutive 
transversions than 3D1, suggesting that even Dpo4 WT is already an attractive polymerase 
for diversity generation in random mutagenesis methods such as SeSaM. The mutational 
spectra of 3D1 differs from the previously reported one (Mundhada et al., 2011b) likely due 
to differences in the composition of the employed genes (bsla is shorter and AT-richer than 
egfp). 
 
 
Figure 33. DNA modification steps from I to IV of the SeSaM random mutagenesis method. 
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Table 4. Mutational spectrum generated with the SeSaM-Tv-II protocol employing 3D1, Dpo4 WT or 
Dpo4 R336N in Step III.  The fraction of consecutive Tv mutations is shown at the bottom of the table 
and highlighted in bold. 
SeSaM G-fwd bsla gene 3D1 Pol Dpo4 WT Dpo4 R336N 
Nr. of clones sequenced 94 97 92 
AT-->GC ( %) 31.7 41.7 32.4 
GC-->AT ( %) 18.3 11.5 10.6 
AT-->TA ( %) 7.3 8.3 6.5 
AT-->CG ( %) 1.8 1.6 3.7 
GC-->TA ( %) 11.6 8.3 4.2 
GC-->CG ( %) 6.1 6.0 6.9 
Ts/Tv ratio 1.9 2.2 2.0 
Deletions ( %) 4.9 16.3 26.9 
WT ( %) 18.9 7.9 12.2 
Ratio of Consecutives mutations/total clones 
(%) 
20.2 13.4 9.8 
Ratio of TvTv mutations/Total nr. of consecutives 
(%) 
5.3 15.4 44 
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4. Summary and conclusions: Engineering of DNA polymerase for Application 
in directed protein evolution 
In random mutagenesis methods, polymerases especially capable of introducing subsequent 
mutations and transversion mutations are essential in order to generate diverse mutant 
libraries. Consecutive nucleotide exchanges result in doubling of the generated chemical 
diversity on amino acid level (Wong et al., 2006c, 2006d, 2007d). Thus far, despite extensive 
directed evolution campaigns on polymerases, only few variants have been reported to 
achieve consecutive nucleotide exchanges. One example is the 3D1 polymerase (a StEP 
variant derived from three genes of the genus Thermus), which has been shown to extend 
consecutive mismatches (d’ Abbadie et al., 2007b). When 3D1 polymerase was employed in 
the Sequence Saturation Mutagenesis (SeSaM) method (mismatch elongation in SeSaM step 
3 is highly desired), most observed consecutive mutations were double mutations of the 
type transversion followed by transition (TvTs) (Mundhada et al., 2011b). These resulted in a 
mutant library with around 40 % increase of unobtainable or “hardly-obtainable” exchanges 
in comparison to other random mutagenesis methods. However, a complete, unbiased 
randomization spectrum was not achieved with consecutive TvTs mutations alone. SeSaM 
can reach its full potential in diversity generation if two or more consecutive transversion 
mismatches could be elongated in SeSaM step 3 (Wong et al., 2007b). A polymerase that 
meets these criteria is unlikely to be found in nature since transitions (which preserve 
chemical diversity on the protein level) are by far the predominant type of mutations that 
occur in vivo (Wong et al., 2007b). Thus, engineering a polymerase with an enriched 
transversion mutational spectrum is highly desirable for random mutagenesis methods such 
as SeSaM. The Y-family of DNA polymerases has been suggested as a promising source for 
enzymes with the right set of properties for the desired application.  
Dpo4 from Sulfolobus solfataricus was selected as a starting point for this engineering 
campaign. As an archetype for the Y-family of polymerases (which naturally function in 
translesion DNA synthesis), Dpo4 holds promise with regard to elongation of consecutive 
mismatches since it has medium-low fidelity, moderate thermostability, and lacks 
displacement or exonuclease activity (Boudsocq et al., 2001); Dpo4’s crystal structure has 
also been solved (Ling et al., 2001) enabling rational protein engineering. Site saturation at 
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21 amino acid residues in Dpo4 yielded two variants with around 2-fold increased elongation 
efficiency of a defined transversion mismatch (GC:GC) and about a 1.5-fold enhanced 
efficiency for a degenerate base mismatch (PP:TC, dPTP – pyrimidine analogue). Both Dpo4 
muteins harbour a single amino acid exchange at position R336 which is located in the little 
finger (LF) domain of Dpo4. The LF domain is a unique feature of Y-polymerases known to 
play a pivotal role in determining Dpo4‘s performance in terms of fidelity and lesion bypass 
capabilities (Boudsocq et al., 2004). Furthermore, a previous computational study of Dpo4 
has shown that R336 is a key residue within the LF domain that is responsible for DNA 
binding and DNA translocation after phosphorodiester bond formation past damaged DNA 
(Wang et al., 2006b). The molecular dynamics studies revealed that after phosphordiester 
bond formation the side chain of R336 rotates by 120° which shorten its lenght by 1.5 Å. 
R336 interacts with the phosphate backbone via two hydrogen bonds (H-bonds) before the 
rotation; after rotation one H-bond is broken and the remaining H-bond is strengthened. In 
this experimental study, Dpo4 variants R336N and R336W which were selected for 
elongating subsequent (GC:GC) transversions, also yielded a similar results with a 
degenerated transversion mismatch. Taken together, the findings from computational and 
experimental studies indicate that position 336 is of global importance for the elongation of 
non-cannonical primer-template pairs by Dpo4. Additionally, previously unreported amino 
acid positions were also identified during screening as hotspots that could be mutagenized 
to improve the translesion DNA synthesis capability of Dpo4, notably V32, R242, R247. 
Mutagenizing these positions resulted to a moderate improvement in performance of Dpo4 
in cell lysate in comparison to the wild-type but lower activity than that measured for the 
variants harboring mutation at position 336. 
Dpo4 R336N performance was directly validated under application conditions in step 3 of 
SeSaM which employs the degenerate pyrimidine analogue dPTP. Comparison of the 
mutational spectra of 3D1 polymerase with Dpo4 WT showed that the selection of Y-
polymerase for generating subsequent transversion mutations was indeed a suitable choice. 
This was backed up by the fact that the use of Dpo4 WT in SeSaM resulted in 10 % more 
subsequent transversions than 3D1 (Table 4). Furthermore, the mutant R336N generates 
twice as many transversion exchanges than Dpo4 WT. The latter also served to demonstrate 
that the Scorpion probe system was applicable to screening for polymerases with a higher 
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elongation efficiency of transversion mutations. Interestingly, Dpo4 WT and Dpo4 R336N 
outperformed 3D1 not only in the frequency of transversion mutations but also in overall 
mutation frequency (3D1: 1.16x10-3; Dpo4 WT: 2.09x10-3; Dpo4 R336N:1.44x10-3). However, 
a higher mutation frequency comes as often to the expense of a higher deletion rate (3D1: 
4.9 %; Dpo4 WT: 16.3 %; Dpo4 R336N: 26.9 %). The deletion frequency is not surprising since 
Dpo4 is known to generate single base deletions at high frequencies in repetitive sequences 
using a template slippage mechanism (Wu et al., 2011). Overall, despite the increased 
fraction of nonsense sequences (WT and deletions) compared to the reference libraries, 
Dpo4 R336N with its current performance is already a significant advancement in 
subsequent transversion generation and especially for the SeSaM random mutagenesis 
method to complement the mutational spectrum of epPCR based methods. 
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6. Introduction 
6.1. Industrial biotechnology 
Industrial biotechnology explores sustainable routes to chemical synthesis. This applied 
approach employs a set of methodologies from e.g., molecular and computational biology, 
microbiology, biochemistry and engineering to develop bio-based industrial and 
environmental products and processes. To achieve this goal, enzymes either in isolated form 
or as whole-cell catalysts are utilized for the production of chemical compounds, feed and 
foods, textiles, in waste water treatment and biomining, etc. (Philp et al., 2013; Wenda et al., 
2011; Woodley et al., 2013). Industrial biotechnology holds great promise for widespread 
application and has the potential to minimize or even completely eliminate most drawbacks 
associated with classical chemical methods such as the dependency on non-renewable 
resources and the associated high environmental costs (Philp et al., 2013). The use of 
biotechnology in industrial processes can change not only the way products are made but 
also to generate novel products, concepts and opportunities for business and academia alike 
(Erickson et al., 2012; Wenda et al., 2011). However, due to the fact that modern industrial 
biotechnology is still in its early stages of development and covers only a small segment of 
industrial processes, the benefits and potential of it are only partially exploited by industry, 
policymakers, and consumers (Woodley et al., 2013).  
Rudimentary biotechnology has been an integral part of human development (Buchholz and 
Collins, 2013). The production of wine and beer, pickled food and cheese can be viewed as 
early biotechnological processes carried out the human kind. Since the 19th centrury, with 
intensification of scientific efforts in chemistry and biology, people started to become aware 
of the existence of microorganisms and their enormous practical potential. From this 
moment on, it didn’t take long to start exploiting this potential. The true biotechnological 
revolution began with the end of World War II (Buchholz and Collins, 2013) and its 
importance to the human kind has been exponentially growing ever since. At present there 
are numerous examples of processes partially or entirely relying on enzymes, some the most 
prominent example being the production of amino acids (e.g., lysine), antibiotics (e.g., 
penicillin), vitamins (e.g., ascorbic acid), alcohols (e.g., butanol) (Soetaert and Vandamme, 
2010). 
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Despite the outstanding versatility and reaction potential of enzymes as well as quickly 
advancing methodologies for their identification and characterization, a number of 
drawbacks associated with biocatalytic reactions exist (Wenda et al., 2011). Some major 
disadvantages are associated with the often insufficient activity of the employed 
biocatalysts, compromised stability outside their natural environment and substrate/product 
inhibition effects. Other stem from carrying out chemical reactions in aqueous environment 
e.g., low substrate solubility and complicated downstream processing steps (Buchholz et al., 
2012). Even though these limitations can be generally overcome, the implementation of 
biosynthetic strategies requires significant monetary investments and still limits the broader 
implementation of enzymes in industrial processes (Soetaert and Vandamme, 2010). 
Nevertheless, emerging tendencies for more environmentally friendly processes that also 
provide the possibility to run more selective or even chemically unfeasible reactions coupled 
to the growing political pressure to refurbish economy towards a more sustainable one 
promises a bright future to industrial biotechnology (Erickson et al., 2012).  
The workhorses of industrial biotechnology, enzymes, are generally classified according to 
the type of reactions they catalyze. Enzymes fall in one of six distinct classes – EC 1: oxido-
eductases (catalyze redox reactions; e.g., laccase), EC 2: transferases (catalyze the transfer a 
chemical group; e.g., glucosyltransferase), EC 3: hydrolases (catalyze hydrolysis; e.g., 
cellulases), EC 4: lyases (catalyze the cleavage of C-C, C-O, C-N and other bonds by means 
other than by hydrolysis; e.g., pectane lyase), EC 5: isomerases (catalyze isomerization of a 
single molecule; e.g., glucose isomerase ), EC 6: ligases (catalyze the fusion of two molecules 
with concomitant hydrolysis of the di-phosphate bond in ATP or a similar triphosphate; e.g., 
DNA ligase) (Schomburg et al., 2012). Members of all but the latter class (EC 6) are currently 
being used in industrial processes (Drauz, 2012). In line with the objectives of this study, 
P450 monooxygenases which fall in the class of oxido-reductase enzymes are introduced in 
the following section. 
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6.2. Cytochrome P450 Monooxygenases  
Cytochrome P450 monooxygenases (P450s) are heme-iron containing oxido-reductases that 
catalyze the insertion of molecular oxygen into a non-activated carbon-carbon bond as 
shown in Fig. 34 (Bernhardt, 2006; Hollmann et al., 2011). P450s are ubiquitously found and 
form one of the largest enzyme superfamilies (Bernhardt, 2006). The name of this enzyme 
class is derived from the observation that the reduced form of the iron-containing heme 
prosthetic group with bound carbon monoxide causes a shift in absorbance maximum from 
420 to 450 nm (Omura and Sato, 1964). P450s naturally function in catabolic and anabolic 
pathways alike. Their ability to catalyze various reactions such as reduction, desaturation, 
cleavage of esters and aldehydes, ring expansion and formation, dehydration, one-electron 
oxidation, coupling reactions by integrating molecular oxygen selectively into non-activated 
carbon atoms under mild conditions makes P450s attractive for applications in chemical 
synthesis (Guengerich, 2001). 
 
 
Figure 34. Schematic of a typical reaction catalyzed by cytochrome P450 monooxygenases.  
 
Cytochrome P450s are cofactor (NADH or NADPH) dependent enzymes and as such they 
require electron transfer partners to perform their function (Montellano, 2005). Upon 
binding of a substrate, the change of oxidation potential of the heme-containing domain 
induces oxidation of the NAD(P)H by a reductase and initiates the transfer of the electrons to 
the enzyme’s active site often via a mediator molecule (ferredoxin or flavin). A large diversity 
with regards to electron transfer systems for P450s exists; 10 classes of electron transfer 
systems or chains have been identified (Hannemann et al., 2007). These include 
multicomponent systems and fusions of the P450 and reductase components into one 
polypeptide chain that can be either membrane-bound or cytosolic. 
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The catalytic cycle of P450s is a complex, multistep process which has to be carried out 
meticulously to ensure efficient substrate hydroxylation. Fig. 25 gives an overview of the 
catalytic mechanism. In the resting state, a water molecule is found at the heme iron (I). The 
water leaves upon substrate binding (II). This leads to an increase of the oxidizing power of 
the heme. One electron from a NAD(P)H cofactor is then transferred via a reductase/redox 
mediator molecule (III) to the heme iron. The reduced heme iron (ferrous state) can bind a 
molecule of oxygen (IV; oxy-complex). A further reduction by another electron takes place 
and a peroxy-complex (V) is formed. After protonation of this complex (VI), compound 0 is 
formed. After a second protonation step, release of a water molecule follows and formation 
of compound I (VII) takes place. The latter represents the active species capable of 
abstracting H-atom from the substrate molecule (VIII). The catalytic cycle is reinitiated with 
the product release the active site. In addition to hydroxylation via rebounding, epoxidation 
of substrates without H-abstraction from the substrate molecule can take place (de Visser 
and Shaik, 2003). P450-catalyzed epoxidation involves a directly attack by compound I (VII) 
at unsaturated carbon atoms (de Visser and Shaik, 2003; Whitehouse et al., 2011). Last but 
not least, in some instances an “uncoupling” reaction can take place in which the electrons 
derived from NADPH are wrongly transferred during the catalytic cycle resulting in hydrogen 
peroxide. The frequency of occurrence of this shuttle pathway is mainly dependent on the 
employed (non-natural) substrate and it is seen as an unwanted artefact in biocatalytic 
reactions with P450s (Grinkova et al., 2013). 
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Figure 35. P450 catalytic cycle (taken from Whitehouse et al., 2012). 
 
6.3. Cytochrome P450 (P450 BM3) 
Cytochrome P450 from Bacillus megaterium (EC 1.14.14.1), for short P450 BM3, is one of the 
best studied members of the P450 enzyme family. P450 BM3, first described in the late 
1980s (Narhi and Fulco, 1987), is a water-soluble, NADPH-dependent monooxygenase in 
which both heme and reductase domains are contained on a single polypeptide chain. 
Although the precise natural function of this monooxygenase remains unknown, there is 
strong evidence that the natural substrate of P450 BM3 are middle and long chain fatty acids 
for which P450 BM3 exhibits excellent NADPH coupling efficiency (Munro et al., 2002). This 
enzyme (and its mutants) was shown to hydroxylate a wide range of substrates, e.g., 
propane, cycloalkanes, naphthalene and testosterone (Whitehouse et al., 2012). The crystal 
structure of P450 BM3 has been solved and reveals that P450 is a dimeric protein formed by 
two identical peptide chains (Fig. 36). The reductase and monooxygenase domains in each 
chain are connected via a short amino acid linker (Govindaraj and Poulos, 1995, 1996) 
ensuring the efficient electron transfer between both monomers. In this thesis, P450 BM3 is 
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used in the context of regioselective biotransformations of aromatic substrates with isolated 
enzyme and as a whole cell catalyst. 
 
 
Figure 36. The crystal structure of the complex between the heme- and FMN-binding domains of 
bacterial cytochrome P450 BM3 (PDB ID. 1BU7) (Sevrioukova et al., 1999). 
 
6.4. P450 BM3 catalyzed hydroxylation of aromatic hydrocarbons 
Cytochrome P450 monooxygenase from Bacillus megaterium (P450 BM3) holds a significant 
potential for application in organic synthesis. The promiscuity of P450 BM3 which is naturally 
optimized for hydroxylation and epoxidation of long-chain unsaturated fatty acids, has been 
vastly enhanced by means of protein engineering, making it one of the most versatile and 
valuable monooxygenases available to chemists (Whitehouse et al., 2012). In a recently 
published study, a triple mutant of P450 BM3 (P450 BM3 M2 (R47S/Y51W/I401M)) was 
engineered into an efficient catalyst for the synthesis of monosubstitued benzenes (Dennig 
et al., 2013). Phenolic compounds are important precursors for chemical synthesis with a 
yearly turnover of 9 megatons (Rappoport, 2004). Preliminary studies have indicated that 
phenols could undergo a second P450 BM3-catalyzed hydroxylation to yield the respective 
1,4-hydroquinones. Similar to phenols, 1,4-hydroquinones find applications in the chemical 
and pharmaceutical industries, e.g., as chemical precursors or antioxidant and bleaching 
agents for the production of rubber, polymers, dyes and pigments, fungicides and 
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herbicides, etc. (Fujimori and Nakamura, 1985; Hua et al., 2002; Hudnall, 2000; Krumenacker 
et al., 2000; Pérez et al., 2000; Ran et al., 2001; Rendon and Horwitz, 2012; Song et al., 
2007). 
Hydroquinones can be chemically synthesized from benzenes via the Hock process 
(rendering phenol), followed by hydroxylation of phenol using, e.g., Fremy’s salt or hydrogen 
peroxide and zeolite as catalysts (Deya et al., 1987; Hudnall, 2000; Krumenacker et al., 2000; 
Rappoport, 2004). This process, accounting for approximately 60 % of the global 
hydroquinone production (Rappoport, 2004), is characterized by low isolated product yields 
and formation of side products (e.g., catechol). Electrochemical hydroxylation of phenol can 
provide alternative for carrying out the second oxidation step (Rautenbach, 2007), yet it also 
generates a mixture of dihydroxylated products. Direct synthesis of hydroquinone from 
benzene was also reported for n-alkane assimilating bacteria without specifying 
performance parameters (Yoshida et al., 1990). Benzene oxidation can be catalyzed by 
aromatic peroxygenase (APO) from Agrocybe aegerita and leads to a variety of side 
products, including 1,4-hydroquinone, in the course of benzene conversion (Karich et al., 
2013). Hydroquinones can be produced from other starting substrates as well. For example, 
the three step chemical process from aniline uses manganese dioxide (20 % excess, in 
sulfuric acid) yielding benzoquinone which then has to be purified by steam stripping and 
reduced to hydroquinone using an aqueous iron suspension (Laha and Luthy, 1990). 
Biochemically, hydroquinone can be produced from quinic acid by a modified E. coli strain 
using glucose as starting material (Ran et al., 2001). Despite that most of the glucose is used 
for biomass and metabolite production (79 to 85 %), the final step is performed in the 
presence of stoichiometric amount of strong oxidizing reactants (K2S2O8 and Ag3PO4; 
(NH4)2Ce(SO4)3) with hydroquinone yields of 51 to 91 %.  
With its hydroxylating potential, P450 BM3 can provide a greener and direct way for 
synthesis of substituted mono- and di-hydroxybenzenes from benzenes and/or phenols as 
substrates. This prospective has been investigated and results are described in section 7.1. 
6.5. The “cofactor challenge” in catalysis with P450 BM3 
Due to the fact that P450 BM3 catalysis is dependent on the use of cofactor (NAD(P)H), 
significant effort has been made in alleviating the need to use stoichiometric amounts of 
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cofactor to drive P450-catalysed reactions. While a number of alternatives have been 
pursued, e.g., non-natural electron transfer systems (Nazor et al., 2008), the in situ 
regeneration of the oxidized nicotinamide cofactor remains the most common approach to 
tackle the “cofactor challenge” (Zhao and van der Donk, 2003). When isolated enzymes are 
used, the pool of reduced cofactor can be restored through the use of enzymatic 
regeneration systems (Schrittwieser et al., 2011) or be replenished by chemical, 
electrochemical or photochemical setups (Hollmann et al., 2011). Cofactor regeneration with 
enzymes (e.g. glucose dehydrogenase) is the most efficient and commonly employed 
approach when cofactor replenishment is necessary. Nevertheless, cofactor regeneration 
systems add significant expenses to the overall process and are generally applied mostly in 
research labs for chemical synthesis of high value products, less commonly in bulk synthesis 
(Liu and Wang, 2007). Regeneration by chemical, electrochemical or photochemical setups is 
a concept creating much excitement but to date no industrially-applicable processes are 
known. Therefore, these approaches are largely at the stage of basic research and validation 
(Schrittwieser et al., 2011). A conceptually different way of carrying out in vitro enzymatic 
synthesis that requires cofactor regeneration is the use of intact whole cells (de Carvalho, 
2011).  
 6.6. Whole cell catalysis 
The use of whole cells in organic synthesis is an attractive prospect as it allows for a cost-
effective cofactor regeneration and eliminates the need for labor-intensive enzyme 
purification. In addition, whole cells provide several advantages over cell-free setups such as 
higher stability and recyclability of biocatalysts. This in turn confers reduction in the costs for 
cofactor regeneration and downstream processing (de Carvalho, 2011).  However, in whole-
cell catalysis the limited permeability of the outer membrane of industrially relevant bacteria 
such as E. coli presents a majopr drawback preventing their broader application in industrial 
processes (Chen, 2007).  
6.7. The outer membrane (OM) of gram-negative bacteria  
The outer membrane (OM) of gram-negative bacteria such as E. coli provides an effective 
barrier for macromolecules, hydrophobic molecules and anionic detergents (Vaara, 1992; 
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Wiener and Horanyi, 2011). As such, it serves a defensive role against potentially harmful 
agents and ensures the cell’s integrity. Selective passage of a limited number of essential 
compounds (e.g., nutrients) is possible either by diffusion through porin channels (e.g., 
OmpF and OmpA of E. coli) or active uptake through substrate-specific channels (e.g., TonB-
dependent transporters of E. coli).  
6.8. Permeability issues in whole cell catalysis 
In whole-cell biocatalytic processes, the limited permeability of the cell envelope of 
industrially relevant microorganisms is often a major drawback causing sub-optimal product 
formation. The limited permeability of membranes results in inadequate intracellular 
substrate availability resulting in reduced reaction rates and overall productivities. Increasing 
the permeability of cell membranes could lead to a significant boost of productivity in whole 
cell catalysis (Julsing et al., 2012; Chen, 2007). 
The issue of substrate permeability in whole-cell biocatalysts has been addressed in a 
number of ways. One strategy to alleviate the problem is the chemical pre-treatment of 
cells. Organic solvent (e.g., toluene, diethyl ether, chloroform for treatment of P. rhodesiae), 
detergents (e.g. Triton X-100 used for pre-treatment of P. pseusoalcaligenes and CTAB 
treatment of Z. mobilis), salt (e.g., NaCl used for permeabilization of E. coli  and R. 
leguminosarum) or other chemical agents (e.g., pre-treatment of E. coli with EDTA, 
polyethylene imine treatment of the yeast Achizosaccharomyces pombe and Polymixin B 
treatment of E.coli) have all been successfully used as pre-treatment agents (Chen, 2007). In 
other studies, physical (freeze/thaw), osmotic stress or a combination of chemical and 
mechanical treatment have been reported to increase the overall rate of whole-cell 
biotransformations (Chen, 2007). These strategies, even though effective, require a multiple 
trials and errors and ultimately results in several extra process steps that complicate large 
scale production. In addition, chemical and physical pre-treatment of cells can cause 
excessive cell lysis or significant damage to membrane-associated systems for cofactor 
regeneration, and complicate product isolation.  
The modulation of membrane permeability can also be achieved by varying the cell growth 
conditions. For example, this strategy has been applied to increase the membrane 
permeability of the gram-positive R. erythropolis (Sokolovská et al., 2003). This strategy, 
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however, is rather uncommon and reported efforts often resulted in only moderate increase 
of permeability after an extensive trial and error optimization process (McGarrity and 
Armstrong, 1981; Sokolovská et al., 2003). 
More recently, molecular engineering strategies have emerged as a more subtle and 
better alternative to classical approaches. For example, the permeability issue in whole 
cell catalysis can be circumvented by displaying enzymes on the surface of microorganisms 
such as E. coli and P. syringae (Chen, 2007; Sroga and Dordick, 2002). However, cell surface 
display can be used to present a limited number of enzymes to the cell’s surface and 
impractical to do with cofactor-dependent enzymes. Increase in permeability of bacteria 
(e.g., E. coli) has also been achieved by genetically modifying the lipid composition of their 
membrane (Ni and Chen, 2004). Modifying the lipid composition may affect cells’ viability 
and generally gives only moderate improvements; however, it also provides the possibility 
for combination with classical permeabilizing methods. Modifications that lead to increase in 
permeability can also be achieved by expressing membrane-active peptides (e.g. 
cinnamonin) and membrane proteins (e.g., AlkL) to the cell membrane in order to increase 
intracellular substrate availability (Cornelissen et al., 2013; Hofzumahaus and Schallmey, 
2013; Julsing et al., 2012). For example, the co-expression of the outer membrane protein, 
AlkL, in E. coli enhanced the hydroxylation of octane (4-fold), nonane (40-fold), dodecanoic 
acid methyl ester (28-fold) (Julsing et al., 2012), and monoterpene hydroxylation rates by a 
factor of 2 (Cornelissen et al., 2013).  AlkL protein was recently shown to be an alkane import 
enabling the uptake of C7-C16 n-alkanes (Grant et al., 2014). The latter concept is 
particularly interesting as it sets forward a general framework for applying membrane 
proteins in whole cell biocatalysis. In this thesis, this concept was applied to the E.coli’s 
native outer membrane protein FhuA, a mutant of which (i.e., FhuA Δ1-160) has been shown 
to form a large passive diffusion channel. In this study, the effect of co-expressing FhuA Δ1-
160 diffusion channel in the outer membrane of E. coli on the whole cell biocatalysis of 
aromatic substrates was investigated. The P450 BM3-catalyzed conversion of the coumarin 
substrate, BCCE, of toluene and anisole was studied and results are presented in section 7.2. 
The mass transfer of substrates in whole cell biocatalysis employing P450 BM3 as catalyst is 
especially important to address due to the need for cofactor regeneration and the 
hydrophobic (and therefore non-permeating) nature of a typical P450 substrate. 
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6.9. Ferric-hydroxamate uptake protein component A (FhuA) 
To satisfy their iron requirement, most bacteria have evolved diverse high-affinity 
acquisition systems for low molecular weight iron complexes (Clarke et al., 2001). Uptake is 
usually mediated by energy-dependent transporters that bind iron chelators with high 
affinity and mediate their uptake across the outer membrane of Gram-negative bacteria 
(Cornelissen, 2003). The energy required to translocate these compounds is derived from 
the proton motive force of the cytoplasmic membrane as transduced by the TonB-ExbB-
ExbD complex (Ferguson, Coulton et al. 2000). 
FhuA is a β-barrel transmembrane protein from E. coli that serves in the active transport of 
ferrichrome (Noinaj et al., 2010). The β-barrel is built up of 22 anti-parallel β-sheets and a 
globular “cork” domain (Ferguson, Hofmann et al. 1998) within the barrel structure formed 
by a four-stranded β-sheet and four short α-helices (Fig. 37). The “cork” blocks most of the 
cross section of the barrel from the periplasmic side which ensures high specificity of the 
transporter for its target molecule. Ferrichrome binds via hydrogen and van der Waals 
contacts in a specific pocket built of 4 amino acid residues from the cork domain and 6 
residues from the barrel domain slightly above the external outer membrane surface (Braun, 
Killmann et al. 1999). In addition to binding ferrichrome, FhuA also functions as the primary 
receptor for some structurally related antibiotics, for several bacteriophages (T1, T5, UC-1, 
and Φ80), for the antimicrobial peptide Microcin 25 and for the bacterial toxin Colicin M 
(Ferguson, Hofmann et al. 1998). Notably, FhuA could be converted into a large passive 
diffusion channel by deleting the globular “cork” domain (Braun et al., 2002). FhuA Δ1-160 
can still fold into the characteristic β-barrel structure and insert into the outer membrane of 
E. coli to form a permanently open channel. Previous investigations of this FhuA variant have 
shown that its presence in the OM of E. coli conferred increased susceptibility to large 
antibiotics (Ferguson et al., 2001) and even allowed the translocation of single stranded DNA 
when FhuA Δ1-160 was incorporated into synthosomes (Nallani et al., 2006).  These findings 
indirectly indicated that FhuA Δ1-160 could also positively affect mass transfer in whole cell 
processes.  
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Figure 37. Three dimensional structure of the outer membrane protein FhuA (PDB ID. 2FCP). The 
native structure including a “cork” domain (in black) and FhuA Δ1–160 without a “cork” are 
presented. 
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6.10. Aim and objectives  
6.10.1. P450 project I: One step enzymatic synthesis of hydroquinones from 
monosubstituted benzenes 
In P450 project I, the one step synthesis of 1,4-hydroquinones from monosubstituted 
benzenes by P450 BM3 was assessed. For this purpose, the P450 BM3-catalysed 
hydroxylation of phenols was studied first. A P450 BM3 variant M2 (R47S/Y51W/I401M) has 
been previously reported to carry out regiospecific, aromatic hydroxylation (Dennig et al., 
2012). The initial product formation rate, coupling efficiency and total turnover number of 
the P450 BM3 variant M2 were determined and compared to those of P450 BM3 WT. The 
product formation and product profile in 24h reactions with varied substrate, the time 
dependent product accumulation and substrate preference of P450 BM3 M2-mediated 
synthesis of hydroquinones from monosubstituted benzenes were also reported. The 
objectives of P450 project I are schematically illustrated in Fig. 38 A. 
6.10.2. P450 project II: Improving the rate of P450-mediated whole cell 
biotransformations by co-expressing a passive diffusion channel in the outer 
membrane of E. coli. 
In P450 project II, one of the main drawbacks of whole cell catalysis with E. coli, i.e., the 
mass transfer across outer membrane of this microorganism was tackled. The hydroxylation 
of monosubstituted benzenes by P450 BM3 was used as a model reaction due to the low 
permeation of this class of substrates across the outer membrane of E. coli as well as the 
requirement for NADPH cofactor regeneration for the aforementioned biocatalytic reaction. 
The implications of the large passive diffusion channel, FhuA Δ1-160, on the mass transfer 
across the membrane barrier of E. coli was studied. This was achieved by comparing the 
performance in whole-cell biocatalysis of an E. coli stain co-expressing FhuA Δ1-160 and 
P450 BM3 M2 (R47S/Y51W/I401M) to the strain expressing solely the P450 BM3 catalyst. 
Two monosubstituted benzenes (anisole and toluene) as well as a more bulky fluorogenic 
P450 substrate (BCCE) were used as model substrates to test this concept. A graphical 
summary of this project is presented in Fig. 38 B. 
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A)          
 
B)     
Figure 38. Schematic summarizing the objectives and goals of the biocatalytic studies with P450 BM3 
monooxygenase as a catalyst. A) One step synthesis of hydroquinones from monosubstituted 
benzenes; B) Improving the mass transfer across the outer membrane of E. coli in whole cell P450-
catalyzed biotransformations. 
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7. Materials and methods 
7.1. Chemicals 
All chemicals were obtained at the highest available purity (i.e., analytical grade) from Sigma 
Aldrich (Steinheim, Germany), ABCR (Karlsruhe, Germany), Fluka (Neu-Ulm, Germany) and 
AppliChem (Darmstadt, Germany).  
7.2. Cloning of FhuA WT and FhuAΔ1-160 in pALXtreme-1a-P450 BM3 M2 
Expression vector pALXtreme-1a harboring gene that encode P450 BM3 M2 
(R47S/Y51W/I401M) and pALXtreme-1a empty vector were available from previous study 
(Dennig et al., 2012). Construction of pALXtreme-1a-P450 BM3 M2+FhuA Δ1-160 was done 
similarly to a previously described construct for co-expression of P450 BM3 and an alcohol 
dehydrogenase (Müller et al.). Both genes (encoding FhuA Δ1-160 and P450 BM3 M2) were 
placed under the control of a T7 promoter via ligase independent cloning, PLICing (Blanusa 
et al., 2010b) such that polycistronic mRNA containing two ribosome binding sites in front of 
each gene sequence was transcribed from the genetic construct. pALXtreme-1a-P450 BM3 
M2 DNA fragment was amplified from pALXTtreme-1a P450 BM3 M2 vector with PTO 
primers (GCTAACAAAGCCCGAAAGGAAGCTGAGTTGGCTGCTG and CCACTTATCCGGATGATTA 
CTAGTGGGTTATTACCCAGCCCACACGTC; phosphorothioated part in bold) using 10 ng 
plasmid template, 0.4 mM of each primer, 0.2 mM dNTPs, 2.5 U Phusion® High-Fidelity DNA 
Polymerase and 1x Phusion® buffer (New England Biolabs, Frankfurt am Main, Germany) and 
the following thermocycling program: 25 cycles; volume: 50 µL; 105° C heated lid) : 98° C 2 
min (1x); 98° C 30 sec, 59° C 30 sec, 72 °C 2 min (24x); Hold 8° C. The DNA fragment 
containing the gene enconding FhuA Δ1-160 was amplified from pPR-IBA FhuA Δ1-160 
plasmid (Tenne and Schwaneberg, 2012) with PTO primers (CCGGATAAGTGG 
AATAAGGAGGTATACCATGGCGCGTTCCAAAACTGC and GGGCTTTGTTAGCTTATTAGAAACGG 
AAGGTTGCGGTTGC; phosphorothioated nucleotides in bold) using 10 ng plasmid template, 
0.4 mM of each primer, 0.2 mM dNTPs, 2.5 U Phusion® High-Fidelity DNA Polymerase and 1x 
Phusion® buffer (New England Biolabs, Frankfurt am Main, Germany) and the following 
thermocycling program: 25 cycles; volume: 50 µL; 105° C heated lid) : 98° C 2 min (1x); 98° C 
30 sec, 61° C 30 sec, 72 °C 1 min (24x); Hold 8° C. The PCR products were purified using PCR 
purification kit (Nucleospin Extract II kit, Macherey Nagel, Düren, Germany), ligated and 
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transformed as previously described (Blanusa et al., 2010b). E. coli DH5α was the strain of 
choice during cloning and for propagation of the genetic constructs. 
7.3. Shake flask expression of P450 BM3 wild type and M2 
E. coli BL21 (DE3) lacIq1 trasformed with pALXtreme-1a P450 BM3 WT and M2 variant were 
grown until culture saturation (250 rpm, 12-14 h, 37 °C) in 4 mL LBKan media. A main culture 
containing 50 mL TB media (10 g L-1  tryptone, 5 g L-1  yeast extract, 4 g L-1 glycerol, 0.1 M KPi 
pH 7.0) supplemented with 0.05 mg L-1  kanamycin and trace elements (final concentrations: 
0.5 mg L-1  CaCl2.2H2O, 0.18 mg L
-1  ZnSO4.7H2O, 0.1 mg L
-1  MnSO4. H2O, 20.1 mg L
-1 Na2-
EDTA, 16.7 mg L-1 FeCl3.6H2O, 0.16 mg L
-1 CuSO4.5H2O dissolved in ddH2O) was prepared into 
a sterile Erlenmeyer flask (500 mL), inoculated with 500 µL pre-culture and grown until OD600 
reached ~0.6. P450 BM3 expression was initiated by addition of 0.1 mM IPTG, 0.5 mM 
aminolevulinic acid and 0.1 mg thiamine. After 24 h, cells were harvested by centrifugation 
(4000 x g, 15 min, 4 °C) using Eppendorf centrifuge 5810 R (Eppendorf, Hamburg, Germany). 
The cell pellets were stored at -20 °C.  
7.4. Shake flask co-expression of P450 BM3 and outer membrane protein 
FhuAΔ1-160 
The co-expression of P450 BM3 M2 and FhuA variants was carried out as described in the 
previouos section with minor changes. The expression strain E. coli BL21 (DE3) lacIq1 was 
transformed with pALXtreme-1a vectors harboring both P450 BM3 M2 gene and FhuA gene 
variants. Pre-cultures were grown for 8 hours and expression was terminated after 16-18 
hours after induction. 
7.5. Purification of P450 BM3 
Purification of P450 was carried out as previously described (Schwaneberg et al., 1999) with 
minor modifications. In short, cell pellet containing expressed P450 BM3 were re-suspended 
in Tris-HCl buffer (0.1 M Tris-HCl, pH 7.8) and lysed by extensive sonication (40% amplitude, 
30 sec on/off cycles, 15 min sonication time) using Vibracell VCX130 sonicator (Sonics & 
Materials, Newton, CT, USA). Cell-free extract was prepared by centrifugation (5000 x g, 20 
min, 4 °C) and further clarified using a 0.45 micron filter to remove residual cell debris. For 
CHAPTER II. Synthesis of Mono- and Di-hydroxy Benzenes using P450 BM3 Monoxygenase  
  Materials and Methods 
 
124 
the purification a glass chromatography column filled with anion exchange matrix (Toyopearl 
DEAE 650S, Tosoh Bioscience, Stuttgart, Germany) was used. During all purification steps a 
flow rate of 5 mL min-1 was used and pressure, UV absorbance at 280 nm, flow rate, 
conductivity were constantly monitored. The column was equilibrated column with 10 
column volumes (CV) of washing buffer (0.1 M Tris-HCl, pH 7.8) prior to sample application 
then the filtered cell extract was loaded on the equilibrated column using washing buffer 
inlet. The anion exchange matrix washed with 10 CV of washing buffer to remove proteins 
that did not bind to the matrix. Next, a second washing with 14 % elution buffer (1 M NaCl, 
0.1 M Tris-HCl, pH 7.8) employing 10 CV; finally, P450 BM3 was eluted with 10 CV at ~24% 
elution buffer. Elution fractions of 3 mL were collected. Fractions containing P450 BM3 and  
purity >70% were pooled and desalted using a gel filtration column (PD-10 column, GE 
Healthcare, München, Germany) equilibrated with phosphate buffer (50 mM KPi, pH 7.5). 
Purified and desalted P450 BM3 protein was frozen in liquid N2 and lyophilized under 
vacuum using freeze dryer Alpha 1-2 LD plus Christ (Osterode am Harz, Germany). 
Lyophilized P450 BM3 protein was stored at –20 °C until used. 
7.6. BCCE activity assay  
The assay was performed in 96-well flat bottom black microtiter plates (Greiner Bio-one, 
Frickenhausen, Germany) in a total volume of 200 µL. The reaction mix contained 20 µL 
normalized cell suspension (OD600 of 10), 1 µM 7-benzoxy-3-carboxy-coumarin ethyl ester 
(BCCE), 2% DMSO and 50 mM glucose in potassium phosphate buffer (KPi 50 mM, pH 7.5). 
The increase of fluorescence was continuously recorded over 20 sec intervals for 20 min 
(λEx: 400 nm, λEm: 440 nm) using an Infinite M1000 microtiter plate reader (Tecan Group, 
Männedorf, Switzerland). 
7.7. Flow cytometry analysis of cell populations expressing P450 BM3 and co-
expressing P450 BM3 and FhuA channel protein variants 
In order to examine the effect of additives on the overall morphology of cell populations, the 
cell suspensions were directly subjected to a FACS analysis or pre-treated with either 60 µM 
Polymixin B or with 1 µM BCCE and 2% DMSO for 20 min before flow cytometry analysis. The 
analysis was carried out by diluting  the (pre-treated) cells suspensions in sterile phosphate 
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buffer saline (1:10 dilution) and sorting of 10 000 events using BD Influx™ cell sorter (BD 
Biosciences, San Jose, California). Whole cell suspensions (final OD600 of 1) of cells expressing 
P450 BM3 M2 or co-expressing P450 BM3 BM3 and FhuA Δ1-160 were prepared in KPi 
buffer (50 mM, pH 7.4). The data for side-scatter (SSC) and forward-scatter (FSC) were 
recorded for each sample. Stringent gating conditions were selected based on the 
population appearance of untreated cells and the same parameters were applied to analyze 
the distribution of cells that were treated with permeabilzing agent (Polymixin B) or 
incubated with fluorogenic substrate (BCCE and DMSO). 
7.8. Long term conversion of toluene and anisole by whole cells expressing 
P450 BM3 or co-expressing P450 BM3 and FhuA channel protein  
Normalized cell suspensions (OD600 of 40) were prepared for each cell type in potassium 
phosphate buffer (50mM, pH 7.4) supplemented with 50 mM glucose. Whole cell 
biotrasformations were carried out in 10 mL glass vials at room temperature under constant 
stirring with Eppendorf Mix Mate shaker (Eppendorf AG, Hamburg, Germany) using 8 mm x 4 
mm stirring bar and stirring speed of 990 rpm. 5 mL normalized cell suspensions (final OD600 
of 40), 10 mM substrate (toluene or anisole) and co-solvent (2% DMSO). Samples (500 µL) 
were collected over 72 hours and extracted with equal volume of MTBE containing internal 
standard (20 mM guaiacol in case of reaction with toluene and 20 mM phenol in case of 
reaction with anisole) and finally subjected to analysis by gas chromatography. All reactions 
were performed in triplicate. The obtained values were corrected for small differences in 
optical density of cell suspensions and the P450 concentration measured for each 
suspension. 
7.9. Long term conversion of benzenes or phenols to hydroquinone with 
purified P450 BM3 
To investigate product titers (product concentrations, TTN, time dependent product 
accumulation) and product profile of P450 variants long term (24 h up to 48 h) reactions 
with a NADPH cofactor regeneration system (glucose dehydrogenase (GDH) based) were 
carried out. The long term conversions were performed with purified monooxygenase in 5 
mL glass vials sealed with a septum and lid. The reactions were carried out in a total volume 
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of 2 mL at room temperature and under constant stirring (500 rpm) and contained the 
following components: 1 μM P450 BM3 WT or M2, 4 U GDH, 60 mM glucose, 2400 U 
catalase, 2 to 20 mM substrate, 2% DMSO, 500 μM NADPH in phosphate buffer with ascorbic 
acid (50 mM K2HPO4, 10 mM ascorbic acid, pH 7.5). DMSO was added to the reactions with 
phenolic substrates which are only available in crystalline form and with low concentrations 
(2 or 4 mM) of benzylic substrates, in order to achieve higher reproducibility. Co-solvent 
(DMSO) was omitted from the reaction mixtures with high concentrations (20 mM) of 
benzylic substrates. Before initiating the monooxygenase reaction by addition of NADPH, the 
solution was always stirred for 5 min. 
7.10. Carbon monoxide differential spectroscopy 
The concentration of active P450 BM3 monooxygenase in solution was measured using CO-
binding assay (Omura and Sato, 1964). A sprinkling of sodium dithionite was dissolved in 
P450 BM3 containing solution in 1 mL polystyrene cuvette (Carl Roth, Karlsruhe, Germany) 
and the baseline absorption spectrum between was recorded using a Varian Cary 50 UV 
spectrophotometer (Agilent Technologies, Darmstadt, Germany). Next, the same solution 
was treated with CO gas for around 45 seconds and the absorption spectrum (600 nm and 
400 nm) was recorded again.  
The concentration of active P450 BM3 monooxygenase could be calculated according to the 
following equation: 
c(P450_BM3active) [µM]=
(A450,CO+-𝐴450,𝐶𝑂−)-(A500,CO+-𝐴500,𝐶𝑂−)*DF*1000 
µ𝑚𝑜𝑙
𝑚𝑚𝑜𝑙
d*ε
 
in which ε = 91 mmol cm-1 L-1  , path length d=1cm, DF=dilution factor, A450,CO+  is absorbance 
at 450 nm after saturation with carbon monoxide, A450,CO-  is absorbance at 450 nm before 
saturation with carbon monoxide, A500,CO+  is absorbance at 500 nm after saturation with 
carbon monoxide  and A500,CO-  is absorbance at 500 nm before saturation with carbon 
monoxide. 
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7.11. Determination of NADPH turnover frequency, coupling efficiency and 
initial turnover rate 
NADPH turnover frequency for phenolic compounds by P450 BM3 variants was measured via 
the change of absorbance at 340 nm in the samples after addition of NADPH using Varian 
Cary 50 UV spectrophotometer (Agilent Technologies, Darmstadt, Germany). The reaction 
mix in 50 mM KPi buffer, pH7.4 as medium contained  10 mM ascorbic acid, 2mM substrate 
in DMSO (2% final), 1 to 2 µM purified enzyme (depending on P450 variant and substrate 
used) and was prepared in UV cuvettes (Carl Roth, Karlsruhe, Germany). After 5 min 
incubation the solution was used as blank and absorbance measurement at 340 nm was 
started. When absorbance value was constant the hydroxylation reaction was initiated by 
addition of 0.2 mM NADPH. The final volume of reaction was 1 mL. Absorbance was 
measured over time until no further decrease could be observed. The enzyme concentration 
in each reaction was chosen so that NADPH was depleted in the time interval between 2 and 
10 min after initiation. A series of reactions without substrate were prepared in the same 
way to determine the background absorbance change in the solution. Immediately after no 
further absorbance decrease was observed. Reactions were stopped by addition of 250 µL 
acetonitrile which was added to 500 µL reaction mix. The samples were centrifuged for 1 
min at 13 000 x g to remove solid particles and the debris-free sample was transferred to a 
glass vial in preparation for product quantification by HPLC.  
The NADPH turnover number (N) was calculated according to the following equation: 
𝑁 [
µ𝑀 𝑁𝐴𝐷𝑃𝐻
µ𝑀 𝑃450 ∗ 𝑚𝑖𝑛
] =
𝐴1 − 𝐴0
𝑡1 − 𝑡0
𝜀𝑁𝐴𝐷𝑃𝐻,340𝑛𝑚 ∗ 𝑐(𝑃450𝐵𝑀3) ∗ 𝑑
 
in which εNADPH,340nm=6.3*10
3
 µM
-1 cm-1, path length d=1 cm, c(P450 BM3) is the 
concentration of active P450 BM3 in µM, A1 and A0 are the absorbance values at 340 nm at 
time points t1 and t0 in min. Time points t1 and t0 were chosen after addition of NADPH when 
absorbance decrease is linear and maximal. 
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NADPH coupling efficiency C was determined as follow: 
𝐶 [
 % ∗  µ𝑀 𝑝𝑟𝑜𝑑𝑢𝑐𝑡
µ𝑀 𝑁𝐴𝐷𝑃𝐻
] =
𝑐(𝑝𝑟𝑜𝑑𝑢𝑐𝑡)
𝑐(𝑑𝑒𝑝𝑙𝑒𝑡𝑒𝑑 𝑁𝐴𝐷𝑃𝐻)
∗ 100 % 
in which c(product)= concentration of product in µM, and c(depleted) is the concentration of 
depleted NADPH in µM. The concentration of product in the initial solution was determined 
by HPLC quantification. 
Product formation rates (PFR) are calculated as shown below: 
𝑃𝐹𝑅 [
 µ𝑀 𝑝𝑟𝑜𝑑𝑢𝑐𝑡
µ𝑀 𝑃450 ∗ 𝑚𝑖𝑛
] =
𝐶 ∗ 𝑁
100 %
 
7.12. HPLC measurement of phenols and hydroquinones 
High performance liquid chromatography (HPLC) was used to analyze the formation of 
mono- and di-hydroxylated products from benzenes and phenols by P450 BM3 WT and M2. 
For this purpose samples of 500 μL were taken from the reaction mixtures as described 
above, quenched with 250 μL acetonitrile, thoroughly mixed, and centrifuged to remove 
insoluble particles (vortex  2 min; centrifugation 20 000 x g for 5 min). Prepared samples 
were separated on a NUCLEODUR® C18ec column (Macherey Nagel, Düren, Germany; flow 
rate of 1 mL min-1, ~68 bar pressure, 50°C) with a mobile phase consisting of 50% (v/v) 
ddH2O and 50% ACN (v/v). Baseline separations were obtained for all six investigated 
benzenes and absorbance spectra were recorded at 280 nm. Mono- and di-hydroxylated 
benzenes were identified with commercially available standards. 
7.13. GC analysis 
Hydroxylated products from P450 BM3 WT and M2 conversions of benzenes were quantified 
on the GC2010 system (Shimadzu GmbH, Duisburg, Germany) equipped with Supreme-5ms 
capillary column (CS-Chromatograpie GmbH, Langerwehe, Germany). Products were 
extracted by partitioning (two-phase extraction) employing methyl tert-butyl ether (MTBE) 
supplemented with an internal standard (20 mM cyclododecanol). Reaction mixtures and 
extraction solvent were mixed at a ratio of 2:1 (vortex 2 min). Both phases were separated 
by centrifugation (20000 x g, 5 min, RT), the organic phase was removed and dried over 
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anhydrous Na2SO4 to remove residual water. As last step, the dried organic phase was 
centrifuged to remove residual salts and supernatants were transferred into glass vials 
containing 200 μL glass inlets. Baseline separation programs were established with 
commercial standards.  
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8. Results and discussion 
8.1. P450 project I: One step enzymatic synthesis of hydroquinones from 
monosubstituted benzenes 
Section 8.1 is divided in three parts that outline (I) the selection of phenolic substrates for di-
hydroxylation by P450 BM3 WT and M2 and optimization of reaction conditions, (II) the 
production of hydroquinones from the corresponding phenols, and (III) the development of 
one step synthesis route to hydroquinones from the corresponding benzenes.   
8.1.1. Selection of phenolic substrates and reaction conditions 
Six monosubstituted phenols (phenol, 2-methylphenol (o-cresol), 2-methoxyphenol 
(guaiacol), 2-chlorophenol, 2-bromophenol, and 2-iodophenol) were selected as suitable 
substrates for P450 BM3 WT and P450 BM3 M2 (R47S/Y51W/I401M). The substrate 
selection was made bearing in mind previous findings on selectivity and productivity P450 
BM3 M2 with monosubstituted benzenes as substrates (Dennig et al., 2013). Only those o-
phenols that were produced by variant M2 with selectivity exceeding 95% were chosen as 
substrates in the present study. In all experiments, P450 BM3 was used in purified form 
whereas protein purification was carried out as previously described (Dennig et al., 2012). 
Product quantification was performed by GC or by HPLC taking advantage of the 
characteristic absorbance of aromatic compounds in the middle-UV range and employing 
commercial standards (not available for 2-iodobenzoquinone) for product identification and 
quantification. The reaction buffer (50 mM KPi, pH 7.4) was supplemented with ascorbic acid 
(10 mM) as antioxidant to minimize the autocatalytic oxidation of the hydroquinone 
products by molecular oxygen. The buffer was prepared such that the optimal pH for P450 
was maintained and the activity of P450 was not negatively affected. This was demonstrated 
in a reference experiment in which the initial conversion rate of a fluorogenic P450 BM3 
substrate, 7-benzoxy-3-carboxy-coumarin ethyl ester (BCCE), was largely unchanged by the 
modified composition of the buffering solution (Fig. 39). 
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Figure 39. Conversion of 7-benzoxy-3-carboxy-coumarin ethyl ester (BCCE) by P450 BM3 M2 in 50 
mM phosphate buffer, pH 7.5 and in 50 mM phosphate buffer with 10 mM ascorbic acid, pH 7.5. 
 
8.1.2. P450-catalyzed production of hydroquinones from phenols as 
substrates 
The initial product formations and cofactor coupling efficiencies of the two investigated 
P450 variants with phenols were determined by measuring the initial NADPH-consumption 
rate of reactions with different substrates and relating the latter to the amount of product 
formed. Total turnover numbers for phenolic compounds were calculated from 24 h 
reactions employing 1 µM catalyst and 4 mM substrates. 
Table 5 summarizes the catalytic performance of P450 BM3 WT and variant M2 towards 
hydroxylation of the phenols. In general, the product profiles obtained from conversion of 
phenols was similar for both investigated P450 variants. The only enzymatically-derived 
products detected in the experiments with phenolic substrates were the respective 
hydroquinones (1,4-benzenediols). In long term conversions with cofactor regeneration 
system some benzoquinones (oxidized hydroquinones, not exceeding 2 - 4% of the total 
product) were also observed. The presence of side products which were formed due to 
susceptibility of hydroquinones to oxidation by molecular oxygen appeared to be influenced 
by the ring substituents (-H, -CH3, -OCH3, -Cl, -Br, or -I) on the phenolic substrates. 
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The catalytic performance of WT with phenolic substrates was generally low.  No NADPH 
depletion and product formation could be detected in the reactions with limited cofactor 
supply (200 µM). The yield from 4 mM phenolic substrate in 24 h reactions with 1 µM WT 
enzyme did not exceed 50% for any of the investigated substrates and was especially 
inefficient for the non-halogenated phenols. The WT enzyme did not hydroxylate guaiacol at 
all while only 1.7% and 8.8% substrate conversion in 24 h were obtained for phenol and o-
cresol, respectively. For halogenated substrates, the highest conversion (~50%) was achieved 
with 2-iodophenol as substrate and the lowest with 2-chlorophenol (18.8%). The conversion 
of 2-bromophenol (40.4%) was about twice as efficient in comparison to that of 2-
chlorophenol and comparable to than that of 2-iodophenol.  
Similarly for P450 BM3 WT, variant M2 exhibited higher reactivity towards halogenated 
phenols than to non-halogenated substrates; however, in relative terms, the overall 
performance of variant M2 was significantly improved. NADPH depletion and products 
formation under limiting cofactor supply could be monitored; therefore, cofactor coupling 
efficiencies and initial product formation rates could be determined with the P450 BM3 
mutant. The coupling efficiency of M2 lied between 39% (o-cresol, guaiacol) and ~70% (2-
iodophenol). The coupling was on average 10 % higher for the halogenated phenols than for 
non-halogenated substrates. The product formation rates and total turnover numbers of 
variant M2 were significantly improved in comparison to WT. The conversion of 4 mM 
halogenated phenols by variant M2 was 2-fold (for 2-bromo and 2-iodophenol) up to 5-fold 
(for 2-chlorophenol) higher. The conversion of non-halogenated phenols by the mutant was 
especially improved by a factor of 6 (for phenol conversion) or higher. Notably, in contrast to 
WT which did not catalyze the hydroxylation of guaiacol under the employed reaction 
conditions, variant M2 could produce up to 1.6 mM of dihydroxylated product with the same 
substrate. The highest yield was achieved for 2-iodophenol (~4 mM, 99% conversion). With 
3.6 mM and 3.8 mM of chlorohydroquinone and bromohydroquinone, respectively formed 
in 24 hours, variant M2 proved to be equally efficient catalyst for hydroxylation of 
halogenated phenols.  
 
 
CHAPTER II. Synthesis of Mono- and Di-hydroxy Benzenes using P450 BM3 Monoxygenase  
  P450 Project I - Results and Discussion 
 
133 
Table 5. Catalytic performance of P450 BM3 WT and variant M2 towards selected phenols.  
P450 BM3 
Variant 
Substrate N1 C [ %]2 PFR3 TTN4 
WT 
phenol 
n.d.a n.d.a n.d.a 68 ± 16 
M2 23.3 ± 2.6 n.d.a n.d.a 353 ± 62 
WT 
o-cresol 
n.d.a n.d.a n.d.a 121 ± 20 
M2 23.3 ± 1.8 38.6 ± 1.3 9.0 1875 ± 138 
WT 
guaiacol 
n.d.a n.d.a n.d.a n.d.a 
M2 20.5 ± 2.1 39.5 ± 4.4 8.1 1580 ± 411 
WT 
chlorophenol 
n.d.a n.d.a n.d.a 753 ± 97 
M2 60.8 ± 5.1 47.2 ± 3.0 28.7 3686 ± 219 
WT 
bromophenol 
n.d.a n.d.a n.d.a 1615 ± 327 
M2 107.9 ± 10.6 53.5 ± 4.2 57.7 3832 ± 366 
WT 
iodophenol 
39.1 ± 6.5 n.d.a n.d.a ca. 2000b 
M2 370.8 ± 25.9 ca. 70b ca. 260b ca. 4000b 
1 
N = NADPH turnover frequency [µmol NADPH µmol P450-1 min-1];  
2 
C [ %] = coupling efficiency [µmolproduct µmolNADPH
-1
]*100;  
3 
PFR = initial product formation rate [µmol product µmol P450
-1 
min
-1
]; 
4 
TTN = total turnover frequency [μmolproduct μmolP450
−1
 24 h
−1
]; 24 hour reactions using 1 µM enzyme and 4 µM 
substrate; 
a 
not detected; 
b 
estimated value calculated with a calibration curve for hydroquinone due to unavailability of commercial 
standard iodohydroquinone; 
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Figure 40. HPLC chromatograms after 24 h conversion of phenolic compounds to hydroquinones 
using P450 BM3 WT and variant M2. In the leftmost column chromatograms of negative control 
reactions (without enzymes) are shown; the middle column contains the chromatograms obtained 
with P450 BM3 WT; the rightmost column, the chromatograms with P450 BM3 M2. The large peak at 
ca. 2,3 and small peak at ca. 3 min are derived from reaction mix components (ascorbic acid and 
NADP+) which absorb light in the middle-UV range. Substrate (phenols) and product (hydroquinone) 
peaks are highlighted by light grey and black arrows, respectively. 
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8.1.3. One step synthesis of hydroquinones from monosubstituted benzenes 
The production of hydroquinones from benzenes by P450 BM3 WT and variant M2 was 
evaluated in long term conversions with cofactor regeneration system. The reactions were at 
first carried out for 24 h with 4 mM substrates and 1 µM enzyme. Fig. 41 summarizes the 
product concentrations measured only for the 2 main products produced by P450 BM3. The 
concentrations of o- and 1,4-dihydroxylated products are plotted while side products 
identified either as p-hydroxylated phenols (≤5% of the total product, in accordance with 
previous findings (Dennig et al., 2013)) are not included in the graph. P450 BM3 WT did not 
convert benzene and toluene at a detectable level and produced o-cresol (0.82 mM) from 
anisole as a sole product. The halogenated benzenes were converted by WT to both 
hydroxylated products and achieved nearly equal concentrations of each product (from 0.55 
to 0.8 mM). Variant M2 could hydroxylate all six substrates and generate both mono- and 
dihydroxylated products, the only exception being benzene for which only hydroquinone 
product (0.14 mM) was detected. The highest concentrations of hydroquinones (between 
1.3 and 2 mM) were achieved with halogenated benzenes as substrates, especially with 
bromo- and iodobenzenes. The latter were converted by variant M2 almost exclusively to 
dihydroxylated product. Halophenol could be detected in the samples with the chlorinated 
and brominated benzenes (0.44 mM and 0.1 mM, respectively) but not with iodobenzene. In 
constrast, the P450 mutant converted anisole mainly to the corresponding cresol (1.4 mM) 
and produced 0.5 mM methylhydroquinone. In the reactions with toluene about 0.5 mM of 
mono- and dihydroxylated was measured. 
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Figure 41. Product titers of the catalytic cascade [benzenes  corresponding phenols  
corresponding hydroquinone] generated by P450 BM3 WT (1 µM) or P450 BM3 M2 (1 µM) in 24-hour 
reactions (4 mM benzylic substrates, 2 vol% DMSO) and NADPH cofactor supplied via a cofactor 
regeneration system (60 mM glucose and 4 U glucose dehydrogenase). Light grey bars show the 
amount of phenols and hydroquinones generated from benzenes by P450 BM3 WT in one step 
reactions. Dark grey and black bar show the amount of phenols and hydroquinones generated from 
benzenes by P450 BM3 M2 in one step reactions. Hydroquinone oxidation products which accounted 
for less than 5% and p-hydroxylated phenols from benzenes which were produced in small amounts 
from iodobenzene (≤5%) are not included in the graph. Quantification was performed by HPLC in all 
reactions and product formation of iodohydroquinone is calculated using a calibration curve for 
benzohydroquinone. 
 
In a second set of experiments the product titers and product profile generated by P450 
BM3 M2 with 2 non-halogenated benzenes (toluene and anisole) and two halogenated 
benzenes (2-chlorobenzene and 2-bromobenzene) at a low (2 mM) and high (20 mM) 
substrate concentrations were assessed (Table 6). Halogenated benzenes were 
predominantly converted to the respective hydroquinone products irrespective of substrate 
load. The concentration of phenolic products was at least twice as low as that of 
hydroquinone. The increase of substrate concentration in the reaction maintained the 
product profile and did not lead to a significant change in titers with these substrates. The 
long term reactions with non-halogenated substrates rendered more phenolic product than 
dihydroxylated product. The increase of substrate concentration increased the product 
amounts of the reaction and changed the obtained product profiles with non-halogenated 
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substrates. In long term reactions with anisole as substrate, the predominantly formed 
product was the respective o-phenol (o-cresol) exceeding the concentration of 
hydroquinone (guaiacol) 2 to 4 times depending on the employed substrate concentration. 
The increased concentration of non-halogenated substrates increased the overall product 
titers ~8-fold. The substrate concentration in long term conversion of toluene affected the 
product concentrations (ca. 3-fold increase) and the product profile as well. At substrate 
concentration of 2 mM, o-cresol and methylhydroquinone were produced at nearly 
equimolar concentration; however, the increase of substrate to 20 mM shifted the ratio of 
products to 2:1 in favor of the phenolic compound.  
Table 6. Catalytic performance of P450 BM3 M2 at 2 different concentrations of benzenes (2 and 20 
mM) and NADPH cofactor provided by a cofactor regeneration system (60 mM glucose and 4 U 
glucose dehydrogenase). Co-solvent DMSO (2 vol%) was only used in the reactions with 2 mM but 
not in the reactions with substrate load of 20 mM. Products were quantified after 24 h conversion by 
GC (not HPLC) employing commercial standards for product identification. (data collected in a 
collaboration work; used with persmission from (Dennig, 2014). 
 
Substrate 
Substrate 
concentration  
(mM) 
Yield  
( %) 
Ph:HQu  
( %) 
Product 
concentration 
(g L-1 ) 
Toluene 
2 62 41:59 0.14 
20 21 69:31 0.47 
Anisole 
2 46 71:29 0.11 
20 33 81:19 0.83 
2-chlorobenzene 
2 65 18:82 0.15 
20 9 24:76 0.24 
2-bromobenzene 
2 54 24:76 0.26 
20 16 27:73 0.32 
Ph = o-phenol; HQu = hydroquinone;  
 
Time dependent conversion of toluene, anisole, chlorobenzene and bromobenzene was 
performed in order to monitor the switch in substrate preference from benzene to phenol 
for variant M2. In these reactions an increased substrate load of 20 mM was used .The 
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product profile is exemplified with toluene, anisole and chlorophenol as substrates (Fig.3) 
The conversion of toluene exhibited formation of two distinct products, o-cresol and 
methylhydroquinone (Fig 3 A). o-Cresol was predominantly formed within the first 4 hours 
reaching the maximum of 1.3 mM. After this time point the concentration of o-cresol 
decreased and remained steady at 0.65 mM until end of the reaction. The concentration of 
methylhydroquinone increased to around 1.3 mM in 24 h and remained constant until the 
end of the reaction. These product concentrations correspond to 0.07 g L-1 o-cresol and 0.16 
g L-1 methylhydroquinone. The observed product profiles are different that those measured 
by GC in 24 hour reactions and could be due to evaporation of the highly volatile benzylic 
substrate (toluene). 
 The time dependent product formation employing anisole as substrate revealed that in the 
first 8 h guaiacol is produced reaching a concentration of ca. 4 mM product (Fig. 3 B). After 8 
h reaction time enough guaiacol is produced so that variant M2 could start producing 
methoxyhydroquinone. The highest product concentration was reached after 24 h with 5.4 
mM guaiacol and 1.4 mM methoxyhydroquinone that corresponds to 0.67 g L-1 guaiacol and 
0.2 g L-1 methoxyhydroquinone.  
In the conversion of chlorobenzene, chlorohydroquinone was the predominantly formed 
product. A product ratio of 2:1 (hydroquinone to phenol) was observed after 48 h (Fig. 3B). 
The final product concentration after 24 h reached 0.55 mM 2-chlorophenol and 1 mM 
chlorohydroquinone. The concentration of chlorohydroquinone exceeded the amount of 2-
chlorophenol after only two hours reaction time. The formation of the respective 
chlorohydroquinone started after 1 h when the concentration of 2-chlorophenol was 0.23 
mM. After 48 h a product concentration of 0.22 g L-1 was obtained. Conversion of 2-
bromobenzene displayed a similar product formation profile to chlorobenzene, i.e., product 
ratios and concentrations for bromohydroquinone and 2-bromophenol. 
The total product concentrations obtained for variant M2 and 20 mM of the respective 
substrates showed the following order: anisole (6.8 mM) > toluene (2.1 mM) > 
bromobenzene (1.6 mM) > chlorobenzene (1.5 mM). The highest concentration for o-
phenols was obtained using anisole (5.4 mM) as substrate. In case of other substrates, the o-
phenolic product did not exceed concentrations of 0.7 mM.  
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A)   
B)  
C)  
D)  
 
Figure 42 Conversion of A) toluene, B) anisole, C) chlorobenzene and D) bromobenzene by P450 BM3 
M2 employing a cofactor regeneration system (60 mM glucose and 4 U glucose dehydrogenase). 
Time-dependent formation of phenols and hydroxyquinones are quantified by HPLC analysis over a 
period of 48 h. 1 µM P450 BM3 M2 with a substrate load of 20 mM without co-solvent (DMSO) was 
employed in all conversions.(data generated in collaboration work; used with permission from 
(Dennig, 2014). 
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8.1.4. Summary and conclusions: One step enzymatic synthesis of 
hydroquinones from benzenes 
To generate a deeper insight into the operational performance and synthetic potential of 
P450 BM3 WT and variant M2, parameters such as regioselectivity, total turnover, and 
product concentrations for a selection of phenolic substrates were investigated in this study. 
In addition, to access information on time dependent product formation and the effect on 
substrate selectivity, the catalytic performance of variant M2 with benzylic substrates was 
analyzed by monitoring the formation of phenol and hydroquinone for 48 h. The engineered 
P450 BM3 variant demonstrated higher product formations than WT for all tested 
substrates. This could be attributed to the increased coupling efficiency and initial activity 
compared to P450 BM3 WT for both phenolic compounds and benzylic substrates. Variant 
M2 was very efficient in hydroxylating halogenated phenols (chloro-, bromo- and 
iodophenol) to hydroquinones with selectivities exceeding 99% and conversions higher than 
90%. The conversion of non-halogenated phenols did not exceed 50% but was still 
performed with excellent regioselectivities.  The good conversion of halogenated phenols 
could be partially attributed to their better solubility in aqueous buffer. The long term (24 h) 
conversion of benzenes by the P450 BM3 M2 increased product concentrations up to 0.83 g 
L-1 and rendered different product profiles depending on the employed substrate 
(halogenated vs non-halogenated) and, in case of non-halogenated benzenes, depending on 
substrate concentration. Long term conversion of halogenated substrates with the P450 
mutant produced predominantly hydroquinones irrespective of the employed substrate 
load. However, the increase of substrate concentration did not lead to a significant increase 
of product formation and decreased yields. In addition, from the time-dependent product 
formation experiments, it was observed that most product formation took place within the 
first 12 h of reaction indicating inhibition effect of halogenated benzenes on the P450 
catalyst at high substrate load. In contrast, in case of non-halogenated substrates, the 
substrate load affected productivity and in case of toluene, the obtained product profile as 
well. In case non-halogenated substrates, the product concentrations significantly increased 
at high substrate concentrations but yields were negatively affected. The product profile in 
the case of toluene was shifted with the increase of substrate concentration. The 
predominant product formed at low concentration was benzohydroquinone; however 
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phenol formation was favored at 10-times higher substrate concentration. This, however, 
might be an artefact from the experimental design; samples were withdrawn from the same 
vessel multiple times and each opening likely lead to loss of toluene through evaporation. o-
Cresol was predominantly produced from anisole at low and high substrate load; the product 
ratios were not significantly affected. Some reasons for the observed substrate selectivity of 
variant M2 are the varying substrate concentrations, but also the pKa values and difference 
in electronegativity of the phenolic substituents.  
Comparison of chemical and biocatalytic production of mono- and di-hydroxylated aromatic 
compounds from benzenes shows that the process described in this study has several 
advantages over chemical synthesis (Table 7). Firstly, P450 BM3 M2-mediated synthesis 
minimizes the need for toxic chemicals. Chemical hydroxylation of benzenes requires large 
amounts of corrosive reactants (e.g., caustic soda, sulfuric acid, hydrochloric acid), metal 
catalysts (e.g., copper/iron catalyst) or strong oxidizing agents (e.g. H2O2, K2S2O8 and 
Ag3PO4). In P450 BM3-mediated synthesis organic co-solvent (e.g., 2% DMSO) can be added 
to the reaction mixtures in order to increase the substrate solubility. However, co-solvent 
addition was necessary only for crystalline substrates (i.e., phenolic substrates). Conversions 
of liquid substrates (i.e., benzylic compounds) at 20 mM substrates load (~2 g L-1) was 
performed in a solvent-free aqueous solution and rendered good overall product titers, e.g., 
with the poorly water-soluble anisole, 0.83 g L-1 total product was formed. Secondly, P450 
BM3-catalyzed phenolic hydroxylation is advantageous with regard to reaction conditions 
and energy efficiency. Individual steps of the chemical synthesis routes may require 
temperature control (cooling) or high temperature (up to 400 ˚C) and high pressure (up to 70 
bar). Monooxygenase hydroxylation of benzenes is performed under mild reaction 
conditions (room temperature, atmospheric pressure) which translate into significant energy 
cost reduction of the overall process. Thirdly, P450 BM3-mediated production of 
hydroquinone is carried out in a rigorous manner with excellent regioselectivity for mono- 
(≥95%) and di-hydroxylation (≥99%). Chemical synthesis of hydroquinones proceed with side 
product formation (1,2- and 1,3-dihydroxylated isomers). P450 BM3 produces exclusively 
1,4-benzenediols which subsequently simplifies downstream processing and reduces 
expenses and loses in separation of ortho- and para-isomers(Hudnall, 2000)(Krumenacker et 
al., 2000). Fourthly, since P450 BM3-catalyzed di-hydroxylation is a one step process, the 
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need to isolate reaction intermediates is eliminated and the whole process is intensified in 
comparison to classical syntheses routes.  In the fifth place, P450 BM3 is a promiscuous 
catalyst which as demonstrated in the present study generates mono- and di-hydroxylated 
products from a variety of monosubstituted benzenes. Chemical synthesis routes are 
applicable to a narrow set of substrates, e.g., hydroperoxidation of diisopropylbenzene can 
be applied solely to benzohydroquinone synthesis; halogenated hydroquinones are not 
synthesized from halogenated benzenes rather via halogenation of benzoquinone. 
In summary, the possibility to produce hydroquinones from benzene educts using P450 BM3 
allows a new and attractive route to building blocks for vitamins (tocopherols), antioxidants, 
pharmaceuticals and polymerization inhibitors (Netscher, 2007; Rappoport, 2004). P450 
BM3 M2 is an excellent catalyst for the one step double oxidation of mono-substituted 
aromatic hydrocarbons and offers opportunities to explore new synthetic routes to the 
production of 1,4-dihydroxylated products, especially of methyl-, chloro-, bromo- and 
iodohydroquinone. P450 BM3 M2 performs the double hydroxylation as single catalyst with 
an excellent regioselectivity. Thereby, the oxidation of benzenes rather than phenols 
becomes the rate limiting step in the one step synthesis of hydroquinones. Nevertheless, in 
order to bring this process to closer an industrial scale, productivity has to further be 
improved and whole cell cofactor regeneration systems have to be developed. 
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Table 7. Comparison of chemical and enzymatic processes for synthesis of phenols and 
hydroquinones 
 
                           
 
Name  
(commercial: 
Yes/No) 
Raw materials/ 
Catalyst 
Products  
(selectivity %) 
% Yield 
Raw 
materials/ 
Catalyst 
Products  
(selectivity %) 
% Yield 
Comments/ 
Reference 
Hock Process 
(Yes) 
Benzene, 
propylene, 
radical initiator, 
H2SO4, H3PO4, 
NaOH, 
temperature 
control, heat, 
pressure 
Phenol (14 %), 
acetone (8 %) 
5 % (on 
benzene) 
- - - 
Multi-step 
process; 
90% of 
world’s 
phenol 
production 
Ref. 
(Zakoshansky
, 2007) 
Direct conversion 
of benzene to 
phenol using VCl3 
in the two-phase 
system  
(No) 
Benzene, 
benznitrile, 
water, air, VCl3 
Phenol (98.1 %) 
3.6 % (on 
benzene) 
- - - 
Not suited 
for practical 
applications 
Ref. (Battistel 
et al., 2003) 
Direct oxidation 
of benzene using 
Pt/Al2O3/V(acac)3 
catalysts  
(No) 
Benzene, air, 
Pd/Al2O3/ 
V(acac)3 
catalyst, acetic 
acid, pressure 
Phenol ( 99 %) 
26 % (on 
benzene) 
- - - 
Ref. (Jiang et 
al., 2013) 
Direct 
hydroxylation of 
benzene using 
zeolites or acidic 
resins  
(No) 
Benzene, air, 
ethanol, water, 
Nafion/silica 
composites 
Phenol (56 %) 
4.6 % (on 
benzene) 
- - - 
Ref. (Laufer 
and 
Hoelderich, 
2002) 
Direct 
hydroxylation of 
benzene by the 
use of palladium 
membrane  
(No) 
Benzene, air, Pd 
surface, heat 
Phenol  
(80-90 %) 
2-16 % 
(on 
benzene) 
- - - 
Ref.  (Niwa et 
al., 2002) 
Direct 
hydroxylation of 
benzene with 
nitrous oxide and 
ZSM-5 zeolites 
(No) 
Benzene, air, 
N2O, ZSM-5 
zeolites, 
heat 
Phenol (98 %) 
26 % (on 
benzene) 
- - - 
Highly pure 
N2O needed; 
rapid catalyst 
deactivation 
Ref. (Ebner 
et al., 1999) 
Direct oxidation 
of benzene to 
phenol by 
hydrogen 
peroxide and 
redox-active 
metals 
(No) 
Benzene, air, 
H2O2, iron 
catalyst, 
Fe(II)complex, 
trifluoroacetic 
acid 
Phenol (97 %) 
8.6 % (on 
benzene) 
- - - 
Ref. (Bianchi 
et al., 2000) 
Direct 
hydroxylation of 
benzene by the 
use of titanium-
containing 
molecular sieves  
(No) 
Benzene, air, 
H2O2, 
titaniumsilicate 
catalyst (TS-1) 
Phenol (99 %) 
13.3 % 
(on 
benzene) 
- - - 
Ref. (Remias 
et al., 2003) 
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Direct oxidation 
of benzene to 
phenol by 
hydrogen 
peroxide and 
oxovanadium 
calatyst 
(No) 
Benzene, air, 
H2O2, 
oxovanadium 
Schiff base 
moieties/silica, 
acetonitrile 
Phenol ( 99 %) 
30.8 % 
(on 
benzene) 
- - - 
Ref. (Reddy 
et al., 1992) 
Hydroperoxida-
tion of 
diisopropylben-
zene 
(Yes) 
- - - 
Diisoopropyl 
benzene, 
radical 
initiator, 
H2SO4, H3PO4, 
NaOH, heat, 
temperature 
control 
Hydroquinone 
(94 %) 
62 % (on 
diisoo-
propyl 
benzene) 
Multi-step 
process; 
60 % of 
world’s 
hydroquinon
e production 
Ref. (Hudnall, 
2000) 
Electrochemical 
hydroxylation of 
aromatic 
substrates 
(No) 
- - - 
Phenol, acid, 
organic 
solvent, 
electric 
current 
Hydroquinone 
(70 %) 
Up to 34 % 
(on phenol) 
Ref. 
(Rautenbach, 
2007) 
Hydroxylation of 
phenol with 
hydrogen per- 
oxide using 
titanium-
containing 
molecular sieves 
(Yes) 
- - - 
Phenol, H2O2, 
TS-1 catalyst 
Hydroquinone 
(up to 50 %) 
92 % (on 
phenol) 
Ref. (Perego 
et al., 2001) 
Gas phase 
oxidation of 
phenol in gas 
phase with 
nitrous oxide and 
ZSM-5 zeolites 
(No) 
- - - 
Benzene, N2O, 
ZSM-5 
zeolites, 
heat 
Hydroqionone 
(up to 90 %) 
76 % (on 
N2O) 
Ref. (Ivanov 
et al., 2002) 
Aromatic 
peroxygenase 
(APO) mediated 
synthesis 
(No) 
Benzene, H2O2, 
AaeAPO 
Phenol (n.r.) n.r. 
Phenol, H2O2, 
AaeAPO 
Hydroquinone 
(n.r.), catechol 
(n.r.), resorcinol 
(n.r.), 
trihydroxy 
benzene (n.r.), 
n.r. 
Ref. (Karich 
et al., 2013)  
Mixed microbial 
and chemical 
synthesis of 
hydroquinone 
(No) 
- - - 
Glucose. E. 
coli QP1.1, 
K2S2O8, 
Ag3PO4, 
(NH4)2Ce(SO4)3 
Hydroquinone 
(99 %) 
 
51 % (on 
glucose) 
Multi-step 
process  
Ref. (Ran et 
al., 2001) 
P450 BM3 M2 
catalyzed 
hydroxylation of 
non-halogenated 
benzenes 
(No) 
Benzene, 
NADPH, P450 
BM3 M2 
Phenol (99 %) -  
Phenol, 
NADPH, P450 
BM3 M2 
Hydroquinone 
(99  %) 
Up to 33 % 
(on 
benzene) 
Up to 46 % 
(on phenol) 
This study 
P450 BM3 M2 
catalyzed 
hydroxylation of 
halogenated 
benzenes 
(No) 
Haolgenated 
benzene, 
NADPH, P450 
BM3 M2 
Phenol  
(95 – 99 %) 
- 
Halogenated 
phenol, 
NADPH, P450 
BM3 M2 
Hydroquinone 
(99 %) 
Up to 50 % 
(on 
benzene) 
Up to 99 % 
(on phenol) 
This study 
n.r. = not reported 
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8.2. P450 project II: Improving the rate of P450-mediated whole cell 
biotransformations by co-expressing a passive diffusion channel in the outer 
membrane of E. coli 
This section outlines I) the generation of genetic construct for co-expression of P450 BM3 
M2 and FhuA Δ1-160, II)  the conversion of the model substrate BCCE  and III) the whole cell 
conversion of toluene and anisole with cells expressing either P450 BM3 or cells co-
expressng a channel protein in their outer membrane.  
8.2.1. Generation of genetic constructs and pilot expressions 
A simple synthetic operon was constructed for the simultaneous transcription of genes 
encoding P450 BM3 M2 and FhuA Δ1-160 whereas the gene that encodes FhuA Δ1-160 
protein also contained an outer membrane targeting sequence. The genes were placed 
under the control of a T7 promoter so that a single polycistronic mRNA molecule containing 
two native E. coli ribosome binding sites in front of each gene was transcribed. This 
construct was assembled into an expression vector (pALXtreme-1a) using a 
phosphorothioate ligase independent cloning, PLICing, and introduced into E. coli BL21 Gold 
(DE3) lacIq1 cells in preparation for preliminary expression studies. The design of the genetic 
constructs is shown in Fig. 43. E. coli transformed with pALXtreme-1a harboring solely the 
P450 gene or no insert were available from a previous study (Dennig et al., 2012) and used 
as controls in the follow-up experiments.  
Pilot expression studies were carried out using the optimized expression conditions for P450 
BM3 resulting in similar wet cell weight at the end of fermentation (~0.02 g mL-1 growth 
after 18 h cultivation at 30 °C) and comparable expression level of P450 BM3. Images of the 
protein gel and cell pellets after expression are presented in Fig. 44 A. In the total protein 
extract of the co-expressing E. coli strain an additional band corresponding to the molecular 
weight of FhuA Δ1-160 could be observed (not present in empty vector control sample). The 
measurement by CO-binding assay of specific P450 concentration in normalized (to OD) cell 
suspensions of both recombinant strains confirmed that P450 could be expressed in soluble 
form. The concentration of catalyst in the co-expressing strain was not severely 
compromised due to the production of a second recombinant protein. Specific 
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concentrations of 6.75 and 9.35 µM were measured in normalized cell suspension (OD600 of 
40), for the strain co-expressing FhuA Δ1-160 and the one producing solely P450, 
respectively (Fig. 44 B). The expression quality and quantity of both proteins were viewed as 
adequate and, therefore used throughout the rest of this study without further optimization 
of expression conditions. 
 
A)  
 
B)          
Figure 43. A) Schematic of the genetic constructs employed in this study. The genetic construct from 
which only P450 BM3 is produced is shown on top. Below, the construct from which simultaneous 
production of P450 BM3 and FhuA Δ1-160 is achieved is below. The expression from both construct 
is controlled by an inducible T7 promote; in the case of the latter genetic construct, the two co-
expressed genes are separated solely by an additional ribosome binding site (RBS); B) Exemplery 
agarose gels of the PCR products for PLICing and the final genetic construct verification after isolation 
from an E. coli host. 
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A)         
 
 B)                                           
Figure 44. Verification of protein expression. A) SDS-PAGE of whole cells with expressed P450 BM3 or 
co-expressed P450 BM3 and FhuA Δ1-160; recombinantly expressed proteins are marked with an 
arrow (lane EV – cells harboring pALXtreme-1a empty vector; lane I – cells harboring pALXtreme-1a 
P450 BM3 M2; lane II – cells harboring pALXtreme-1a P450 BM3 M2 + FhuA Δ1-160; expected 
protein sizes – ~120 kDA for P450 BM3 M2 and ~55 kDA for FhuA Δ1-160). The picture on the right 
shows the wet cell pellets from 50 mL culture obtained after harvesting of E. coli transformed with 
pALXtreme-1a P450 BM3 M2 (I) and pALXtreme-1a P450 BM3 M2 + FhuA Δ1-160 (II); B) Graphical 
representation of the specific P450 concentration of normalized cell suspensions (OD600 of 40) of E. 
coli transformed with pALXtreme-1a P450 BM3 M2 and pALXtreme-1a P450 BM3 M2 + FhuA Δ1-160 
measured by CO - binding assay (Omura and Sato, 1964). 
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8.2.2. Whole cell biotransformation of 7-benzoxy-3-carboxy-coumarin ethyl 
ester (BCCE) – a model fluorogenic substrate for P450 BM3 
In a proof-of-principle experiment, the fluorogenic 7-benzoxy-3-carboxy-coumarin ethyl 
ester (BCCE, Ex. 400 Em. 440), was used as substrate with whole cell suspensions of 3 E. coli 
strains – one harboring an empty vector (negative control), another expressing P450 BM3 
and a third co-expressing P450 and FhuA Δ1-160. The initial rate of BCCE conversion with cell 
suspensions normalized to small differences in the optical density as well as specific P450 
BM3 concentration was 4.1-fold higher for the strain expressing the channel protein 
compared to the E. coli strain containing only the P450 catalyst (Fig. 44A).  
In order to evaluate the effect of BCCE and the co-solvent used (DMSO) in this assay on cells’ 
membrane integrity, a flow-cytometry analysis of 10 000 events from the two cell types was 
performed (Fig. 45B). The light scattered upon passage of individual cells through the laser 
beam of a flow cytometer gives information about cell’s dimensions (forward scatter, FSC) 
and complexity/ smoothness of the cell’s membrane (side scatter, SSC) and the plots of cells 
distributions across FSC vs SSC plot can be used to monitor changes in physical appearance 
of the cell population. Cells incubated with permeabilizer (Polymixin B) and untreated cells 
served as positive and negative control for the determination of the region (gate) in the FSC 
vs SSC histogram corresponding to intact cells and cells with compromised integrity. This 
analysis showed that under the reaction conditions employed in the BCCE assay (1 µM 
substrate, 2% DMSO, 20 min incubation), the cell populations remained largely unaffected; a 
population shift less than 1% outside the gated region was observed for either of the tested 
cell types (Fig. 45 B). Taken together, these findings suggested that the increased rate of 
BCCE hydroxylation is due to an increased mass transfer of substrate across the cell wall due 
to the presence of the large passive diffusion channel in the outer membrane of E. coli. 
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   A)              
B)              
Figure 45. A) Initial conversion rates of 7-benzoxy-3-carboxy-coumarin ethyl ester (BCCE) with whole 
cells with empty vector and recombinantly expressed P450 BM3 M2 or co-expressed P450 BM3 M2 
and FhuA Δ1-160; B) Analysis of populations of E. coli cells (10 000 events) harboring P450 BM3 and 
co-expressed P450 BM3 M2 and FhuA Δ1-160. Before analysis OD-normalized cell suspensions were 
either left untreated or were incubated with permeabilizer (60 µM Polymixin B) or BCCE substrate in 
DMSO (1 µM BCCE, 2% DMSO) for 20 min prior to population analysis. Gate P1 was selected 
according to the appearance the population of untreated E. coli cells harboring solely P450. The 
fraction (in %) of the outlying population is shown for each strain type and treatment method.
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8.2.3. Long term biotransformation of toluene and cresol with whole cells 
expressing P450 BM3 M2 or co-expressing P450 BM3 M2 and FhuA Δ1-160 
Whole cell biocatalysis of two monosubstituted benzenes (toluene and anisole) was 
attempted as a second validation step of the proposed concept. The reactions were 
performed with resting cells over a 72-hour period.  Glucose was added to the reaction 
mixes to ensure co-factor regeneration (NAD(P)H), necessary for P450-mediated phenolic 
hydroxylation of the selected substrates. Substrate concentration of ~1 g L-1 (0,1% (v/v)) and 
2% DMSO were used so that no major disturbances in the membrane integrity are caused 
due to the presence of organic compounds. When toluene was employed as substrate, a 
total of 1.6 mM of o-cresol (2-methyl phenol) was formed by the E. coli strain co-expressing 
FhuA Δ1-160 in 48 hours (Fig. 46 A). Interesting, most of the product was formed in the time 
interval between 24 and 48 hours. Cell expressing solely the P450 catalyst produced 6 times 
less o-cresol, most of it formed in the first 24 hour of biotransformation. A similar trend was 
observed in case of whole cell biotransformation of the more polar monosubstituted 
benzene, anisole. E. coli co-expressing FhuA Δ1-160 produced 2.6 mM guaiacol (2-methoxy 
phenol) over 48 hours with ~75% of the product being generated in the period between 24 
and 48 hours (Fig 46 B). This accounted for 10 times higher product formed compared to the 
reaction carried out with E. coli without the outer membrane protein. Side product 
formation (p-hydroxylated products) with either substrate accounted for less than 5% of the 
total products formed (not shown) and did not affect the reported trend. Production of 
hydroquinones was surprisingly not detected in these experiments although this could be 
assumed from conversion with purified enzyme. This is possibly attributable to the analytical 
method and thermal program settings used in the study (GC vs HPLC in the study described 
in section 3.1). Nevertheless, monitoring of only first product formed in the catalytic reaction 
still provides strong indications about the influence of the channel protein on the whole cell 
bioconversion of benzenes. 
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A)    
B)     
Figure 46. Formation of A) o-cresol from toluene and B) guaiacol from anisole in whole cell catalysis 
with E. coli expressing P450 BM3 and co-expressing P450 BM3 and FhuA Δ1-160. Samples were 
collected over 72 hour period and specific product formation was quantified by gas chromatography. 
The sharp increase in product concentrations between 24 and 48 h was a reproducible result; 
however, the reasons for this were not investigated in detail and remain unclear. 
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8.2.4. Summary and conclusions: Improving the rate of P450-mediated whole 
cell biotransformations by co-expressing a passive diffusion channel in the 
outer membrane of E. coli 
The barrier formed by the outer membrane of gram-negative bacteria is a primary reason for 
the suboptimal productivity of whole-cell processes. In this study, an improvement of the 
mass transfer across the outer membrane of E. coli was realized by recombinant co-
expression of an outer membrane mutant protein, FhuA Δ1-160, which forms a passive 
diffusion channel in the outer membrane of E. coli. This approach was applied to P450-
catalyzed conversion a fluorogenic coumarin substrate (BCCE) and 2 monosubstituted 
benzenes (toluene and anisole). Our data indicated that the heterologous co-expression of 
FhuA Δ1-160 has a beneficial effect on whole cell conversion of the coumarin substrate BCCE 
and the monosubstituted benzenes - anisole and toluene. The whole cell conversion of BCCE 
was improved 4.1-fold for E. coli co-expressing FhuA Δ1-160 and P450 BM3 in comparison to 
cells containing solely the P450 catalyst. In addition, ~10-fold relative increase of phenolic 
product formation was observed in a 48-hour long biotransformation with cells co-
expressing FhuA Δ1-160 and P450 BM3 M2 (R47S/Y51W/I401M), a variant engineered for 
regiospecific, aromatic hydroxylation (Dennig et al., 2012, 2013).  
The membrane modification was achieved via a genetic construct carried on a plasmid 
vector. The plasmid-borne nature of the artificial operon allows for easy genetic 
manipulation (e.g., gene exchange) and straightforward transfer to any E. coli strain of 
interest by a simple transformation. This is important as the presented approach might be 
relevant to whole cell biocatalytic processes in general as the permeability change effected 
by the presence of a big diffusion channel is possibly of global nature. 
The observed improvements were not at the expense of severely compromising the growth 
and expression level of the strain co-expressing the channel protein. Nevertheless, the 
marked relative increase in product formation with the engineered whole-cell catalyst 
suggests that the outer membrane is likely significantly altered by the presence of the 
protein forming a diffusion channel. Yet, cells co-expressing FhuA Δ1-160 yielded nearly as 
much wet cell weight and as high P450 concentration as the strain without membrane 
modifications, despite that these cells harbored a genetic construct of larger size from which 
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two individual genes were produced. Still, the cells co-expressing a membrane component 
were able to nearly completely compensate for the membrane defects that can potentially 
interfere with the proton motif force across the semi-permeable outer membrane and 
compromise the cell’s integrity. In addition, the small difference in growth and yield of 
catalyst caused by the expression of FhuA Δ1-160 seemed to pose little obstacle in the 
biocatalytic process, especially taking into account that the gain in product amounts in 48 h 
was generally substantial for the investigated substrates – toluene, anisole and BCCE. The 
means by which cells manage to cope with this extra burden remain unclear. The elucidation 
of this rescuing mechanism can help to better explain the different performance of the 
strains in the biotransformation process as well. 
The observed relative increase in productivity with whole-cells suggests that the 
modification of cellular membrane composition and mass transfer barrier properties through 
co-expression of a channel protein could be after further optimization a general approach 
for whole cell biocatalysis. The relative gain in performance of the whole cell catalysis due to 
the presence of an outer membrane channel appears to be a general trend, however we 
cannot rule out the dependency of mass transfer on the molecular features of the substrate 
molecules To investigate further the relation between permeability and substrate structure, 
the presented approach should be tested with substrates of systematically varied size, 
hydrophobicity, and ionic charges. Finding a correlation between mass transfer across the 
modified outer membrane and the molecular features of substrates will provide further 
information for rationalizing the experimental data. It can be expected that the properties of 
the employed substrate as well as substrate concentrations to certainly cause a difference in 
the mass transport rates across the modified outer membrane of E. coli. As a final remark, 
the relative gains in performance of the whole cell catalysis due to the presence of an outer 
membrane channel are possibly of global nature, and may provides a general platform for 
alleviating the issue of limited mass transfer in whole cell biocatalysis. 
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FURTHER SCIENTIFIC CONTRIBUTIONS  
1) “Lessons from diversity of directed evolution experiments by an analysis of 3,000 
mutations” 
 
Jing Zhao, Tsvetan Kardashliev, Anna Joëlle Ruff, Marco Bocola and Ulrich Schwaneberg 
Accepted in Biotechnology and Bioengineering 
 
Diversity generation by random mutagenesis is often the first key step in directed evolution 
experiments and screening of 1,000–2,000 clones is in most directed evolution campaigns 
sufficient to identify improved variants. For experimentalists important questions such as 
how many positions are mutated in the targeted gene and what amino acid substitutions can 
be expected after screening of 1,000–2,000 clones are surprisingly not answered by a 
statistical analysis of mutant libraries. Therefore three random mutagenesis experiments 
(epPCR with a low- and a high-mutation frequency and a transversion-enriched sequence 
saturation mutagenesis method named SeSaM-Tv P/P) were performed on the lipase BSLA 
and in total 3,000 mutations were analyzed to determine the diversity in random 
mutagenesis libraries employed in directed evolution experiments. The active fraction of the 
population ranged from 15% (epPCR-high), to 52% (SeSaM-Tv P/P), and 55% (epPCR-low) 
which correlates well with the average number of amino acid substitutions per protein (4.1, 
1.6 and 1.1). In the epPCR libraries transitions were the predominant mutations (>72%), and 
>82% of all mutations occurred at A- or T-nts. Consecutive nucleotide (nt) mutations were 
obtained only with a low fraction (2.8%) under highly error-prone conditions. SeSaM-Tv P/P 
was enriched in transversions (43%; >1.7-fold more than epPCR libraries), and consecutive nt 
mutations (30.5%; 11-fold more than epPCR-high). A high fraction of wild-type BSLA protein 
(33%) was found in the epPCR-low mutant library compared to 2% in epPCR-high and 13% in 
SeSaM-Tv P/P. An average of 1.8–1.9 amino acid substitutions per residue was obtained with 
epPCR-low and -high compared to 2.1 via SeSaM-Tv P/P. The chemical composition of the 
amino acid substitutions differed, however, significantly from the two epPCR methods to 
SeSaM-Tv P/P. 
 
 
2) “A competitive flow cytometry screening system for arginine-metabolizing enzymes 
under physiological conditions with suitability in cancer treatment” 
 
Feng Cheng, Tsvetan Kardashliev, Christian Pitzler, Aamir Shehzad, Hongqi Lue, Jürgen 
Bernhagen, Leilei Zhu, Ulrich Schwaneberg 
Accepted in ACS Synthetic Biology  
 
A ligand-mediated gfp-expression system (LiMEx) was developed as a novel flow cytometry 
screening platform that relies on a competitive conversion/binding of arginine between 
arginine deiminase and ArgR. In contrast to standard product-driven detection systems, the 
competitive screening platform allows to evolve enzymes to efficiently operate at low 
substrate concentrations under physiological conditions. The principle of this competitive 
screening system was validated using the example of the anti-tumor therapeutic arginine 
deiminase. 
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FINAL SUMMARY AND CONCLUSIVE REMARKS 
This doctoral thesis addressed three fundamental questions from the related fields of 
protein engineering and biocatalysis: 1) advancing methods for diversity generation in 
directed protein evolution, 2) establishing biocatalytic processes for oxy-functionalization of 
generally unreactive aromatic C-H bonds and 3) postulating a strategy for improving the 
mass transfer in whole cell biocatalysis.  
In CHAPTER I, the challenge of diversity generation in protein engineering has been tackled 
by addressing the remaining bottleneck of a highly advanced random mutagenesis method, 
the Sequence Saturation Mutagenesis (SeSaM) method. Improvement of SeSaM’s 
mutational spectrum was accomplished by increasing the frequency of consecutive 
transversion nucleotide substitutions in SeSaM libraries. To achieve this, a DNA polymerase 
was engineering for more efficient transversion mismatch elongation; polymerases with 
such capabilities are essential in SeSaM step 3. For the purposes of the engineering 
campaign, a novel screening system for directed evolution of DNA polymerases employing a 
fluorescent Scorpion probe as a reporter was developed. The screening system was 
validated in a directed evolution experiment of a distributive polymerase from the Y-
polymerase family (Dpo4 from Sulfolobus solfataricus) which was improved in elongation 
efficiency of consecutive mismatches. The engineering campaign yielded improved Dpo4 
polymerase variants and identified previously unreported mutational hotspots that can 
modulate the translesion DNA synthesis capabilities of Dpo4, notably V32, R242, R247, R336. 
One of the identified mutants (Dpo4 R336N) was successfully benchmarked in a Sequence 
Saturation Mutagenesis experiment especially with regard to the desirable consecutive 
transversion mutations (2.5-fold increase in frequency relative to a reference library 
prepared with Dpo4 WT). The Scorpion probe screening system enabled to re-engineer 
polymerases with low processivity and fidelity, and no secondary activities (i.e. exonuclease 
activity or strand displacement activity) to match demands in diversity generation for 
directed protein evolution. In addition, the identified Dpo4 mutant with its current 
performance was already a significant advancement in subsequent transversion generation 
and especially for the SeSaM random mutagenesis method to complement the mutational 
spectrum of epPCR based methods.  
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In CHAPTER II of this thesis, P450 BM3 monooxygenase was studied in the context of 
regioselective biotransformations of benzenes with isolated enzyme (P450 Project I) and as a 
whole cell catalyst (P450 Project II). In P450 Project I, the one step synthesis of 
hydroquinones from benzene derivatives was performed with the monooxygenase P450 
BM3 (CYP102A1) as a sole catalyst. The catalytic conversion of six aromatic hydrocarbons 
(toluene, anisole, chlorobenzene, bromobenzene, iodobenzene) to the corresponding o-
phenols (o-cresol, guaiacol, 2-chlorophenol, 2-bromophenol, 2-iodophenol, respectively) by 
the P450 BM3 variant M2 (R47S/Y51W/I401M) was reported to proceed with high 
regioselectivity (o-hydroxylation ≥95 %). Furthermore, P450 BM3 M2 could catalyze the 
hydroxylation of mono-hydroxylated benzenes to di-hydroxylated products with high 
regioselectivity (>99 %) and halogenated phenols were converted with high catalytic 
activities (28.7 up to ~260 nmolproductnmolp450
-1min-1) and yields >90 %. Hydroxylation of non-
halogenated phenols was performed with catalytic activity of up to 9 nmolproductnmolp450
-
1min-1 and yields ≤50 %. One step double hydroxylation of the aforementioned benzenes to 
hydroquinones was performed at prolonged conversion times (24 h; 4 mM substrate; 1 µM 
P450 BM3 M2). Halohydroquinones were the predominant products formed (~1.5 mM up to 
~2 mM) from halogenated benzenes and especially the conversion of iodobenzene yielded 
only 2-iodo-1,4-benzediol. A mixture of o-phenols and hydroquinones was generated from 
toluene and anisole as substrates; in case of toluene nearly equimolar concentrations of 
mono- and di-hydroxylated products were obtained (~0.5 mM each). For anisole, the 
concentration of o-phenol (~1.5 mM) was approximately 3 times higher than that of the 
respective hydroquinone. Finally, under non-optimized reaction conditions, total product 
concentrations between 0.24 up to 0.83 g L-1 were obtained in one step syntheses. These 
results indicate that P450 BM3 M2-catalyzed hydroxylations offer alternative routes for 
semi-preparative scale synthesis of phenols and hydroquinones from the corresponding 
benzenes. This biosynthetic route provides significant advantages over chemical synthesis 
methods in terms of reduction of toxic chemical use, mild reaction conditions and energy 
efficiency, process intensification (one step process), regioselectivity, promiscuity and 
reaction yields (espectially for halogenated substrates). 
In P450 project II, an improvement of the mass transfer across the outer membrane of E. coli 
was achieved by recombinant co-expression of an outer membrane mutant protein, FhuA 
Δ1-160, which forms a passive diffusion channel in the outer membrane of E. coli. This 
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approach was applied to P450 BM3-catalyzed conversions due to the cofactor dependency 
of this enzyme.  A fluorogenic coumarin substrate (BCCE) and 2 monosubstituted benzenes 
(toluene and anisole) were tested with the aforementioned setup. The recorded data 
indicated that the heterologous co-expression of FhuA Δ1-160 was beneficial for increasing 
product titers in whole cell catalysis of the coumarin substrate BCCE and both investigated 
monosubstituted benzenes. The whole cell conversion of BCCE was 4.1-fold higher for E. coli 
co-expressing FhuA Δ1-160 and P450 BM3 in relation to cells containing solely the P450 BM3 
enzyme. In addition, ~10-fold relative increase of phenolic product formation was observed 
in a 48-hour long biotransformation with cells co-expressing FhuA Δ160 and P450 BM3 M2 
(R47S/Y51W/I401M), a variant engineered for regiospecific, aromatic hydroxylation (Dennig 
et al., 2012, 2013). The relative gains in performance of the whole cell catalysis due to the 
presence of an outer membrane channel appeared to be of global nature, and possibily 
provides a general platform for alleviating the issue of limited mass transfer in whole cell 
biocatalysis. 
As a final point, the scientific contributions made during my PhD studies include: 
 Identification, expression and preliminary characterization of 3 putative polymerase 
gene; 
 Development of Scorpion probe-based screening system for directed evolution of DNA 
polymerases and engineering of DNA polymerase towards improved efficiency of 
mismatch elongation; 
 Advancement of the Sequence Saturation Mutagenesis (SeSaM) protocol; 
 Development of an one step biosynthetic route to regioselective mono- and di-
hydroxylation of monosubstituted benzenes;  
 Development of a concept for improving the mass transfer in whole cell biocatalysis; 
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pmol  Picomoles 
qPCR  Quantitative Polymerase Chain Reaction 
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Figure 47. Vector maps of Y-family polymerase genes from Metallosphaera sedula DSM 5348 (mse) 
and Pictophilus torridus DSM 9790 (pto), Thermoanaerobacter pseudethanolicus ATCC 33223 (tps) 
and Dpo4 from Sulfolobus sulfataricus (sso) cloned in pET28a vector 
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Figure 48. Vector maps of Y-family polymerase genes from Metallosphaera sedula DSM 5348 (mse) 
and Pictophilus torridus DSM 9790 (pto), Thermoanaerobacter pseudethanolicus ATCC 33223 (tps) 
and Dpo4 from Sulfolobus sulfataricus (sso) cloned in pALXtreme-1a vector. 
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Figure 49. Vector maps of Y-family polymerase genes from Metallosphaera sedula DSM 5348 (mse) 
and Pictophilus torridus DSM 9790 (pto), Thermoanaerobacter pseudethanolicus ATCC 33223 (tps) 
and Dpo4 from Sulfolobus sulfataricus (sso) cloned in pBADN vector. 
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Figure 50. Vector maps of the genetic constructs used in P450 projects I and II. The gene encoding 
P450 BM3 was cloned in pALXtreme-1a vector as a standalone gene and used in both P450 projects. 
A pALXtreme-1a harboring a simple synthetic operon comprising of P450 BM3 and FhuAΔ1-160 was 
generated and used in P450 Project II. 
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